Metabolic engineering of acid formation in Clostridium acetobutylicum by Kuit, W.
Metabolic Engineering of
Acid Formation in
Clostridium acetobutylicum
Wouter Kuit
Thesis committee
Promotor
Prof. dr. G. Eggink
Professor of Industrial Biotechnology
Wageningen University
Co-promotor
Dr. A.M. Lo´pez-Contreras
Senior scientist at Food and Biobased Research
Wageningen University
Other members
Prof. dr. ir. V.A.P. Martins dos Santos, Wageningen University
Prof. dr. N.P. Minton, University of Nottingham, England
Dr. H. Stam, DSM Food Specialties, Delft
Dr. R.A. Weusthuis, Wageningen University
This research was conducted under the auspices of the Graduate School VLAG
(Advanced studies in Food Technology, Agrobiotechnology, Nutrition and Health
Sciences).
Metabolic Engineering of
Acid Formation in
Clostridium acetobutylicum
Wouter Kuit
Thesis
submitted in fulfilment of the requirements for the degree of doctor
at Wageningen University
by the authority of the Rector Magnificus
Prof. dr. M.J. Kropff,
in the presence of the
Thesis Committee appointed by the Academic Board
to be defended in public
on Monday 7 January 2013
at 4 p.m. in the Aula.
Wouter Kuit
Metabolic Engineering of Acid Formation in Clostridium acetobutylicum,
182 pages.
PhD thesis, Wageningen University, Wageningen, NL (2013)
With references, with summaries in Dutch and English
ISBN 978–94–6173–446–4
For my family

Contents
1 General Introduction 1
1.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Fossil Resources . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.3 Resource Limitations . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.4 Additional Drivers for Fossil Fuel Replacement . . . . . . . . . . . 3
1.5 Traditional Transport Fuels . . . . . . . . . . . . . . . . . . . . . . 4
1.6 Biofuels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
1.7 Butanol as Biofuel . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.8 The ABE-Fermentation . . . . . . . . . . . . . . . . . . . . . . . . 11
1.9 Metabolic Engineering of Clostridia . . . . . . . . . . . . . . . . . . 19
1.10 New Genetic Tools for Clostridia . . . . . . . . . . . . . . . . . . . 19
1.11 Metabolic Engineering Targets . . . . . . . . . . . . . . . . . . . . 23
1.12 Alternative Butanol Production Hosts . . . . . . . . . . . . . . . . 29
1.13 Project Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
1.14 Outline of This Thesis . . . . . . . . . . . . . . . . . . . . . . . . . 31
2 Molecular Biology Methods for Clostridium acetobutylicum 33
Part 1:
A Method for Storing Electro-Competent
C. acetobutylicum Cells . . . . . . . . . . . . . . . . . . . . . . . . 33
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Note . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
Part 2:
Development of a Mobile Group II Intron-
Based Gene Knock-Out Method for Clostridia . . . . . . . . . . . . 37
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.2 Material and Methods . . . . . . . . . . . . . . . . . . . . . . . . . 40
2.3 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . 43
2.4 Conclusions and Recommendations . . . . . . . . . . . . . . . . . . 48
vii
Contents
3 Disruption of the Acetate Kinase (ack) Gene of Clostridium
acetobutylicum Results in Delayed Acetate Production 51
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . 53
3.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
3.5 Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
4 Fermentation Analysis of a Novel Clostridium acetobutylicum
buk1– Mutant and C. acetobutylicum buk1– ack– Double Mutant 75
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
4.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . 78
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
4.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
4.5 Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
5 d-2,3-Butanediol Production Due to Heterologous Expression of
an Acetoin Reductase in Clostridium acetobutylicum 103
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
5.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . 105
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 113
5.5 Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
6 General discussion and conclusions 121
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
6.2 Premiss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
6.3 Biological butanol production . . . . . . . . . . . . . . . . . . . . . 122
6.4 Non-native butanol production hosts . . . . . . . . . . . . . . . . . 125
6.5 Metabolic engineering of Clostridium acetobutylicum . . . . . . . . 128
6.6 Butanol stress . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
6.7 Recommendations . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
6.8 Concluding remarks . . . . . . . . . . . . . . . . . . . . . . . . . . 135
References 137
Summary 161
Samenvatting 165
Acknowledgements 171
viii
Contents
Curriculum Vitae 175
List of Publications 177
Overview of Completed Training Activities 181
ix
Parts of this chapter have been published in two book chapters:
I. Ana M. Lo´pez-Contreras, Wouter Kuit, Marco A. J. Siemerink, Serve´ W. M. Kengen,
Jan Springer and Pieternel A. M. Claassen; “Production of longer-chain alcohols from bio-
mass — butanol, iso-propanol and 2,3-butanediol”, In: Bioalcohol production: Biochem-
ical conversion of lignocellulosic biomass; Editor Keith Waldron, Woodhead Publishing, 2010,
ISBN 978–1–84569–510–1, DOI: 10.1533/9781845699611; and
II. Ana M. Lo´pez-Contreras, Wouter Kuit, Jan Springer and Pieternel A. M. Claassen; “Novel
Strategies for Production of Medium and High Chain Length Alcohols”, In: Microbial Tech-
nologies in Advanced Biofuels Production; Editor Patrick C. Hallenbeck, Springer US, 2012,
ISBN: 978–1–4614–1208–3, DOI: 10.1007/978–1–4614–1208–3 11.
1 
Chapter 1
General Introduction
1.1 Introduction
The work described in this thesis focuses on improving a known renewableprocess for the production of n-butanol through fermentation of sugars bythe bacterium Clostridium acetobutylicum. Butanol has applications as afeedstock for the chemical industry and as a transport biofuel. This chapter
will first provide a background on fossil resources, on renewable alternatives, and
the on reasons for developing these. This is then followed by an introduction to
the fermentative production of butanol, an inventory of genetic methods that can
be applied to improve the process, and an overview is given of mutants described
in the scientific literature. The chapter concludes with the proposed research
plan and listing of the thesis outline.
1.2 Fossil Resources
In this day and age virtually everyone is affected, directly and indirectly, by
the use of fossil resources for almost every aspect of their life. For example,
we use natural gas to cook our food and to heat our houses, coal for electricity
generation in power plants, and we use oil as a source for transport fuels and a
chemical feedstock for various industries. These industries in turn produce very
diverse products, ranging from toothpaste to plastic shopping bags.
1.3 Resource Limitations
1.3.1 Finite Resources
A resource is a source or supply from which benefit is produced. Whenever a
resource is consumed at a rate higher than at which it is created, the possibility of
1
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future shortages arises and the resource is rendered non-renewable. The fact that
a resource is finite if the consumption rate exceeds the formation rate, regardless if
it is coal, whale oil,1 or wood, means that a society must keep its consumption rate
below the formation rate, if it wants to use that resource on a renewable basis.
Prominent resources that are used in a non-renewable way include (tropical)
forests, fishing grounds, and fossil fuels, e.g. coal, natural gas, and petroleum.
1.3.2 Petroleum Supply
According to the biogenic oil formation theory, a petroleum deposit is cre-
ated over a period of millions of years.2,3 The current rate at which mankind is
consuming these deposits, years to decades, renders petroleum a non-renewable
resource.4 Already in 1956, M. K. Hubbert, an American geologist, proposed a
model for the extrapolation of a production curve from a finite resource into the
future.5 The model assumes that production levels start at zero, and return to
zero when the resource has been exhausted. In between these, the production
curve passes through one or several maxima. Although the shape of each produc-
tion curve may vary, its integral is limited by the maximum recoverable amount
of that particular resource.6 The maximum amount that can be recovered is in-
fluenced by several factors, including technological and economical ones, and in
most cases will be less than the total amount that is available. When Hubbert
applied the model to oil production, a graph as plotted in Figure 1.1 was obtained.
Initially there was very little production, but as oil became accepted as a useful
energy carrier, and a resource for the production of chemicals, demand increased
and so did production. This was expected to increase further until a maximum
production rate is reached, a point referred to as peak oil. At this point the
production rate cannot increase any further as it is limited by the discovery rate
of new oil reserves, technology, economics, and other factors.4 After this peak,
or plateau, production rate levels will decrease until all reserves are depleted,
at least from an economical perspective. The most recent predictions of the
International Energy Agency (IEA) assert that peak oil has already occurred at
presently discovered fields.7 Peak oil can of course be delayed by more quickly
taking recently discovered fields into production and utilising unconventional oil
sources (such as tar sand and heavy oils), but this only postpones the inevitable
shortage of this non-renewable resource.
1.3.3 Petroleum Demand
The increasing demand for fossil fuels is exacerbating the situation. The
increase stems from a growing world population living at increasingly higher
levels of economic welfare, which results in increased petroleum usage per capita.
The major share of this increase is taken up by the upcoming economies China
and India, although the United States of America (U.S.A.) are still expected to
be the second largest consumer of oil by 2035.7
2
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Figure 1.1: Peak oil graph (redrafted from Hubbert5) Black, cumulative production;
dark grey, proven reserves; light grey, future discoveries; bbls, oil barrels.
The inherently finite nature of petroleum, the decrease in supply, and increase
in demand has resulted in a search for alternatives for our current petroleum
based society. Besides these reasons to endeavour on a search for alternatives,
also other arguments exist that call for replacement of petroleum, as discussed
in the next section.
1.4 Additional Drivers for Fossil Fuel
Replacement
1.4.1 Global Warming
Although there is still some controversy if anthropogenic heating, i.e. global
warming caused by human activity, actually occurs,8–11 governmental policies
have been changed in response to the reports of the Intergovernmental Panel on
Climate Change (IPCC) which has been reporting on the issue since its establish-
ment in 1988. It has been put forward that the release of several gasses, amongst
which are CO2, CH4, and N2O, in the atmosphere results in the so-called green-
house effect i.e. part of the infra-red radiation that would normally escape into
space is absorbed by the greenhouse gasses (GHG) and results in an increase in
the temperature in the upper layers of the atmosphere. It is of interest to note
that water, as a gas, is one of the largest contributors to the greenhouse effect,
3
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especially due to its abundance. Its very nature however precludes its taxation
as a GHG despite its large share towards global warming (36–66 %) compared to
CO2 (9–26 %).12 It has been argued that the greenhouse impact of water is less
than that of carbon dioxide, because its residence time in the upper atmosphere
is much shorter than that of the latter, rendering it a feedback, rather than a for-
cing, component.13 However, the influence of clouds on the earth’s annual global
mean energy budget is however still not fully understood.
In response to the perceived dangers of global warming, most governments
have signed and ratified the Kyoto Protocol. Signees of the protocol strive to cut
back on the emission of greenhouse gasses to below the levels of 1990.14 One way
of reducing net CO2 emissions is by using carbon based energy sources that have
only recently taken up CO2 from the atmosphere, such as plant biomass.
1.4.2 Energy Security
Energy security is divined to exist “if the energy sector does not cause (major)
welfare-reducing frictions in the economy at national and global levels”.15 The
majority of all oil barrels produced at the moment originates from countries
which are considered to be economically and politically unstable regions, like
Iraq, Venezuela, and Nigeria.16 The increasing demand for oil and gas further
increases the dependence of America, Europe, and Asia on imports from the
Middle East and other unstable regions. It has been recognised by the EU,17 the
U.S.A.,16 and others that this dependency should be reduced by identifying and
exploiting alternative sources of energy.
1.5 Traditional Transport Fuels
According to OECD‡-International Energy Agency data, a large part of to-
day’s total energy consumption of the U.S.A. and Europe, met by the use of fossil
fuels, is used for transportation purposes. In 2005, transport accounted for 29 %
of EU energy consumption while this figure was with 41 % even higher for the
U.S.A.18
Petrol and diesel are the two main fuel types for cars, trucks, and other trans-
portation vehicles at the moment, and their characteristics are shown in Table 1.1.
The current resource from which these fuels are derived is oil. The reasons to
develop alternatives for fossil fuels listed in the previous section, combined with
the expected increase in the use of oil-derived products by the transport sec-
tor, have resulted in a world-wide search for alternative energy sources for the
transport sector. Important parameters to compare these various alternatives
by are their energy-content-to-weight and energy-content-to-volume ratios (see
Figure 1.2). These parameters give an indication for the transportability of the
energy source. For example, hydrogen gas at standard pressure and temperature,
‡Organisation for Economic Co-operation and Development
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although very light, is not a very useful alternative as you would require a vast
volume of it to be able to travel any reasonable distance. By compressing the
gas, the volume is reduced and the energy-content-to-volume ratio is increased
(at the expense of the energy needed to compress it).
Table 1.1: Comparison between the composition of carbohydrate-rich biomass and
petroleum-based fuelsa
Property Petrol Gasoil/
Diesel
Jet fuel Carbohydrate
Carbon chain 5–10 12–20 8–16 [5–6]n
O/C molar ratio 0 0 0 1
H/C molar ratio 1–2 ∼2 1.9 2
Phase behaviour
[at ambient T ]
liquid liquid liquid solid
Polarity non polar non polar non polar polar
Preferred structure branched/
aromatic/
cyclic/
unsaturated
linear/
saturated
linear/
branched/
aromatic/
cyclic
linear/cyclic
a Data taken from Petrus and Noordermeer,19 Lee et al.,20 and Edwards.21
The high energy-content-to-weight ratio of liquid fuels compared to other al-
ternatives such as batteries for use with electric cars, or the use of compressed
hydrogen gas, to drive transport vehicles, makes liquid fuels still the most desir-
able energy carrier at the moment22 although this has been contested by others
based on the fact that electric cars are more efficient in conversion of stored
energy to kinetic energy.23,24 However, considering the fact that our current in-
frastructure is built around these liquid fuels it is likely that alternatives will have
to be compatible with the existing approach, or at least in a transition phase.
Renewable (liquid) fuels, commonly referred to as biofuels, and their production,
will be discussed in the next sections.
1.6 Biofuels
Biofuels are energy carriers whose energy has been stored by means of bio-
logical carbon fixation over a — from a geological perspective — short period
of time (up to a few decades), or that have been derived from such material.
This definition excludes petroleum which builds up over much longer periods,
but includes for example hydrogen gas produced by fermentation of sugars. Bio-
fuels can be very diverse and range from gasses (e.g. hydrogen and methane),
to liquids (e.g. ethanol, butanol, or fatty acid methyl esters [FAMEs]), to solids
5
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Figure 1.2: Volumetric versus mass energy density of glucose, various fermentation
products, liquid fuels and gasses. HHV, higher heating value; * indicates
value for gas compressed at 200 bar. Adapted from K. J. J. Steinbusch,25
with permission. Additional data from Fischer et al.23
(e.g. wood). The most prominent biofuels are bio-ethanol and bio-diesel, both of
which are currently produced at large scale.
Subsidies and regulatory requirements have created a market for the produc-
tion and use of these compounds as fuel additives. In 2009 the EU adopted a
directive that 10 % of all transport fuel should be renewable by 2020.26 Also
the U.S.A., in 2007, put regulation in place requiring an aggregate of 36 billion
gallons ethanol equivalents (136 × 109 L), made from renewables, to be used in
transport fuels by 2022.27 Many other countries implemented similar measures.28
These measures have resulted in a large increase in biofuel production. In 2008,
the U.S.A. was the world’s largest producer of bio-ethanol (33.7 × 109 L) fol-
lowed by Brazil (24.3× 109 L), whereas bio-diesel production is concentrated in
Europe (9.2× 109 L), with Germany as the main producer, the U.S.A. is second
(3.1×109 L).28,29 Worldwide, bio-ethanol production almost quadrupled between
2000 and 2008 from 16 940 to 65 690 million litres, while bio-diesel production
increased by more than 18 times from 797 to 14 574 million litres.28
1.6.1 First Generation Biofuels
Currently the majority of these biofuels are so-called ‘first generation’ biofuels,
meaning that they are derived from easily accessible and digestible sugar sources
6
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such as starch (from corn and wheat) and sucrose (from sugar cane and sugar
beet) in the case of bio-ethanol, and from oils from pressed plant seeds in the
case of bio-diesel.30 There is increasing awareness that the large-scale cultivation
of crops for the production of these first generation biofuels is associated with
sustainability and environmental issues, something they were intended to rem-
edy.31 In 2006, 20 % of the total U.S.A. corn supply was allocated to fuel ethanol
production.32 Biofuels have therefore, in part, been blamed for the increasing
food prices between 2003 and 2008,33–37 although this has also been disputed29
based on the observation that between 2007 and 2009 many basic food commod-
ity prices have significantly declined without there being any reduction in biofuel
production.
Besides criticisms for the increased linkages between the food and energy sec-
tors, life-cycle analysis (LCA) studies of first generation biofuels have highlighted
a negative net contribution in GHG emission reduction for specific types of feed-
stock crops and processing techniques. Results of LCA studies show quite some
divergence, however, corn (starch) based ethanol consistently showed the most
harmful LCA profile.28
1.6.2 Second Generation Biofuels
Certain drawbacks of first generation biofuels that are based on starch, sucrose
or vegetable oils, can be countered by using lignocellulosic biomass as a feedstock
for the production of so called ‘second generation’ biofuels.29 The advantage of
using lignocellulose is that it cannot be used for human consumption and there-
fore does not directly compete with food production. Lignocellulosic biomass
can be derived from agricultural by-products such as corn stover, wheat straw,
and rice straw, residuals that now have hardly any economic value. By using
these resources, synergy is created between food production (starch component)
and the remaining plant parts (lignocellulose). But also dedicated, so-called ‘en-
ergy crops’ can serve as a source, provided that their production does not affect
food crop land use. Energy crops include for example perennial grasses, such as
Miscanthus giganteus38 and Panicum virgatum (switchgrass),39 which have low
subsistence requirements and can be grown on marginal lands that are unsuitable
for food crop cultivation. In addition, wood and related materials from sustain-
ably managed forests can be used, as well as organic waste streams for municipal
or industrial sources.40 Use of these second generation substrates does require
extensive pre-treatment by mechanical, chemical, and/or enzymatic methods, in
order to release the sugars from the lignocellulosic matrix so that they are avail-
able for fermentation.
The nomenclature is sometimes extended to third (or even fourth41) gener-
ation biofuels, but this is less well-established. ‘Third generation’ is sometimes
used to refer to examples of biofuels produced using a consolidated bioprocessing
approach (i.e. the biomass pre-treatment step is combined with the fermentation
step resulting in combined sugar release and fermentation),42 or to refer to the
7
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use of algae that produce oils that can be harvested for direct use as a biofuel
without the need for a fermentation process.43
1.7 Butanol as Biofuel
Biofuel is a term to describe various, often very different, compounds that are
used to store energy. Ethanol is currently the most widely produced biofuel, but
this popularity is mostly a reflection of the ease with which it can be produced
rather than its properties as a fuel replacement. The linear, four carbon long
alcohol n-butanol can also be produced by fermentation. The different physical
properties of butanol compared to ethanol (see Table 1.2 and Table 1.3), make
it a superior fuel replacement. Its advantages over ethanol include: (i) a higher
energy density (see Figure 1.2); hence more kilometres per unit of mass of fuel,
(ii) a lower vapour pressure; resulting in lower tail pipe emissions in the lower
blending range (0–25 %),44 (iii) a less corrosive nature; consequently transport is
possible using existing infrastructure, as opposed to ethanol, (iv) a lower water
solubility; therefore reduced hygroscopicity of the resulting fuel blend and better
miscibility with the fuel, and (v) the fact that cars do not require modification
of their engines to use mixed butanol petrol or even pure butanol as a fuel,45–47
where this is not the case for fuel containing more than 10 % ethanol.48,49 The
possibility to use pure butanol as a motor fuel has been shown by David Ramey
from ButylFuel LLC (now part of Green Biologics Ltd.), during two long car trips
in the U.S.A. in 2005 and 2007 (www.butanol.com, accessed 13 January 2009),
thus building the case for the use of higher alcohols as a ‘drop in’ fuel replacement.
The research in this thesis is therefore focused on renewable butanol production,
or derivatives thereof such as 2,3-butanediol.
1.7.1 Butanol Production from Petroleum
Currently, the majority of n-butanol is produced by petrochemical synthesis
for use in the chemical industry. The three most important processes are oxo-
synthesis, Reppe synthesis, and crotonaldehyde hydrogenation.50 In the oxo-
synthesis (hydroformylation) process, carbon monoxide and hydrogen are added
to the carbon–carbon double bond of propene using catalysts such as cobalt-
, rhodium-, or ruthenium-substituted hydrocarbonyls. The resulting aldehyde
mixtures obtained in the first reaction step are then hydrogenated to produc-
tion butanol. The isomeric ratios in which the resulting butanol is produced
can be controlled by reaction conditions such as pressure and temperature, as
well as by the choice of catalyst. The Reppe process also starts from propane
and carbon monoxide but uses water instead of hydrogen. The Reppe process
directly produces butanol at low temperature and pressure. The third route for
butanol synthesis shows similarities with the biological production route (subsec-
tion 1.8.2, page 12) and starts from acetaldehyde (an activated C2 compound just
8
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like acetyl-CoA), followed by an aldol condensation, a dehydration, and finally a
hydrogenation to yield butanol.
Butanol is used in a wide range of industrial applications, including the pro-
duction of butyl acrylate, used in the manufacturing of, e.g. polymeric coatings,
adhesives, elastomers and plastics; and butyl methacrylate, used in resins, dental
products, as an oil additive and in the leather and paper industry. Other products
derived from butanol are butyl glycol, used mainly as an industrial solvent, butyl
acetate, used in paints and a flavouring agent in the food industry, butylam-
ine,e.g. used in the production of thiocarbazides and butylbenzenesulfonamide,
used as plasticizer in nylon.45 Its annual production has been estimated to be
between 3.1 – 5.4×109 kg52,53 and since its market expansion is projected at 3 %
per year,50 bio-butanol could also be interesting for these applications, provided
that the process is economically competitive.
Table 1.3: Properties of alcohols as fuels compared to petrol.a
Compound Heat of Heat of Energy RONb MONb
combustion vaporisation density
(ΔcH°) [kJ/mol] (ΔvapHm°) [kJ/mol] [MJ/kg]
Petrol 4817c 36 43.5 95 85
Methanol 726 37 22.7 133 99
Ethanol 1368 42 29.7 130 96
iso-Propanol 2006 45 33.4 121 96
n-Butanol 2670 51 36.0 113 94
2-Butanol 2661 42 35.9
2,3-Butanediol 2461 67 27.3
a Data from NIST54 and others.46,55,56
b Abbreviations: RON, Research octane number; MON, Motor octane number;
Both are octane rating numbers related to the performance of a liquid in a
combustion engine.
c Data for heptane.
1.7.2 History of Biological Butanol Production
Although now a petrochemical product, during the first part of the 20th cen-
tury, butanol was produced by bacterial species of the genus Clostridium at an
industrial scale by fermentation of sugars (molasses) or starch, via the acetone-
butanol-ethanol (ABE) process.57,58 Butanol is one of the longest linear alcohols,
together with 2,3-butanediol, that is a natural, major end-product of microbial
fermentation. Microbial production of butanol was reported for the first time by
Louis Pasteur in 1862, long before the production of acetone in 1905.59 Initially,
the ABE process was mainly operated for the production of acetone, rather than
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butanol, as there was a huge demand for it during World War I for the produc-
tion of cordite, a family of smokeless propellants used in weapons to replace gun
powder.57
The fermentative production of acetone was pioneered by Chaim Weizmann,
a Jewish Russian organic chemist working in England. He isolated a bacterial
strain from the species Clostridium acetobutylicum, now termed the Weizmann-
strain, which could grow on starch and produce acetone with high yield. During
the First World War, access to acetone became of great military importance
and Weizmann assisted the war effort by overseeing the implementation of his
process to produce it.§ Despite the success of the process, the increasing price
of the substrates (starch or molasses) made it increasingly difficult to compete
with the upcoming petrochemical processes, and from 1960 onwards fermentative
production of acetone and butanol had essentially stopped in the U.S.A. and
Great Britain. Several countries continued to operate the process for various
reasons, including South Africa (up to 1981),57 the U.S.S.R.,60 and China (until
the mid-1990s).61 The increasing substrate price combined with cheaply available
oil ultimately led to the downfall of the process, but increases of the oil price have
rekindled interest in the process after the oil crises of 1973 and 1979. From 2007
onwards, fermentative butanol production has once again commenced in China58
and Brazil,62 and pilot-scale production is undertaken in, amongst others, the
U.S.A. and Great Britain.
1.8 The ABE-Fermentation
1.8.1 Solvent Producing Bacteria
The best butanol-producing (also referred to as solventogenic) microorgan-
isms known to date are all bacterial strains belonging to the Clostridium genus
and have been classifieds into four species: (i) Clostridium acetobutylicum (type
strain ATCC 824); (ii) C. beijerinckii (type strain NCIMB 9362); (iii) C. sac-
charobutylicum (type strain NCP 262); and (iv) C. saccharoperbutylacetonicum
(type strain ATCC 27021).63–66 Clostridia are anaerobic, endospore forming,
gram positive, rod shaped bacteria. All known solventogenic clostridia contain
DNA with a low GC-ratio and are mesophilic. The toxicity of butanol increases
with temperature and it is likely that the fact that they are mesophilic is re-
lated to that. Fermentations by these organisms result in either production of
acetone, butanol, and ethanol (ABE fermentations) or in some cases acetone is
further reduced to iso-propanol resulting in an IBE fermentation (by e.g. C. beij-
erinckii NRRL B-593 and LMD 84.48). The Clostridium acetobutylicum strain
ATCC 824 is the most extensively studied solventogenic bacterium. The strain
was isolated from Connecticut garden soil in 192464 and was selected to be the
C. acetobutylicum type strain. In this strain, most of the genes involved in solvent
§He later became the first president of the state of Israel in 1949.
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production are located on a megaplasmid of 210 kb (pSOL1). The loss of this
megaplasmid results in asporogenous strains unable to make solvents67 which are
normally produced in a 3:6:1 ratio (A:B:E). The whole genome of C. acetobutyli-
cum ATCC 824 has been sequenced and is publicly available,68 as is the genome
of C. beijerinckii NCIMB 8052.69 The genomes of two other C. acetobutylicum
strains are also publically available: DSM 173170 and EA 2018.71 In addition
to the genome sequences, microarrays are available for C. acetobutylicum71–73
and C. beijerinckii,74 and both stoichiometric and kinetic metabolic models have
been published for C. acetobutylicum,75–80 C. saccharoperbutylacetonicum,81,82
and C. beijerinckii.83
A characteristic of most, if not all, of these strains which negatively affects
the stability of the cultures is their gradual loss of solvent production when they
are kept in a vegetative stage for long periods of time (i.e. during repeated
transfers or long periods of continuous cultivation), a phenomenon known as ‘de-
generation’.57 In addition to their lack of solvent production, degenerated strains
show different morphological and physiological characteristics compared to the
parent strain; larger and translucent colonies with irregular shapes,84 a longer or
thinner cell shape and a characteristic infrared spectrum.85 The loss of solvent
production seems to be linked to the loss of the ability to sporulate, since several
asporogenous degenerated mutants have been isolated during prolonged continu-
ous cultures.84,86 However, a solvent-producing asporogenous mutant has been
described, and used in the development of a continuous ABE-process.87 As earlier
mentioned, the loss of the pSOL1 plasmid in C. acetobutylicum ATCC 824 res-
ults in degenerated strains,67 but in other solvent-producing strains, a different
mechanism for degeneration is expected, since they do not contain such a plasmid
and the genes involved in solvent production are still present in the degenerated
mutant.88,89 Recently, a cell density-dependent regulatory mechanism (quorum
sensing) has been proposed to be involved in the degeneration of strain C. sac-
charoperbutylacetonicum N1-4, since solvent production in a degenerated mutant
could be restored after the addition to the cultivation medium of concentrated
broth extract from a wild-type fermentation.89
In addition to the four solventogenic species mentioned previously, several less
well-known butanol producers are also described. C. pasteurianum, a classic acid
fermenter, is capable of ABE-solvent production under certain conditions,90,91
and so is C. aurantibutyricum.92 Also C. tetanomorphum93 has been reported
to produce butanol and ethanol, but no acetone or iso-propanol.94 In addition,
species such as C. sporogenes and C. cadaveris produce minor amounts of n-
butanol, but acetone and iso-propanol are not detectable.92
1.8.2 Metabolism
A typical ABE batch fermentation by C. acetobutylicum goes through two
phases: (i) a growth-associated phase during which the acids acetate and butyr-
ate are formed, called the acidogenic phase; and (ii) a stationary phase during
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which part of the acids are taken up and the solvents butanol, acetone, and eth-
anol are formed, termed the solventogenic phase. Common to both phases are
the biochemical pathways leading from carbohydrates to acetyl-CoA (Figure 1.3).
Hexose sugars are metabolised via the Embden-Meyerhof-Parnas pathway result-
ing in 2 moles of pyruvate per 1 mole of hexose, with the net production of 2 moles
of ATP and 2 moles of NADH. The organism also seems to have the possibil-
ity to produce NADPH instead of NADH during conversion of glyceraldehyde-
3-phosphate at the expense of 1 ATP when using the EMP pathway.95,96 The
utilisation of pentoses takes place via the pentose phosphate pathway (Warburg-
Dickens pathway) of which only the non-oxidative part is functional.97,98 The pyr-
uvate resulting from glycolysis is cleaved by pyruvate ferredoxin oxidoreductase
in the presence of coenzyme A to yield CO2, acetyl-CoA and reduced ferredoxin.
In the proposed mechanism of PFOR, pyruvate is decarboxylated to first form
the hydroxyethyl-thiamine pyrophosphate intermediate (TPP) which then reacts
with coenzyme A (CoA) to produce acetyl-CoA. Recent metabolic tracer ana-
lysis suggest that the carboxylic group in pyruvate interchanges rapidly with
CO2, although the overall PFOR reaction is essentially irreversible.98 Reduced
ferredoxin can be oxidised by the reduction of protons to molecular hydrogen by
the hydrogenase enzyme. Acetyl-CoA is the central intermediate in the branched
fermentation pathways leading to both acid and solvent production.
Acidogenic Phase
During the acidogenic phase, sugars are typically metabolised to acetate, bu-
tyrate, carbon dioxide and molecular hydrogen. The enzymes involved in this
stage in the acetate and butyrate producing pathways are phosphate acetyltrans-
ferase (Pta), acetate kinase (Ack), butyryltransferase (Ptb), and butyrate kinase
(Buk1), respectively. In both pathways additional ATP is generated in the last
substrate level phosphorylation reaction. Butyryl-CoA is produced by coupling
two acetyl-CoA molecules catalysed by thiolase (ThlA), resulting in acetoacetyl-
CoA. This is subsequently reduced to β-hydroxybutryl-CoA using NADH by the
enzyme 3-hydroxybutyryl-CoA dehydrogenase (Hbd), followed by a dehydration
by crotonase (Crt) to crotonyl-CoA. The double bond of crotonyl-CoA can be re-
duced by butyryl-CoA dehydrogenase (Bcd) using NADH via two electron trans-
fer flavoproteins, EtfA and EtfB. Recently it has been shown in C. kluyveri that
this very exergonic reaction actually uses 2 NADH equivalents.99 The reducing
power that is not used for reduction of crotonyl-CoA is used to generate reduced
ferredoxin, resulting in NADH mediated hydrogen production.
Solventogenic Phase
During this first phase, the short chain fatty acids acetate and butyrate accu-
mulate in the extracellular medium, thereby lowering the pH. After some time,
what has been called the ‘solventogenic switch’ or ‘metabolic switch’ occurs,
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which triggers the organisms in taking up the previously produced acetate and bu-
tyrate, and converting them to solvents, combined with continued glucose utilisa-
tion and carbondioxide and hydrogen release. Several solvent pathways genes are
now expressed and the enzyme complex acetoacetyl-CoA:acetate/butyrate:CoA
transferase (CtfAB) and the enzyme acetoacetate decarboxylase (Adc) now en-
able the activation of excreted acids to their corresponding CoA intermediates
with concomitant acetone production. In addition to this pathway, the butyrate
pathway is inverted and used to take up butyrate from the medium by expression
of the butyrate kinase 2 (Buk2) enzyme. Although the acetate concentration in
the medium drops, there is evidence that the acetate pathway remains active to
generate ATP, but the acetate production rate is lower than the acetone medi-
ated uptake route.76 An interesting observation is that metabolite measurements
indicate that there is rapid interchange between extracellular and intracellular
acetate, and that the aceate formation pathway is highly reversible.101 Next to
acetone formation, aldehyde and alcohol dehydrogenases such as AdhE, BdhA,
and BdhB (sometimes referred to as Aad, Bdh I, and Bdh II respectively) are
expressed and reduce acetyl-CoA and butyryl-CoA to ethanol and butanol, re-
spectively. Under certain so-called alcohologenic conditions, AdhE2 is expressed,
resulting in solventogenesis without acetone formation.
Initiation of solvent formation requires a low pH, threshold concentrations of
acetate and butyrate, and a suitable growth limiting factor such as phosphate or
sulphate,102,103 Solvent formation appears to be associated with the availability
of ATP and NADP(H)104 and can be controlled, in continuous culture, by vary-
ing the pH in the bioreactor.105 If the transition does not occur and the culture
continues to produce acids, then the culture is said to undergo an ‘acid crash’.106
During the transition of an acid-forming culture to a solvent-forming one, a num-
ber of observations can be made. The pH stabilises due to termination of net acid
Figure 1.3 (following page): Biochemical pathways in C. acetobutylicum and C. beij-
erinckii.57,99,100 Substrate (glucose) and fermentation products are shown in boldface.
Enzymes catalysing the different reactions are indicated by abbreviation of their name:
Ldh, lactate dehydrogenase; Als, acetolactate synthase; Ald, acetolactate decarboxylase;
PFOR, pyruvate-ferredoxin oxidoreductase; HydA, hydrogenase; Pta, phosphate acet-
yltransferase (phosphotransacetylase); Ack, acetate kinase; ThlA, thiolase; Hbd, 3-
hydroxybutyryl-CoA dehydrogenase; Crt, crotonase; Bcd, butyryl-CoA dehydrogenase;
Ptb, phosphate butyryltransferase (phosphotransbutyrylase); Buk1, Buk2, butyrate
kinase 1 and 2, respectively; AdhE, AdhE2, aldehyde-alcohol dehydrogenase 1 and
2, respectively; BdhA, BdhB, butanol dehydrogenase A and B, respectively; CtfAB,
acetoacetyl-CoA:acetate/butyrate:CoA transferase subunits A and B; Adc, acetoacetate
decarboxylase; Adh, primary and secondary alcohol dehydrogenase (in C. beijerinckii
NRRL B593). Other abbreviations: CoA, coenzyme A; EMP, Embden-Meyerhof-Parnas
pathway; Etf, electron transfer flavoprotein; Fd, ferredoxin; NAD(P)+ Nicotinamide ad-
enine dinucleotide (phosphate), oxidised; NAD(P)H Nicotinamide adenine dinucleotide
(phosphate), reduced; Pi, phosphate.
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production, cells no longer divide and undergo major physiological changes. The
vegetative cells are highly motile, thin, and rod-shaped but subsequently change
into swollen, phase-bright, cigar-shaped cells when the transition to solventogen-
esis is initiated.107,108 The cells accumulate granulose, which is an amylopectin-
like storage polymer, possibly supplying the cells with carbon and energy during
sporulation.109 The cells lose their motility and produce an extracellular capsule.
This stage is normally followed by the initiation of endospore formation, which
involves the production of a fore-spore septum at one or both poles of the cell,
followed by endospore production and finally cell lysis, resulting in the release of
the mature spore. Spores provide the organism with a possibility to withstand
unfavourable conditions such as oxygen exposure, heat, desiccation, and toxic
chemicals, but make it metabolically inactive.
The solventogenic phase can be seen as a response of the organism to the
decreasing pH to a level where it would no longer be able to grow. By taking up
the produced acids from the medium and converting them to neutral solvents,
the organism can continue to generate ATP by fermenting glucose. This allows it
time to form an endospore that can survive the adverse conditions by the accu-
mulated acids and solvents. Hence solventogenesis and sporulation are expected
to the intimately linked,110 with the former ultimately resulting in the latter and
thus termination of growth. It should be noted, however, that actively growing
solventogenic cultures do exist, for example in continuous culture fermentations,
which has an actively dividing solvent forming culture.111,112 Recently, Tracy et
al., based on fluorescence-assisted cell sorting (FACS) data, suggested that not
the cells with the typical swollen shape are the solvent-forming cells but rather
that solvent formation is carried out by normally dividing cells. These vegetative
cells are predominately responsible for butanol production, and are likely to be
a precursor to clostridial-form cells.113
1.8.3 Drawbacks and Possible Improvements
There is significant industrial interest in the ABE process as a green process
for the production of butanol to be used as chemical or as fuel, being the BP-
Dupont joint venture Butamax (www.butamax.com) one of the most developed
initiatives. As it occurs with other fermentation processes for the production of
alcohols and chemicals from biomass resources, improvements are necessary in
order to make these economically viable, including substrate costs and availabil-
ity, diluted product streams and the presence of multiple fermentation products
which makes the separation very costly (see Table 1.4). One of the most import-
ant bottlenecks to be solved in the ABE process is the separation of the solvent
products, which are present at low concentration, from the fermentation broth
in an energetically and economically efficient manner.114
The substrate costs of a conventional ABE plant using corn starch would
make up to 79 % of the overall operating costs of the process.115 It is therefore
essential that alternative, cheap and renewable substrates are found. As put for-
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Table 1.4: Key issues associated with the ABE-process57,115–118
Area Issue Possible solution
Substrate Substrate cost (starch, molasses) Use of alternative (ligno-cellulosic)
feedstocksCompetition with food production
Process Product inhibition levels around
2 % butanol
Develop more resistant microbes or
use other production hosts
Apply in situ product removal
Mixed fermentation products
(acids, hydrogen)
Develop microbes which produce a
reduced number of by-products
Batch process operation Strains selected for use in a con-tinuous fermentation process
Improved process conditions
Low substrate to product
conversion efficiency
Improved microbes with higher
butanol yields and/or higher
butanol to other solvents ratios
Phage infections Isolate phage resistant strains
Product recovery Product isolation from dilute
water streams
Low energy methods for solvent re-
covery and purification
The fermentation process
produced large volumes of
eﬄuent, which required the
development of specific processes
for handling, treatment, and
processing
Recycling of process water back
through the fermentation
ward in subsection 1.6.2, lignocellulose is a prime target for this. Lignocellulose
is composed of cellulose, hemicellulose, and lignin. Both cellulose and hemicellu-
lose are sugar polymers, whereas lignin consists of hydrophobic, aromatic groups.
Plants use lignocellulose for their structural integrity and have therefore evolved
to resist degradation from outside sources. In turn, organisms that can grow on
lignocellulosic plant material have found ways to degrade it. Anaerobic cellu-
lolytic microorganisms have developed dedicated large enzyme complexes called
cellulosomes,119 while some aerobic living microorganisms secrete synergistically
acting individual endoglucanases, exoglucanases, and ancillary enzymes to attack
plant cell walls.120 Unfortunately, C. acetobutylicum ATCC 824 cannot degrade
crystalline cellulose, even though the genome encodes eleven proteins identified
as cellulosomal components, ten of which are organised in an operon like cluster
(ca c0910 to ca c0919) with a gene order similar to that of C. cellulolyticum and
C. cellulovorans.116,121 Although solventogenic strains are not cellulolytic, they
are able to utilise all sugars (C5, C6) present is cellulosic biomass, which rep-
resents an important advantage compared to other organisms, such as current
industrial yeasts for ethanol production. In addition, clostridial species are able
to degrade and utilise poly- and oligosaccharides from (hemi) cellulose,122,123 and
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this may result in the need of less stringent methods for biomass pre-treatment
and hydrolysis compared to those for other processes. An alternative strategy
would be the change the butanol production host, use co-cultivation, or through
heterologous expression of a functional cellulosome, enable the organism to use
lignocellulosic substrates.
The main challenge for the ABE process is the low butanol concentration
in the fermented broth (1.2-1.6 %), which causes problems with product recov-
ery and large volume waste streams. The ABE fermentation results in several
end-products, which has as a consequence that the yields of butanol obtained
are less than optimal. Various methods to improve the efficiency (higher yields
of butanol per gram of feedstock) of wild-type strains have been applied: (i) to
inactivate or reduce expression of genes encoding enzymes involved in pathways
leading to by-products;124–126 (ii) by creating regulatory mutants;127 or (iii) by
overexpression of certain beneficial genes.128,129 These mutations attempt to dir-
ect metabolic intermediates (acetyl-CoA, acetoacetyl-CoA, butyryl-CoA) towards
butanol formation, thereby increasing the production selectivity (i.e. the amount
of substrate that is used to produce butanol versus other products). An in-detail
discussion of the various mutants is provided in section 1.11 of this chapter.
Another reason for the low efficiency of the process is the fact that butanol is
toxic to the producing organism at low levels (1–2 %) and thus ultimately limits
production to around 21 g/L.130 Butanol has membrane-distorting properties due
to its hydrophobic chain and polar group, which cause severe cell damage.131,132
Several factors could be involved in the stress that microorganisms experience due
to the presence of solvents, which include disruption of: (i) nutrient transport;
(ii) ion transport (sodium-potassium pump); (iii) phospholipid composition of
cell membranes; and (iv) cell metabolism.130 Many efforts have been made in
the past to obtain clostridial strains with increased 1-butanol tolerance, but with
limited success.133–138 An important observation is that increased resistance to 1-
butanol does not necessarily impart greater butanol production by the organism:
it can even result in strains producing less butanol.
An alternative to strain improvement is the continuous removal of solvents
during the course of the fermentation by adsorption, gas stripping, liquid-liquid
extraction, perstraction, pervaporation, reverse osmosis, or liquid demixing.130
This results in the organism experiencing lower butanol levels. However, all these
techniques are either too energy-intensive, or still require further development to
improve their selectivities (pervaporation and adsorption).114
Phage infections were a reoccurring problem of the classical ABE-process,
illustrated by the loss of solvent production as recorded for industrial process
runs in South Africa in the 1980s. The infections required strain rotation and
isolation of resistant strains to the particular phage causing the infection.139
Lastly, the batch style nature of the fermentation results in increased down-
time compared to a continuous process, increasing costs. It should be noted
however that semi-continuous process conditions have been employed in both
Russia and China at production scale.
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In summary, strain improvements towards increased butanol production, se-
lectivity, productivity, and final production titres would contribute to once more
make the ABE-fermentation process commercially viable. The application of
metabolic engineering techniques and strategies could be a solution to these prob-
lems and is the goal of the work described in this thesis. In the next sections,
an update of the available genetic techniques will be given and various mutants
known from the scientific literature will be discussed.
1.9 Metabolic Engineering of Clostridia
Metabolic engineering (i.e. the purposeful modification of intermediary
metabolism using recombinant DNA techniques)140 of solventogenic clostridia
is a developing field. Various basic tools have been available for some time
and have recently been reviewed.50,141 These include shuttle plasmids, like
pMTL500E,142 pIMP1,143 pSYL2144 three antibiotic resistance markers (ermB
erythromycin/clarithromycin; catP, chloramphenicol/thiamphenicol; tetM, tetra-
cycline); random chemical mutagenesis;145 transposon mutagenesis;146 and trans-
formation protocols.141 Unfortunately, the chosen type strain for the ABE fer-
mentation, C. acetobutylicum ATCC 824, expresses a restriction endonuclease
enzyme, Cac824I, that cuts any foreign, not properly methylated DNA trans-
formed into the cell.147 The host restriction enzyme can be circumvented by
in vivo methylation of the DNA, using a methyltransferase gene from Bacillus
subtilis phage φ3T.147 This method allows for transformation of plasmids into
C. acetobutylicum with increased efficiency, although it is still very low compared
to organisms like E. coli and B. subtilis.
The creation of gene knock outs by single cross-over homologous recombin-
ation using suicide plasmids in C. acetobutylicum148 and C. beijerinckii149 was
reported but these gene knock outs are not stable, because the process is revers-
ible, resulting in revertants with a wild type genome in the absence of selective
pressure. Recent developments have made it now possible to create stable knock-
out and knock-in mutants. Because one of these techniques played a pivotal role
in the project, the various methods will be discussed in the following section.
1.10 New Genetic Tools for Clostridia
Recently, four new technologies have emerged that make it possible to perform
targeted, stable gene knock-outs in Clostridia. Additionally, these tools can also
be used to integrate additional DNA sequences in the bacterial genome.
1.10.1 Mobile Group II Introns
One technique is based on the use of mobile group II introns. These introns, in
their active form, are catalytic RNAs, found frequently in organelles and bacteria.
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The Lactococcus lactis Ll.LtrB intron is used as a model system for these kind
of introns and the sequences in the intron RNA that determine its insertion site
have been elucidated by the Lambowitz group.150 This allows one to retarget
the intron into virtually any gene in the genome, causing gene disruption. The
mobility of the intron is based on a mechanism termed retrohoming, which is
mediated by a ribonucleoprotein (RNP) complex (See Figure 1.4). The RNP
complex, consisting of an RNA lariat and an intron encoded protein, inserts the
bound RNA into one strand of a double-stranded DNA target site, resulting in
an RNA/DNA hybrid strand. Reverse transcription of the RNA, removal, and
replacement of it by DNA residues by the host repair machinery then results in
a stable integrated intron. The system has been commercialised under the name
TargeTron by Sigma Aldrich.151
While the intron II system is almost completely host independent, the vector
and some features of the system are host dependent. The Minton group ad-
apted the system for use with the clostridial genus.152 The clostridial system,
called ClosTron, now basically has the same features as the original E. coli sys-
tem, and more.153,154 The strong suit of the system is an erythromycin-based
retrotransposition-activated selectable marker (RAM)151 which is an adaptation
of the kanamycin RAM present in the TargeTron system. This marker system
allows one to differentiate between mutants containing a successfully integrated
intron element and transformant cells were integration did not take place. The
so-called second generation Clostron system also has FRT sites situated around
the erythromycin gene. The flp recombinase system can then be used to remove
the erythromycin selection marker from the genome, after successful isolation
of a mutant. After only a few months, several labs had created more than 60
mutants in the clostridial species C. difficile, C. sporogenese, C. botulinum, and
Figure 1.4 (following page): Schematic depiction of the way mobile group II intron
insert in the genome. From top to bottom. The intron II mRNA is transcribed from
the introduced plasmid using a host compatible promoter. Near the 3′-terminus of the
mRNA is an open reading frame (ORF) that encodes the LtrA protein, the protein is
produced, folds and binds the mRNA. The LtrA protein encodes four function and the
first, the maturase, function cuts the 5′ and 3′-end of the mRNA. Included in the 3′-end
is the ORF encoding the LtrA protein which is therefore lost from the final integrated
intron. The matured mRNA complexed with the LtrA protein is referred to as the
RNP (for ribonucleoprotein). In the second phase the RNP finds its target site in the
DNA of the host using helicase activity, its second function. When the target site is
found both DNA strands are cleaved (third function) and the RNA that is bound to
the RNP is inserted into one of the DNA strands creating a DNA/RNA hybrid. The
last function of the LtrA, reverse transcriptase activity, allows it to reverse transcribe
(RT) the inserted RNA sequence. The host DNA repair systems then remove the RNA
and fill in the resulting gap with the complementary sequence. Because the mobility
function of the intron is encoded by the ltrA gene, which is removed from the host upon
loss of the plasmid the mutation is a stable one.
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C. acetobutylicum, whereas up to that time in total only 10 defined, knock-out
mutants were described in the literature.155
A specific site within the intron can be used to insert additional genetic ma-
terial, e.g. genes, in the genome. The RNP complex will integrate the intron plus
the additional inserted sequences in a site-specific manner, resulting in a stable
genomic insertion. The upper size limit for this is around 2 kilo base pairs.
Other researches also reported the construction of a TargeTron-based system
for use with C. acetobutylicum.156 The system is similar to the Clostron but does
not utilise a RAM to expedite selection of the mutant. To successfully isolate a
knock-out using that system, a possibly extensive colony PCR screen is proposed
to identify the correct clone. The advantage is that once isolated, the strain can
immediately be used for a next round of mutagenesis.
1.10.2 Double Crossover Homologous Recombination
The three other systems that have been developed are based on homologous
recombination and are aimed at stably integrating new sequences into the genome.
They can also be used to delete, or mutate genes that are already present in the
genome. The first system, developed by Soucaille and co-workers, uses a negative
selection marker for the second cross-over event.157 This approach, based on the
same strategy in B. subtilis,158 allows for selective pressure to be applied to
identify the, rare, second cross-over event.
As first step to creating a knock-out using this method a mutant strain of
C. acetobutylicum is created that lacks the uracil phosphoribosyl-transferase gene
(upp), yielding it resistant to 5-fluorouracil. A knock-out plasmid is created con-
taining two stretches of sequences that flank the region that is to be deleted
from the genome. Between these sequence stretches, an erythromycin resistance
cassette, flanked on both sides by FRT sites, is inserted. The plasmid further
contains a functional copy of the upp gene, like the one that is removed from
the genome. When the plasmid is then used to transform a C. acetobutylicum
strain, 5-fluorouracil and erythromycin resistant colonies can be obtained. After
sub-culturing and selection on erythromycin and 5-fluorouracil, clones will be ob-
tained that underwent a double cross over event. Subsequent introduction of a
plasmid that expresses a Flp recombinase, allows for removal of the erythromycin
resistance cassette, and for additional knock-outs to be made. Next to the eryth-
romycin cassette, also additional cargo can be inserted, generating stable gene
integrants. This has been exemplified by Von Abendroth et al., who introduced
an algal hydrogenase that replaced the native clostridial gene.159 Disadvantage
of this system is that, to isolate the strain that has lost the plasmid and has
undergone two homologous recombination events, extensive replica plating has
to be undertaken.
A similar approach has been described by Tracy and Papoutsakis,160, how-
ever their approach reportedly uses expression of a heterologous B. subtilis recU
resolvase gene (involved in genetic recombination) to increase the recombination
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frequency in C. acetobutylicum. Similar to the previously discussed approach, this
method also depends on the extensive use of serial transfers and replica plating
to isolate strains that have undergone the desired recombination event, and have
lost the plasmid. The method has been applied successfully to generate knockout
strains of various genes.107,161,162 However, the reported use of recU expression
for an improved recombination efficiency is unclear as all mutant reported in the
peer-reviewed literature underwent only a single recombination event, not the
desired two. The usefulness of the approach is therefore unclear because a sim-
ilar, but better, result can be obtained by suicide plasmids reported previously
as the currently reported strains have gained two antibiotic selection markers as
opposed to one.
The last approach based on homologous recombination was reported by Heap
et al.163 and relies on an intricate combination of carefully designed plasmid com-
ponents to obtain genomic integrands via homologous recombination in either a
wild-type or uracil auxotroph background. The system relies on a pIM13 replicon
which exhibits segregational instability in C. acetobutylicum, resulting in quick
loss of the plasmid in the absence of selective pressure, and on asymmetrical
homology arms flanking the DNA sequence that needs to be inserted into the
genome. This approach allows for multi-step stable insertion of DNA into the
chromosome, paving the way for expression of multiple genes or large operons,
that would otherwise be too large to clone, from a chromosomal location. In
addition recently also a new counter selection marker, CodA, was described for
C. difficile that could also have applications in C. acetobutylicum.164
1.11 Metabolic Engineering Targets
Several metabolic engineering strategies have been published that resulted
in the creation of recombinant strains with increased production of butanol, to-
gether or in conjunction with the other solvents. A short discussion of the most
successful and interesting approaches is presented in the next paragraphs. A
listing of all discussed mutants can be found in Table 1.5.
1.11.1 Catabolic Pathways
Most studies to date have focused on changing catabolic pathway fluxes dir-
ectly involved in butanol or in by-product formation. Two of the first targeted
knock out mutants produced were affected in their capacity to produce acids.
Phosphotransacetylase (pta) as well as butyrate kinase (buk1 ) was inactivated
by Green et al.126 Both mutants were obtained by homologous, single cross-over
recombination. The pta mutant had reduced acetate and increased butyrate
levels, and the converse was true for the buk1 inactivated mutant. However,
only the solvent forming characteristics of the buk1 mutant were affected. It
turned out to be a butanol super-producer reaching up to 225 mM butanol as
23
General Introduction
end concentration in batch cultures.128 Ethanol production by the mutant had
also increased, but acetone levels were unaffected. Later studies showed that the
buk1 mutant, as expected, accumulated high levels of butyryl-phosphate. This
molecule is implicated in intercellular regulation in C. acetobutylicum and as-
sociated with the transition into solventogenesis.165 A recently constructed ptb
knock-out mutant166 confirmed the essentiality of PTB in butyrate production
as the mutant did not accumulate it. Depending on the pH the mutant pre-
dominately produced ethanol with butanol becoming the second most abundant
product. Butyrate feeding experiments demonstrated that the mutant was still
able to take up butyrate from the medium, presumably via acetoacetyl-CoA:acyl-
CoA/butyrl-CoA transferase enzyme complex.
Although Nair et al. demonstrated that over-expression of adhE, the main
alcohol producing dehydrogenase, in the wild-type did not result in altered solvent
production titres,167 the over-expression of adhE in a buk1 deficient background
did result in increased ethanol production.128 It was however not successful in
increasing butanol production, indicating that the rate-limiting step for that
compound was not the dehydrogenase, but probably lies with the production of
the precursor butyryl-CoA.
In C. acetobutylicum ATCC 824, the only polycistronic transcript involved in
solvent production is the sol operon. It contains the adhE gene and the two genes
coding for the subunits CtfA and CtfB of the acetoacetyl-CoA:butyrate/acetate-
CoA transferase enzyme. This complex enables the uptake of acids under the
concomitant production of acetoacetate, which can then be decarboxylated to
yield acetone. Over-expression of the ctfA/B and adc acetone production genes
almost doubled acetone titres and reduced acid levels due to increased uptake.168
The sol operon is preceded by orf5, also referred to as solR for sol locus
repressor. An initial report by Nair et al.169 suggested that the gene coded for a
transcriptional repressor of the sol operon. This was later shown to be incorrect
as the gene encoded a glycosylase/deglycosylase protein, that was shown to be
localised on the outer side of the cell membrane.170 The reduction of solvent levels
when over-expressing orf5 was shown to be due to erroneously subcloning part of
the regulatory region of the sol operon.171 However, combined with adhE over-
expression, the orf5 knock-out mutant is still the top butanol producing strain to
date, reaching 238 mM (17.6 g/L) in pH-controlled batch fermentations. Acetone
and ethanol levels are also increased in this mutant, making up to 28 g/L of total
solvents.127
The C. acetobutylicum M5 strain172 is called degenerated because it can no
longer produce solvents or sporulate due to the loss of the pSOL1 megaplas-
mid.67 In several studies, it has been used as a platform to reintroduce some
of these solvent genes to partly restore alcohol production without acetone pro-
duction. Reintroduction of the adhE gene results in partly restored butanol and
ethanol production.173 Recent work by Sillers et al. demonstrated that the M5
strain lacks the metabolic flexibility to alter oxidation/reduction pathways to
achieve electron balance.129 Inactivation of acid production pathways in an M5
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background resulted in strongly increased doubling times, and in reduced acid
production of the down-regulated pathway. When attempts were made to over-
express the adhE gene in these acid production mutants, only the strain with an
inactivated acetate kinase could produce transformants. This did however not
result in increased butanol or solvent production, but rather the inverse, increased
acid production and decreased solvent production.129 This suggests that the M5
strain is limited in its ability to balance the electron flow, and mainly uses bu-
tyrate production to balance the production of reducing equivalents. The recent
discovery that in C. kluyveri, and probably C. acetobutylicum too, reduction of
crotonyl-CoA results in the concomitant reduction of ferredoxin, could hint at a
way for the organism to regulate the flow of acetyl-CoA towards butyryl-CoA.99
It is suggested that this inelasticity could be related to a missing gene or genes
that are present on the pSOL1 megaplasmid. Alternatively, pSOL1 also encodes
many transcription factors and DNA-binding proteins that could be important
in facilitating the electron flow.129
Antisense RNA technology has been also applied to down-regulate gene ex-
pression of specific genes. By making antisense constructs against the genes ptb,
buk,174 adc, ctfA, and ctfB125 the fluxes through several pathways were altered.
Especially the last construct was effective in almost completely abolishing acet-
one production. Because the adhE gene, involved in butanol production, is part
of the same polycistronic operon, butanol levels were also negatively affected. In
a later study it was demonstrated that overexpression of adhE from its native
promoter resulted in increased butanol and ethanol levels, however it also rein-
troduced limited acetone production.124 A follow-up study demonstrated that,
when using different promoters to compensate for titration effects and by con-
stitutive expression of adhE, down-regulation of acetone production results in a
predominantly alcohologenic fermentation.175 The strain produced 30 gram/L of
total solvents, and made ethanol, for the first time, the major product of the
fermentation. In an effort to divert more acetyl-CoA units to butyryl-CoA, a
butanol precursor, thl and adhE were both overexpressed. This however, res-
ulted in slightly increased acetate production, while lowering production of all
other products.175
Quite recently Lehmann et al. reported on several knock-out mutants. In
one report 3-hydroxybutyryl-CoA dehydrogenase (HBD) was disrupted using the
ClosTron system.176 This is the first time that the central C2 to C4 pathway
was blocked in C. acetobutylicum, and possibly in butyrate forming clostridia,
and it resulted in a strain producing predominantly ethanol and some acetate
and acetone. Lactate was reported not to be formed to any significant level,
however the carbon-balances for respectively the glucose, xylose, and fed-batch
glucose fermentations, was only 66 %, 91 %, and 85 % respectively (my calcu-
lations, omitting biomass formation which normally accounts for about 10 % of
carbon consumption) This would suggest that in the case the glucose fermenta-
tions other products were formed besides those reported. Nonetheless their work
demonstrates that C. acetobutylicum can survive and produce solvents without
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apparent accumulation of butyryl-phosphate.
In a second article Lehmann et al. report on the generation and analysis
of mutants in the acetate (pta) and acetone (ctfA, adc) pathways and double
mutants thereof.179 Disappointingly, the mutants displayed reduced solvent pro-
duction, especially in the case of the double mutants (pta– adc– and pta– ctfA–)
which produce only marginal amounts of solvents and their main fermentations
product is butyrate. However also here the carbon-balances are incomplete (wild-
type, 96 %; pta– adc–, 52 %; pta– ctfA–, 61 %; all not accounting for biomass).
Their pta– knock-out mutant did not give under the tested conditions any signi-
ficant differences with the wild-type, however the functional inactivation of PTA
was not borne out by enzyme activity assays.
1.11.2 Increasing Butanol Resistance
The toxicity of the solvents that are produced is caused by the destabil-
ising effect that especially butanol has on proteins and by its impact on mem-
brane fluidity. Approaches to increase the tolerance of C. acetobutylicum towards
butanol using metabolic engineering have been described as well. Examples in-
clude the over-expression of the GroES and GroEL heat shock proteins137 and
CAC1869,135 a putative transcriptional regulator. The groES and groEL genes
were over-expressed together as the groESL operon. Under stress conditions,
these proteins assist in the refolding of misfolded proteins. When this operon
was over-expressed, growth inhibition by butanol was reduced by 85 % and 40 %,
at concentrations of 2 and 4 g/L respectively, compared to the plasmid control
strain. Their increased resistance to butanol stress allowed the strain to realise
a 33 % increase in final solvent titres compared to the plasmid control strain.
The ca c1869 gene was identified by selective enrichment of a culture that was
transformed with a C. acetobutylicum genomic library. Serial transfers of the cul-
ture in medium with progressively higher butanol concentrations allowed for the
selective enrichment of several different plasmid carrying strains. Which library
fragments conferred increased resistance to butanol was detected by microarray
analysis. One of the enriched fragments contained ca c1869. A strain over-
expressing the ca c1869 gene showed 80% increased resistance toward butanol,
relative to the plasmid control strain.
In this context of butanol stress it is of interest to mention compatible solutes.
The folding and proper conformation of macromolecules such as proteins, DNA,
and RNA is in most cases essential for their stability and function. Various
stressors such as high or low temperatures, hydrostatic pressure, high concentra-
tions of inorganic salts or other compounds can destabilise these macromolecules
and disrupt their functioning. Cells can accumulate various low molecular weight
compounds called compatible solutes to help them withstand these stresses. The
sometimes very high concentration (up to the molar range) protects the cells,
while not interfering with cellular processes. For this reason they are called com-
28
1 
Alternative Butanol Production Hosts
patible solutes but also the terms counteracting solutes, compensatory solutes,
and chemical chaperones have been used in the literature.182–188 The general hy-
pothesis is that almost all stresses, also butanol stress, are ultimately related to
loss of water from the cell. The compatible solutes help to maintain water inside
the cell and, to some extend, replace it, to keep proteins in solution by preventing
aggregation.
Compatible solutes can be classified in four major groups based on their chem-
ical composition. These are: a) Carbohydrates, mainly uncharged forms but
diglycerol phosphate has also been described in certain archaea; b) Amino acids
and derivatives, almost all are zwitterions; c) Methylamine and methylsulph-
onium zwitterions; d) Urea, the only class with only one member.182 No reports
have appeared in the literature as far as we could identify that describe the use
application of these kind of compounds for increased butanol production.
1.11.3 C. beijerinckii BA101
Currently the bacterium with the highest butanol and total solvent producing
characteristics belongs to the species C. beijerinckii. A chemically-induced (ran-
dom mutagenesis) mutant of strain NCIMB 8052, strain BA101, produces signi-
ficantly increased amounts of butanol181,189–192 and constitutes one of the most
interesting strains developed so far. This strain consistently produced double
amounts of butanol and showed increased butanol tolerance when grown in batch
cultures on glucose compared to the wild-type strain. The final butanol concen-
trations reached at the end of batch cultures carried out in a 200-L bioreactor were
240 mM and 171 mM by the BA101 and wild-type strains, respectively. An eco-
nomic assessment of butanol production from corn using this mutant strain res-
ulted in a price for butanol below the price of petrochemically produced butanol
at that time.193
1.12 Alternative Butanol Production Hosts
In order to circumvent some of the intrinsic drawbacks of the solventogenic
Clostridia (especially the relatively high ratio of by-products, complex life cycle,
and the limited genetic tools available compared to other species), several research
groups have reported attempts to produce n-butanol using other organisms. This
approach of heterologous expression of genes from a clostridial background in well-
studied, genetically easily accessible, organisms such as E. coli or S. cerevisiae
comes at a price. These last mentioned organisms, amongst other drawbacks,194
tend to be more sensitive for butanol in the growth medium than native produces
and have a narrower susbtrate range. Possibly, some lactic acid bacteria, such as
Lactobacillus, Pediococcus, Enterococcus, and Leuconostoc would be an interesting
platform for n-butanol production, since they have been reported to be relatively
tolerant to high concentrations of this alcohol.195,196
29
General Introduction
Studies have been published that are based on the production of n-butanol
using the clostridial pathway. In E. coli both Atsumi et al.197 and Inui et
al.,198 and Nielsen et al.199 succeeded in detecting butanol production levels of,
550, 1200, and 520 mg/L respectively. Similar results were obtained by others
using Lactobacillus brevis (300 mg/L),200 S. cerevisiae, (2.5 mg/L)201 Bacillus
subtilis (25 mg/L) and Pseudomonas putida (122 mg/L).199 Examples of patent
applications in which the introduction of the C. acetobutylicum butanol path-
way in alternative micro-organisms is claimed are those filed by Dupont (WO
2007/041269), DSM (WO 2008/05991) and Arbor Fuels Inc (EP 2008 0841766).
In these patent applications, the results described for fermentations in batch
cultures by recombinant yeast strains show butanol production at very low con-
centrations (< 1 mM).
The group of James Liao also explored another approach and used inter-
mediates of amino acids biosynthesis routes present in E. coli as precursors for
longer chain alcohols.202 In their approach α-keto-acids were decarboxylated to
the corresponding aldehyde by the keto acid decarboxylase (KDC) from Lacto-
coccus lactis and then reduced to the alcohol by alcohol dehydrogenase 2 (Adh2)
of S. cerevisiae. This resulted in various linear and branched chain alcohols
(butanol, propanol, iso-butanol, 2-metyl-1-butanol, 3-methyl-1-butanol, 2-phen-
ylethanol) depending on the amino acid precursor. Production of iso-butanol
reached the highest level at 300 mM (22 g/L), whereas n-butanol did not surpass
9.2 mM (0.68 g/L).
The wider substrate range of clostridial butanol producers, combined with
their higher butanol production levels and previous industrial application still
make clostridia the organisms of choice for n-butanol production.
1.13 Project Approach
The goal of the research described in this thesis was to reduce the number and
especially the amount of by-products formed during the ABE-process. The main
focus was on reducing the amount of acetone produced as part of the ferment-
ation, for two reasons. Firstly, acetone in the fermentation broth complicates
downstream processing (DSP). The mixture of solvents — acetone, butanol, and
ethanol — and water creates an azeotropic mixture which makes the butanol
separation harder and more energy consuming. By preventing acetone forma-
tion that particular azeotrope is removed. Secondly, acetone formation reduces
butanol yields per amount of substrate. One molecule of glucose is used for every
acetone molecule produced, whereas this could also have been used to produce
butanol. As expected, previous attempts to inhibit acetone production resulted
in increased acid concentrations.124,125,203 as acetone production is an important
acid uptake route.
The approach taken for this thesis was therefore to impede acid production,
both that of acetate and of butyrate, which is expected to lead to the desired effect
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of reduced or eliminated acetone production, because there would not be acet-
ate or butyrate to take up. Butyrate kinase was selected for inactivation of the
butyrate pathways, because previous results suggested that butyryl-phosphate
accumulation had a regulatory function implicated in triggering solvent form-
ation,165 and had resulted in increased solvent formation.128 The analogously
functioning acetate kinase was selected to inactivate acetate production, because
it was shown that the enzymes of the butyrate pathway could substitute for those
used in acetate pathway and possibly vice versa. It was envisioned that butanol
and ethanol would become the major liquid fermentation end-products possibly
combined with lactate formation. As inactivation of both acid production path-
ways would reduce ATP generation quite considerably, inducible expression of a
functional acetate kinase gene was considered to allow establishment of sufficient
biomass followed by shift to alcohols-only production by taking away the inducer.
The proposed mutant could then be used in a cell recycling based process to allow
semi-continues operation.
1.14 Outline of This Thesis
Chapter 2 describes the adaptation of a gene-knockout mutagenesis system
based on a mobile group II intron to selectively, and permanently inactivate
genes in Clostridium acetobutylicum and potentially other clostridia. It further
also describes a method to store electro-competent C. acetobutylicum cells for
later transformation for a period of at least two and half years.
The work discussed in chapter 3 describes the generation and characterisa-
tion of a C. acetobutylicum strain with an inactivated acetate kinase gene. Batch
fermentations in two different media are discussed and their results compared.
Chapter 4 then builds on the work done in chapters 2 and 3 and first de-
scribes a mutant strain with an insertionally inactivated butyrate kinase gene
and how it differs in batch fermentation performance, from an earlier described
mutant strain with an inactivated butyrate kinase gene. Subsequently, the acetate
kinase gene in this strain is also inactivated resulting in the first ever C. acetobuty-
licum strain with targeted inactivation of genes in both acid production pathways.
The effect on production formation of the fermentation pH and the addition of
acetate to the medium is evaluated.
In chapter 5 an alternative approach to circumvent the toxicity of 1-butanol
while maintaining its interesting biofuels properties is explored. The goal is to
produce 2-butanol and this chapter takes the first step towards that by expressing
an acetoin reductes gene from C. beijerinckii in C. acetobutylicum to reduce
natively produced acetoin to d–2,3–butanediol.
Lastly, chapter 6 is a general discussion chapter, in which the results of the
previous chapters are evaluated, and suggestions for future research are made. In
addition it summarises the general conclusions from this thesis.
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Chapter 2
Molecular Biology Methods
for Clostridium
acetobutylicum
Part 1:
A Method for Storing Electro-Competent
C. acetobutylicum Cells
Abstract
Preparation of electrocompetent cells of C. acetobutylicum, and related species,
and their transformation is a time consuming process typically requiring more
than 11 hours. Here we describe how electrocompetent cells can be stored for up
to two and a half years at −80 ◦C, for later transformation.
Note
Clostridium acetobutylicum is a rod-shaped, Gram-positive, anaerobic bac-terium that can ferment starch and various sugars to the acids acetate andbutyrate, and the neutral solvents acetone, butanol, and ethanol (ABE).57The ABE-fermentation was once performed at industrial scale for the pro-
duction of acetone and butanol, but was unable to compete with the more eco-
nomical petrochemical process during the second half of the 20th century in most
parts of the world.58,60,115 Recently the process has received renewed interest for
the production of butanol from various renewable feedstocks including, amongst
others, molasses, starch, and lignocellulosic materials. Applications of butanol
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include its use used as fuel extender and as a chemical feedstock.45
Although the ABE process is known for more than a hundred years, at-
tempts to improve yield, selectivity, and productivities have had limited suc-
cess.204 Among the four clostridial species66 know to produce butanol as their
main fermentation product, C. acetobutylicum ATCC 824 is the most well studied
strain at the molecular and genetic level. Methods and genetic tools that have
been reported for this strain include transformation protocols, expression plas-
mids, random mutation, selective inactivation of genes, and integration of new
DNA sequences in the chromosome.141,154,157,160,163 Protocols for transforma-
tion by electroporation have been described by Oultram et al.,142 Mermelstein et
al.,143 and others.205
To date, no protocols for storage of competent cells of solventogenic Clostri-
dia have been described in literature, as it has been reported for a large range of
organisms; Gram-negative bacteria (Escherichia coli,206,207 Pseudomonas aeru-
ginosa208), Gram-positive bacteria (Lactococcus lactis,209 Geobacillus stearother-
mophilus,210 Lactobacillus casei, L. plantarum,211 and Bacillus subtilis212), and
yeasts (Schizosaccharomyces pombe, Saccharomyces cerevisiae)213 can be stored
competent at −80 ◦C. All reported methods for transformation of C. acetobuty-
licum, and related strains such as C. beijerinckii, require preparation of freshly
prepared competent cells.141,143,214 One report by Klapatch et al.215 describes the
storage of electrocompetent C. thermosaccharolyticum cells at −80 ◦C but gives
not details as to how this was accomplished. Otherwise we have been unable to
identify a publication in the literature demonstrating storage of electrocompetent
obligatory anaerobic bacteria. Here we describe, to the best of our knowledge,
for the first time how to store electrocompetent cells of C. acetobutylicum strains
ATCC 824 and WUR, the later a strain closely related to ATCC 824,216,217 for
later transformation.
Competent C. acetobutylicum cells were essentially prepared as described by
Oultram et al.142 200 mL mCGM medium216 was inoculated with 20 mL of an
overnight pre-culture from heat shocked spores (10 minutes, 80 ◦C) and grown
up to an OD600 of 0.7 (corresponding to a biomass concentration of approxim-
ately 0.35 mg/mL) at 37 ◦C. The culture was transferred to a large centrifuge
tube closed with a plug with an O-ring, and a screw cap and then wrapped with
plastic paraffin film. The tube was cooled in an ice-water mixture and centri-
fuged for 10 minutes (5 468 × g, 4 ◦C). The supernatant was removed and the
pellet was washed with 20 mL ice-cold anaerobic electroporation buffer (270 mM
sucrose, 1 mM MgCl2, 7 mM sodium phosphate buffer, pH 7.4) and transferred
to a smaller centrifuge tube. The tube was again closed and wrapped as before
and centrifuged again under the same conditions. The supernatant was removed
and the pellet was resuspended in 4 mL ice-cold electroporation buffer. The com-
petent cell suspension can now be used in 300 µL portions for electroporation in
an electroporation cuvette or stored inside 1.5 mL polypropylene cryovials closed
with a rubber O-ring fitted screw cap (Greiner Bio-One, The Netherlands, Cat.-
No. 717 261). Vials are then transferred to a wide bore 250 mL glass infusion
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bottle and closed off with a thick (1.0–1.5 cm) butyl rubber stopper and an alu-
minium screw cap. The flask with cryovials was then transferred outside the
anaerobic environment and stored at −80 ◦C.
During storage and afterwards great care must be taken not expose the glass
bottle to any additional stresses as the glass might easily break due to the temper-
ature and pressure differences. All manipulations, except for the centrifugation,
were carried out anaerobically. Storing competent cells in cryovials that were
not placed inside a glass bottle resulted in undetectable transformation frequen-
cies and low numbers of viable cells (data not shown). Presumably as oxygen
diffuses through the plastic walls and inactivates key enzymes resulting in non-
viable cells.218 Storing cells inside glass test tubes that are closed off with a
butyl rubber stopper and a screw cap, as we do at our lab with non-sporulating
strains, would facilitate storage inside −80 ◦C freezers due to their less bulkiness.
We however did not test this. It has been reported that, at least for chemical
competent cells, E. coli loose competence when stored in glass containers.207
When a transformation is performed the glass bottle was taken from the
−80 ◦C freezer, wrapped inside a large cloth and placed inside the airlock for
entry into the anaerobic chamber. After the airlock is made anaerobic the flask
is opened, still wrapped in the cloth, and the desired number of cryovials is taken
out. If any vials are left the flask is closed again and transferred outside for
storage at −80 ◦C. The cells are thawed and used as fresh cells for electrotrans-
formation. Approximately 2.4 µg of methylated plasmid DNA147 was added to
fresh or thawed cells and incubated on ice for at least 1 minute. Cells were then
electroporated (0.2 cm gap with; 1.25 kV; 25 µF; 100 Ω) with time constants
between 1.2 and 1.8 ms. The electroporated cells were cooled on ice and then
incubated with 3 mL pre-warmed mCGM at 37 ◦C for 3 hours. The cells were
concentrated and resuspended in 200 µL mCGM and plated with appropriate
dilutions on pre-warmed mCGM plates containing erythromycin.
To compare the competency of cells stored as described above we transformed
stored and freshly prepared competent cells with 2.4 µg pMTL500E plasmid.142
Stored C. acetobutylicum WUR cells from batches that were 1 month (n=2),
2.5 years (n=2), and 4.5 years (n=4) old were tested and compared to fresh cells
(n=2). Each transformation was plated in duplicate to determine the number
of transformants. Mean values are plotted in Figure 2.1. Except for an initial
increase in competence upon storage after 1 month, competence seems to remain
stable for up to at least 2.5 years. After 4.5 years it is clearly reduced, although
transformants were still obtained in all four independent transformations carried
out with 4± 0.8 CFU/µg (mean ± SEM).
To determine if C. acetobutylicum ATCC 824 cells (obtained from H. Bahl,
Rostock, Germany) behaved similar to the WUR strain, fresh competent cells
were prepared and transformed with 2.4 µg pMTL500E plasmid. Similar trans-
formation efficiencies were obtained for the fresh ATCC 824 cells compared to
the WUR strain cells. Upon storage for one month at −80 ◦C cells remained
competent to the same level compared to the fresh cells, but with lower efficiency
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Figure 2.1: Transformation efficiency of competent C. acetobutylicum WUR and
ATCC 824 cells. Prepared fresh or after storage at −80 ◦C for the in-
dicated period of time. Error bars indicate SEM for n = 2 except for the
4.5 year WUR sample (n = 4) and the fresh ATCC 824 sample (n = 1).
compared to one month old WUR-strain cells.
In summary, the storage method outlined above allows electrocompetent Clo-
stridium acetobutylicum cells to be stored at −80 ◦C and remain competent. It
is essential to keep the cell suspension anaerobic by storing the plastic tubes in-
side a glass container with a thick rubber stopper as storage of the same tubes
alone results in loss of competence and reduced viability. Use of this method will
allow the storage of competent cells for later use, resulting in similar flexibility
for C. acetobutylicum as for E. coli with regard to the ‘ease-of-use’ of competent
cells. This procedure could potentially also be applied to other obligate anaerobic
microorganisms.
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Development of a Mobile Group II Intron-
Based Gene Knock-Out Method for Clostridia
Abstract
Creating targeted gene knock-out mutants is one of the requirements to establish
a metabolic engineering ‘toolbox’ for the modification and remodelling of meta-
bolic pathways. Here we describe the adaptation of a mobile group II intron-based
gene knock-out system for its use with Clostridium acetobutylicum. The systems
is expected to work in a wide range of clostridia due to it pAMβ1 replicon and
generally recognised thiolase promoter for the expression of the intron. Applic-
ation of the system for the generation of an acetate kinase knock-out mutant is
demonstrated by PCR. A pure culture could not be obtained after colony PCR
screening or attempts at phenotypical selection, indicating that screening meth-
ods need to be improved. This method has been used for the generation of a
second knock-out in a recombinant strain, described in chapter 4 of this thesis.
2.1 Introduction
Prior to 2007 no genetic tools were available in the literature to stably in-activate genes in a targeted manner in clostridial species. Up to that timeclostridial genes could only be inactivated using non-replicating, so-called‘suicide’, plasmids. Using this method, the cells are transformed with a
plasmid that cannot replicate itself inside the new host. The plasmid further
contains a gene that confers a selectable trait (normally an antibiotic resistance
gene) and contains an internal fragment that is homologous to a targeted region
on the chromosome (i.e. an internal part of the gene to be inactivated). The
internal gene fragment allows for host mediated homologous recombination to
occur (Figure 2.2). During this process the DNA strands are exchanged between
the two homologous sites and this results in an interrupted targeted site, of which
there are now two copies on the chromosome, interleaved by the sequence of the
rest of the plasmid. If the inserted plasmid sequence is in the coding region of the
gene then this normally results in an inactive gene product. The presence of the
selection marker on the plasmid, for example an antibiotic resistance gene, allows
for the selection of a genome integrated plasmid, because the plasmid does not
contain an origin of replication. This situation is however not a stable one. The
genome still has two homologous regions (indicated in grey in Figure 2.2) and so
the process just described can be reversed and the plasmid will be removed from
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the genome. If this happens when the selective pressure is still applied these cells
will not survive.
Target Gene (TG) 
Marker 
IF TG 
  5' TG Marker 
    Target Gene 3' 
Homologous 
recombination event 
Figure 2.2: Schematic depiction of a homologous recombination event resulting in dis-
ruption of the targeted gene (abbreviation TG). The introduced plasmid
does not contain an origin of replication that will function in the host,
thus for the host to acquire the marker gene it must recombine the plas-
mid in the genome. To guide this process and increase the efficiency, the
plasmid contains an internal fragment of the targeted gene (IF TG). Once
recombination has occurred the marker gene is integrated in the genome
of the host.
Because the recombination frequency in clostridia is very low and there was
no known method to select for the second recombination event (i.e. a negative
selection marker on the stretch of plasmid DNA that should be lost on completion
of the second homologous recombination event), it proved impossible to screen
for those particular mutants. Instead various single cross-over mutants have been
constructed126,148,149,169 and assessed for how quickly the integrated plasmid was
lost from the culture when the selective pressure (antibiotic) was removed.149,219
Although reportedly loss of some integrated plasmids was low, none were highly
stable. In addition, a separate positive selection marker (i.e. antibiotic res-
istance marker) is needed for each separate insertion. The main differences of
C. acetobutylicum compared to other organisms where double cross-over mutants
can more easily be obtained are the low frequency of both transformation and
recombination, and the absence of a conditional replication system for clostridial
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vectors.
To find a way to obtain stable gene knock-out mutants we searched the lit-
erature for possible methods. We focussed on one called TargeTron which is
based on the targeted insertion of mobile group II introns for two reasons; (i) the
TargeTron approach works almost independent from any host factors to complete
the mutagenesis process;150 (ii) Chen et al.220 had inactivated the alpha toxin
gene in C. perfringens using this system, demonstrating that it can function in a
clostridial species.
The TargeTron system is built around a mobile group II intron present in
Lactococcus lactis called Ll.LtrB. These kind of catalytic RNA elements occur in
a wide range of prokaryotic and eukaryotic organisms (in their chloroplasts and
mitochondria) and consist of six domains (I through VI) that are a result of the
intricate folding of the intron.221 The tertiary structure that is a result of this
folding assures that specific nucleotides are positioned in such a way that they
can perform their catalytic function. Mobile group II introns have an intron-
encoded-protein (IEP) that has RNA splicing, DNA endonuclease, and reverse
transcriptase activities.150 In the Ll.LtrB intron the IEP is called LtrA and is
599 amino acids long.
Mobility initiates when the IEP helps the intron RNA fold into the catalyt-
ically active RNA structure to promote splicing, resulting in ligated exons and
an intron lariat-IEP ribonucleoprotein (RNP) complex. In the modified L. lactis
intron the LtrA encoding gene is placed outside the intron lariat boundaries res-
ulting in an RNP complex without an encoded IEP on the RNA part, as opposed
to the wild-type system where the ltrA gene is located on domain IV of the in-
tron lariat. This arrangement assures that the gene is not present anymore after
removal of the plasmid. The RNP complex recognizes specific DNA target sites
and promotes integration by reverse splicing of the intron RNA directly into one
strand of the target DNA. The IEP then cleaves the opposite strand and uses it
as a primer for target DNA-primed reverse transcription of the inserted intron
RNA. The opposite strand of the resulting cDNA copy of the intron is generated
by host DNA repair mechanisms resulting in an dsDNA intron copy inserted in
the target site.
The direction in which the intron is inserted in the gene is referred to as the
sense, or anti-sense orientation. If the intron is oriented in sense then the LtrA
protein, expressed from the plasmid, is able to recognise the intron sequence in
the mRNA of the inactivated gene and remove it from the transcript, restoring the
wild-type mRNA.222 It is therefore important in cases of sense intron insertion to
ascertain if the plasmid, and therefore the LtrA encoding gene, has been lost from
the mutant. If the intron is inserted anti-sense then the intron sequence cannot
be removed from the mRNA transcript even if the LtrA protein is expressed.
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Although the group II intron itself performs almost all required function in
a host independent manner several modifications to the plasmid that carried the
intron were needed. These were:
i an additional Gram-positive origin of replication compatible with
clostridia;
ii another selection marker then ampicillin on the TargeTron carrying plas-
mid;
iii a suitable promoter to replace the T7 promoter and lacZ system used to
drive and control the expression of the TargeTron as it is not expected to
work in clostridia;
iv removal of the RAM§ as C. acetobutylicum is not sensitive to kanamycin
and larger introns have reduced insertion efficiency.
The work in this chapter describes how the E. coli based TargeTron system was
modified to work in C. acetobutylicum and describes its application to generate an
acetate kinase (ack) knock-out mutant. Three methods to isolate the generated
mutant are described but were unsuccessful. Later work, described in chapter 4,
was after all able to demonstrate the system’s successful application to obtain
the desired mutation. The approach there relied on a new colony PCR protocol
to screen a large number of colonies for the mutant.
2.2 Material and Methods
2.2.1 Strains, Plasmids and Primers
Table 2.1 lists all bacterial strains and plasmids used for the study. Stock
cultures of C. acetobutylicum were maintained as spore suspensions in sterile 15 %
(v/v) glycerol at −20 ◦C. E. coli XL1-Blue was used for vector maintenance and
cloning and stored as competent cells or glycerol stock at −80 ◦C.
2.2.2 Media and Growth Conditions
Lysogeny broth (LB) medium223,224 was used for growth of E. coli strains
at 37 ◦C, 250 RPM supplemented with the appropriate antibiotics. Clostridial
spore suspensions were prepared as previously described216 and heat shocked
for 10 minutes at 70 ◦C, prior to using them as an inoculum for pre-cultures.
C. acetobutylicum was plated on RCM (Oxoid) or mCGM medium containing
1.2 % agarose. Liquid cultures were grown in mCGM medium. Liquid media were
made anaerobic by flushing with nitrogen gas for 10 to 30 minutes depending on
the volume of the liquid. All clostridial culture experiments were performed at
37 ◦C, without shaking, and anaerobically in (i) an anaerobic chamber (Sheldon
Manufacturing, Oregon U.S.A.; gas mixture consisting of 15 % CO2, 4 % H2, and
§Retrotransposition Activated Marker, see subsection 1.10.1.
40
2 
Part 2: Material and Methods
81 % N2); or (ii) in glass serum vials as described previously.225 Culture media
were supplemented with ampicillin (100 µg/mL), chloramphenicol (30 µg/mL),
thiamphenicol (15 µg/mL), or erythromycin (40 µg/mL standard; 5–10 µg/mL
for initial mutant isolation) when appropriate.
2.2.3 Mutant Selection
For mutant isolation plates appropriate amounts of a filter sterilised (0.2 µm,
Sartorius) 4 M sodium fluoroacetate solution were added to not yet solidified
RCM-agar after it was autoclaved. Overnight liquid cultures of wild-type and
transformants were plated and incubated and checked for growth after 24, 48,
72 hours. For selection on chloroacetate the same procedure was followed except
that a 1 M sodium chloroacetate solution was used for medium supplementation.
2.2.4 DNA Isolation and Modification
Standard molecular work was done according to established protocols.224 Re-
striction enzymes were from New England Biolabs (Bioke´, The Netherlands) and
used according to their instructions. DNA from C. acetobutylicum was isol-
ated using the GenElute Bacterial Genomic DNA Kit (Sigma-Aldrich) using the
Table 2.1: Bacterial strains an plasmids used in this study
Strain or plasmid Relevant characteristicsa Source
Strains
C. acetobutylicum WUR Wild type Laboratory
stock216,217
E. coli XL1-Blue recA1 endA1 relA1 Tn10 (Tetr) gyrA96(nalr)
lac lacIq D(lacZ)M15
Laboratory
stock
E. coli DH10B(pAN1) D(mrr-hsdRMS-mcrBC) Laboratory
stock
Plasmids
pAN1 p15A ori; Cmr φ3tI Laboratory
stock147
pMTL500E ColE1 ori; pAMb1 ori; MLSr Apr; lacZ′ Laboratory
stock142
pACD4K-C p15A ori; Cmr; intronII-RAM-ltrA-T1T2
terminator
Sigma-
Aldrich
pWOK001::Cac-ack-84s ColE1 ori; pAMb1 ori; MLSr Apr;
Pthl-intronII-DRAM-ltrA-T1T2 terminator
This study
pWOK001::Cac-ack-1027a ColE1 ori; pAMb1 ori; MLSr Apr;
Pthl-intronII-DRAM-ltrA-T1T2 terminator
This study
pWOK002::Cac-ack-1027a ColE1 ori; pAMb1 ori; MLSr Apr;
Padc-intronII-DRAM-ltrA-T1T2 terminator
This study
a MLSR, confers resistance to erythromycin, amongst others; p15A ori, E. coli origin of rep-
lication; φ3tI, Bacillus subtilis phage gene encoding the φ3T I methyltransferase; ColE1 ori,
E. coli origin of replication; pAMb1 ori, clostridial origin of replication; CmR, chloramphenicol
resistance; ltrA, the intron-encoded protein of the Lactococcus lactis Ll.LtrB group II intron
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Gram-positive isolation procedure which incorporates a lysozyme (from chicken
egg white; Fluka) treatment. E. coli plasmid DNA was isolated by the GenE-
lute Plasmid Miniprep Kit (Sigma-Aldrich). Both kits were used according to
the manufacturer’s instructions. PCR products intended for cloning were amp-
lified using PWO master mix or the High Fidelity PCR kit (both Roche) and
used according to the manufacturer’s instructions. Clostridial colony PCRs were
done with PWO master mix and for E. coli colony PCRs RedTaq master mix
(Sigma) was used. The retargeting and related procedures of the TargeTron
system (Sigma-Aldrich) were performed according to the manufacturer’s instruc-
tions. Prior to transformation into C. acetobutylicum, plasmids were methyl-
ated in vivo147 by electroporation into E. coli DH10B(pAN1) cells. Electro-
transformation of C. acetobutylicum was carried out as previously described.142
All manipulations were carried out anaerobically and on ice. After transformation
and recovery, the cells were plated on pre-warmed plates containing erythromy-
cin.
2.2.5 Primers and DNA Sequencing
All DNA primers used in the study are listed in Table 2.2. Primers were
obtained from Eurogentec (Seraing, Belgium). DNA sequencing of clones was
done by BaseClear (Leiden, The Netherlands).
Table 2.2: Primers used in this study
Primer name Sequence (5′ → 3′)a
AK1027a ibs aaaaaagctt ataattatcc ttaTGTTTcT GCATAgtgcg cccagatagg gtg
AK1027a ebs1d cagattgtac aaatgtggtg ataacagata agtcTGCATA TTtaacttac ctttctttgt
AK1027a ebs2 tgaacgcaag tttctaattt cgGttAAACA Tcgatagagg aaagtgtct
AK84s ibs aaaaaagctt ataattatcc ttaGTACTcG CTAAAgtgcg cccagatagg gtg
AK84s ebs1d cagattgtac aaatgtggtg ataacagata agtcGCTAAA GGtaacttac ctttctttgt
AK84s ebs2 tgaacgcaag tttctaattt cgAttAGTAC Tcgatagagg aaagtgtct
EBS Univ cgaaattaga aacttgcgtt cagtaaac
TT1027Apa Fw AAAAGGgcCC ataattatcc ttatgtttct g
TT84Apa Fw AAAAGGgcCC ataattatcc ttagtactcg c
TT XhoI Rev CCTCGAGcgt tctgctttcc tgatgc
CA Pthl Fw GGCATGCgaa tttagaatga agtttcttat gc
CA Pthl Rev AAAAGGGCCC ccatagttta tccctaattt atacg
CA Padc Fw GGCATGCatg ggaaagccaa cattgc
CA Padc Rev AAAAGGGCCC cttcacatta taaatcgcct ct
Cac ack fwd atgaaaaact tagttattaa ctgcg
Cac ack rev ttattttaac ttgcctacta tatcttt
a Nucleotides that are not complementary to the template sequence are given in uppercase.
HindIII, BsrGI, ApaI, and XhoI restriction sites incorporated in the primers are underlined.
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2.3 Results and Discussion
2.3.1 Clostridial TargeTron Construction
The TargeTron kit supplies the pACD4K-C vector for application in E. coli
mutagenesis, however this is unsuitable for work in clostridia. Therefore a clo-
stridial version of the plasmid was constructed. Because the plasmid is supplied
as a linearised version with the kit, it needs to be circularised using a retar-
geted region. This region determines where the intron will insert in the genome
and is generated using a one-step SOEing PCR with a specially prepared tem-
plate supplied with the kit. As our initial target will be the acetate kinase (ack)
gene from C. acetobutylicum we chose to select two insertion sites within that
gene. Although the sites were insertion can take place are flexible, recognition
of certain nucleotides is dependent on the protein part of the RNP complex and
cannot be changed.150 Where potential insertions sites are located within a given
DNA sequence can be computed using a developed and published algorithm.226
Sigma, the company selling the TargeTron kit, has set up a website (http://www.
sigma-genosys.com/targetron/) to provide these insertion sites within a specified
sequence, using an access code supplied when buying a kit. There is however also
a free alternative available (http://clostron.com/clostron2.php) that is based on
the aforementioned Perutka et al.226 algorithm. Besides possible insertion sites
the websites also provide details on the PCR primers needed to re-target the
intron to the selected insertion site.
Two top scoring sites within the ack gene were selected from the Sigma-website
results, and the corresponding PCR primers (AK1027a ibs, AK1027a ebs1d,
AK1027a ebs2; and AK84s ibs, AK84s ebs1d, AK84s ebs2; were used, combined
with the universal primer EBS Univ (Table 2.2) supplied with the kit, to gener-
ate two re-targeted regions, one aimed at insertion after base pair 84 in the sense
orientation, and one after base pair 1027 in the anti-sense orientation of the
ack gene, respectively. The PCR products were isolated from gel, digested with
HindIII and BsrGI and ligated into the pACD4K-C vector. The resulting vec-
tors, pACD4K-C::Cac-ack-1027a and pACD4K-C::Cac-ack-84s, were sequence
verified and then digested with MluI, gel purified, and self-ligated to remove
the RAM-cassette from the intron, creating pACD4K-C::Cac-ack-1027aΔRAM
and pACD4K-C::Cac-ack-84sΔRAM. The intron and ltrA gene containing sec-
tion of these plasmids were PCR amplified using primers TT1027Apa Fw and
TT84Apa Fw respectively as the forward primers and TT XhoI Rev as the re-
verse primer in both reactions. Both forward primers were designed to mutate
the HindIII site, that is used to insert the re-targeted region into the intron, to
an ApaI site because the intended clostridial shuttle vector already contained a
HindIII site in its backbone and it was therefore necessary to remove it from
the intron sequence. This also means that future IBS primers, which will have a
HindIII site incorporated near the 5′ end, will have to be adapted to so that the
corresponding nucleotides are changed to an ApaI site.
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The pACD4K-C vector relies on the T7 promoter for transcription of the in-
tron RNA but is not expected to work in C. acetobutylicum. Two native C. aceto-
butylicum promoters were selected to drive transcription of the intron RNA, Pthl
and Padc. The thiolase promoter (Pthl) provides strong, constitutive expression
while the acetoacetate decarboxylase promoter (Padc) results in even stronger
expression, but is expressed in the late-exponential and stationary phase.227,228
Both promoters were amplified from C. acetobutylicum genomic DNA using pri-
mers CA Pthl Fw and CA Pthl Rev, and CA Padc Fw and CA Padc Rev, for
Pthl and Padc respectively.
The E. coli-C. acetobutylicum shuttle vector pMTL500E was selected to sup-
ply the E. coli (ColE1) and clostridial origin of replication (pAMβ1) and resist-
ance genes (AmpR, MLSR¶) for our gene knock-out plasmids. The three parts,
vector backbone, promoter, and intron\LtrA components were three-way lig-
ated to obtain plasmids pWOK001::Cac-ack-1027a and pWOK001::Cac-ack-84s,
containing the thl promoter, and pWOK002::Cac-ack-1027a and pWOK002::Cac-
ack-84s, containing the adc promoter.
2.3.2 Generation of C. acetobutylicum Mutants
Plasmids pWOK001::Cac-ack-1027a and pWOK002::Cac-ack-1027a were used
to transform C. acetobutylicum to test if the system worked. Several erythromy-
cin resistant colonies were isolated after transformation and genomic DNA was
isolated from them after liquid cultivation under erythromycin selective pressure
to allow for intron expression. Using primers Cac ack fwd and AK1027a ebs2 to
amplify across the left gene-intron border, and primers EBS Univ and Cac ack rev
to amplify across the right gene-intron border (Figure 2.3a), resulted in PCR
products of the correct sizes (Figure 2.3b and c) for transformants harbouring
plasmid pWOK001::Cac-ack-1027a, which is based on the thl promoter. For the
adc based pWOK002 system the efficiency seemed to be much lower as only very
low levels of mutated genes were present (Figure 2.3b, lane 4).
These results suggest that adc driven expression of the intron II did only
result in low levels of correct mutants. There could be several reasons for this
observation. First of all, the adc promoter only becomes active during late ex-
ponential and stationary phase resulting in induction of the system is in a later
stage of growth. It is possible that cells at that stage are in such a condition
that the RNP complex cannot assemble, or is no longer active, because of the
drop in intracellular pH that occurs during acid production.229 However, as the
intron used is derived from Lactococcus lactis that experiences a stronger drop in
internal pH,230 this would seem less likely.
Another possibility is that cells expressing adc enter cell differentiation state
ultimately leading to spore formation, that could make their DNA unrecoverable
¶MLS; Macrolide-Lincosamide-Streptogramin resistance gene conferring resistance to,
amongst other antibiotics, erythromycin.
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Figure 2.3: (A) The ack gene of the C. acetobutylicum WUR ack– strain after success-
ful insertion of the group II intron and the location of the confirmation
primers relative to the gene; (B) PCR products after separation on an
1.0 % agarose gel using primers spanning the 5′-end of the intron;(C) PCR
products after separation on an 1.0 % agarose gel using primers spanning
the 3′-end of the intron. Templates for PCRs in lanes for both B and C:
1, Water; M, Marker; 2, gDNA WT; 3, gDNA isolate #32 (pMTL500E);
4, gDNA isolate #38 (pWOK002::Cac-ack-1027a); 5, gDNA isolate #45
(pWOK001::Cac-ack-1027a); 6, plasmid pWOK001::Cac-ack-1027a; 7,
gDNA isolate #47 (pWOK001::Cac-ack-1027a); 8, plasmid pMTL500E;
9, plasmid pWOK002::Cac-ack-1027a.
during a normal genomic DNA isolation. The recent observation that solvent
producing cells are also dividing cells seems to negate that possibility.113
Lastly, it is possible that not enough cells of a colony growing on mCGM
medium, that only contains 12.5 g/L glucose, enter solventogenesis. Prolonged
incubation and/or a growth medium that allows for solventogenesis to occur could
both help to increase the number of mutants using the adc construct.
Sequencing of the PCR products amplifying across the gene-intron borders
of the pWOK001 derived mutants, showed that insertion had taken place as
predicted by the algorithm used to detect the insertion site. Amplification
of the acetate kinase gene from genomic DNA using primers Cac ack fwd and
Cac ack rev did however show that only a small fraction of liquid culture used to
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isolate the genomic DNA from contained the insert (Figure 2.4). These results
demonstrated that the system was functional and able to insert into the insertion
site it was designed for. However, the (very) low levels of insertion detected by
amplification of the whole ack gene indicated that a quick screening method was
needed to isolate the mutants.
 1 2 3 4 5 6 7 8 9 M 
 − 8 kbp 
 − 3 kbp 
 − 2 kbp 
 − 1.5 kbp 
 − 1.2 kbp 
 − 0.5 kbp 
 − 1.0 kbp 
Figure 2.4: PCR amplification of the ack gene using primers Cac ack fwd and
Cac ack rev from genomic DNA isolated from liquid cultures of trans-
formants harbouring the pWOK001::Cac-ack-1027a plasmid. The wild
type gene product is 1.2 kbp in size the expected mutant product
is 2.3 kps. Lane 1, Water; 2 & 3, gDNA C. acetobutylicumWUR
(pMTL500E); 4, gDNA C. acetobutylicum WUR (pWOK002::Cac-ack-
1027a), clone 1; 5 & 6 & 7, gDNA of three different clones of C. acetobuty-
licum WUR pWOK001::Cac-ack-1027a; 8, gDNA C. acetobutylicumWUR
(pMTL500E); 9, gDNA C. acetobutylicum WUR (pWOK002::Cac-ack-
1027a), clone 2; M, Marker.
2.3.3 Attempts at Mutant Isolation
Use of colony PCR would allow for the analysis of large numbers of colonies
and immediately gives the desired information. To test if a C. acetobutylicum
colony PCR method could be established a preliminary test was run using stand-
ard E. coli conditions (10 minutes at 94 ◦C) and primers flanking the ack gene.
No product could be detected for colony samples, genomic DNA used as a posit-
ive control did give a product (data not shown). A literature search for a specific
method for C. acetobutylicum was fruitless. Various approaches were tried to find
a suitable method, these included the following; (i) heating the cells to 99 ◦C for
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5 minutes, (ii) microwaving the cells for 30 or 60 seconds at 900 W, (iii) addi-
tion of up to 3 % isoamyl alcohol to the reaction, and (iv) addition of up to
3 % n-butanol to the reaction, however not one was successful. A C. tetani
colony PCR protocol, employing TE-buffer and two subsequent heating steps
(60 ◦C, 30 minutes and 95 ◦C for 10 minutes), from the literature231 was tried
but without success.
As we failed to get a colony PCR method working at this stage it was de-
cided to move to a phenotypical screening method for the, presumed, acetate
kinase knock-out mutant. In the literature the isolation of various acid produ-
cing mutants after random mutagenesis has been described due to their resistance
to halogen analogues of these acids.232–235 Initially fluoroacetate was used to try
to discriminate between wild-type and mutants. Fluoroacetate resistance of the
wild-type was tested at concentrations of 5 to 50 mM in 5 mM increments, and
at 70 mM added to reinforced clostridial medium (RCM) plates. Although some
growth inhibition was seen towards the higher concentrations this was not enough
for a useful screening method. To increase the toxicity of fluoroacetate Brown et
al.232 used pyruvate as a carbon source instead of glucose.
As C. acetobutylicumcan also grow on pyruvate as the sole carbon source
this could be tested, but concerns about the highly toxic nature of fluoroacetate
to mammals (oral LD50 0.1–5.0 mg/kg), led to the testing of chloroacetate as an
alternative (oral LD50 180–350 mg/kg). Chloroacetate sensitivity of the wild-type
was assessed on RCM plates containing 0.5, 1, 2, 3, 5, and 10 mM chloroacetate.
Growth of the wild-type was reduced at 2 and 3 mM and completely repressed
at 5 mM levels. Colonies of C. acetobutylicum transformants harbouring the
pWOK plasmids with introns targeted to insert in the acetate kinase gene were
plated on 5 mM chloroacetate containing plates. Between 3 (pWOK002) and
20 (pWOK001) resistant colonies could be seen on the plates. After restreaking
on chloroacetate containing plates genomic DNA was isolated from these strains
and the acetate kinase gene was amplified by PCR using gene flanking primers.
All tested colonies showed wild-type length PCR fragments. Amplification with
an intron specific and a gene flanking primer did show that mutants were still
present but apparently were not enriched by the chloroacetate selection.
Although chloroacetate was previously successfully applied to isolate acid-
pathway mutants of various clostridial species that were subjected to random
mutagenesis, it failed to aid in isolation of a targeted ack insertional mutant.234
Interestingly 5 mM chloroacetate containing plates did result in selected growth of
a low number of colonies. These colonies were however not mutants, nor enriched
in the mutant population. It is therefore unlikely that ack inactivation gave a
growth advantage. It is possible that the presence of the intron II bearing plasmid
resulted in an additional mutation, or mutations, in the genome that resulted
in a growth advantage over the wild type cells in the presence of chloroacetate.
These mutations would most likely be associated with other acetate production or
uptake routes. The resistant cells were not further characterised but likely targets
are enzymes that are part of the acetone production pathway (ctfA and ctfB) as
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well as phospho-transacetylase (pta). To determine if additional insertions had
taken place a Southern blot, using the intron sequence as a probe, would have
been able to identify if this were the case. Inverse PCR could then have been
used to identify the gene or genes affected.
During the execution of the work described we gained access to the pMTL007
system which was also a TargeTron based knock-out system for clostridia and
it was equipped with an erythromycin-RAM allowing for selection of the integ-
rants.152 As this new system would facilitate rapid isolation of the mutant the
current work was abandoned in favour of the pMTL007 vector system. This
resulted in the successful isolation of an ack– mutant as described in chapter 3.
2.4 Conclusions and Recommendations
In this chapter we describe the development of a clostridial gene knock-out
system based the TargeTron methodology. The systems was shown to function
in C. acetobutylicum for the insertion of the intron into the acetate kinase gene.
During the development of the system we noted that Pthl seemed to be a better
promoter for expression of the intron II then the adc promoter with regard to
the tested insertion sites. Work by Heap et al. seems to confirm this as they
concluded that constitutive expression was more beneficial for mutant isolation
then inducted expression.154 The disadvantage of the original pMTL007 system
is however that system still relies on a non-removable selectable marker mak-
ing multiple mutations impossible when using the same system. We therefore
later applied a modified version of the here described pWOK001 plasmid for the
targeted inactivation of acetate kinase in an erythromycin resistant strain (see
chapter 4), thereby demonstrating that our system can be used to obtain targeted
mutants.
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Chapter 3
Disruption of the Acetate
Kinase (ack) Gene of
Clostridium acetobutylicum
Results in Delayed Acetate
Production
Abstract
In microorganisms, the enzyme acetate kinase (AK) catalyses the formation of
ATP from ADP by dephosphorylation of acetyl phosphate into acetic acid. A
mutant strain of Clostridium acetobutylicum lacking acetate kinase activity is
expected to have reduced acetate and acetone production compared to the wild
type. In this work, a C. acetobutylicum mutant strain with a selectively disrupted
ack gene, encoding AK, was constructed and genetically and physiologically char-
acterized. The ack– strain showed a reduction in acetate kinase activity of more
than 97 % compared to the wild type. The fermentation profiles of the ack– and
wild-type strain were compared using two different fermentation media, CGM
and CM1. The latter contains acetate and has a higher iron and magnesium
content than CGM. In general, fermentations by the mutant strain showed a
clear shift in the timing of peak acetate production relative to butyrate and had
increased acid uptake after the onset of solvent formation. Specifically, in acetate
containing CM1 medium, acetate production was reduced by more than 80 %
compared to the wild type under the same conditions, but both strains produced
similar final amounts of solvents. Fermentations in CGM showed similar peak
acetate and butyrate levels, but increased acetoin (60 %), ethanol (63 %) and
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butanol (16 %) production and reduced lactate (−50 %) formation by the mutant
compared to the wild type. These findings are in agreement with the proposed
regulatory function of butyryl phosphate as opposed to acetyl phosphate in the
metabolic switch of solventogenic clostridia.
3.1 Introduction
Expected shortage of petroleum in the near future and concerns regardingthe net increase of carbon dioxide emissions by fossil fuel combustion haveresulted in a search for sustainable sources for the production of transportfuels and chemicals. Butanol derived from lignocellulosic materials could
provide such an alternative method to the current petrochemical production pro-
cess.45,50 Fermentative butanol production is carried out by various clostridial
species as part of the acetone–butanol–ethanol (ABE) process.50,57,115,194 Two of
the most important drawbacks of the ABE process are the low butanol yields, due
to the formation of by-products and the toxicity of butanol itself to the cultures,
and the high costs of the separation of the different products.236
Several strategies to increase the production of butanol and reduce by-product
formation by metabolic engineering have been described.204,237 To date, only
two gene knockouts (phosphotransacetylase, pta; butyrate kinase, buk1 )126,156
and five asRNA constructs (acetoacetyl-CoA:acetate/butyrate:CoA-transferase,
ctfA and ctfB; acetoacetate decarboxylase, adc; phosphotransbutyrylase, ptb;
buk1 )124,125,174 pertaining directly to the reduction of by-product formation in
C. acetobutylicum ATCC 824 have been reported. Inactivation of buk1 resulted
in a 42 % increase in butanol levels128 while inactivation of the pta, involved
in acetate formation, did not show improved solvent production (WT A:B:E
production, 72:133:13 mM vs. 79:131:11 mM for the pta– mutant).126
In related strains, three genes have been knocked out: adc in C. acetobutyli-
cum EA 2018203 and acetate kinase (ack) and buk1, both in C. acetobutylicum
M5.129 Impairment of the acetone pathway results in all cases in increased acid
accumulation, as expected for strains that can no longer efficiently take-up acids
from the growth medium. Strain M5 is a degenerated strain, isolated after chem-
ical mutagenesis, which no longer has the pSOL1 megaplasmid and therefore is
devoid of solvent production.172 To restore solvent productivity, Nair and Pa-
poutsakis173 expressed the alcohol dehydrogenase gene (adhE), normally located
on pSOL1, in strain M5 from a replicative plasmid. Butanol and ethanol pro-
duction was restored without acetone formation, but at reduced levels compared
to the wild-type ATCC 824 strain, while large amounts of acetate and butyr-
ate accumulated in the growth medium. To reduce the acid production in this
M5 background, Sillers et al.129 created an acetate kinase knockout strain (M5
AKKO) and a butyrate kinase knockout strain (M5 BKKO). Both strains had
reduced, but not eliminated, acid accumulation corresponding to the inactivated
pathway and grew more slowly. Attempts to restore solvent formation by these
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acid production mutants by plasmid based adhE expression were unsuccessful for
the M5 BKKO strain. M5 AKKO could be transformed, but it still produced
large amounts of acetate and butyrate with reduced alcohol production compared
to the M5 adhE expressing strain.
Based on the fermentation results of the pta– and buk1 – mutants and a later
study measuring the intracellular levels of phosphorylated acids in C. acetobuty-
licum, it was proposed that butyryl phosphate is a regulatory molecule involved
in the transition from acidogenesis into solventogenesis.165 The enzymes involved
in acetate production in C. acetobutylicum, phosphotransacetylase and acetate
kinase, are encoded by the pta-ack operon. A C. acetobutylicum strain in which
the acetate kinase (ack) gene is inactivated is expected to accumulate acetyl
phosphate, a phosphorylated intermediate with a potential regulatory function
in Escherichia coli.238,239 On the contrary, a pta– mutant is not expected to accu-
mulate this intermediate.239 The influence of ack disruption on solvent production
in a wild-type background has not been studied yet. Formation of acetate, bu-
tyrate, ethanol and acetone limits the amount of metabolic precursors available
for butanol production. In our current research, we therefore focus on reducing
formation of these by-products by a targeted gene disruption. By inactivating
the genes involved in their production, we wished to investigate the effects on
the overall metabolism and butanol production. In this study, we describe a
mutant of C. acetobutylicum with an inactivated acetate kinase (ack) gene, ob-
tained using the ClosTron system for selective gene inactivation in Clostridia.152
The resulting ack– mutant has been characterized, and its fermentation profile
under batch conditions has been compared to that of the wild-type strain.
3.2 Materials and Methods
3.2.1 Bacterial Strains and Plasmids
All bacterial strains and plasmids used in this study are listed in Table 3.1.
Stock cultures of C. acetobutylicum were maintained as spore suspensions in
sterile 15 % (v/v) glycerol at −20 ◦C. Chemical competent E. coli TOP 10 cells
(Invitrogen) were used for vector maintenance and cloning.
3.2.2 Media and Growth Conditions
E. coli strains were grown in lysogeny broth (LB) medium223,224 at 37 ◦C,
200 rpm supplemented with the appropriate antibiotics. Clostridial spore sus-
pensions were prepared as previously described216 and heat-shocked for 10 min
at 70 ◦C, prior to using them as an inoculum for precultures. Liquid cultures
of C. acetobutylicum were grown in CM1 medium, based on Nimcevic et al.,240
containing per litre: yeast extract, 5.00 g; KH2PO4, 1.00 g, K2HPO4, 0.76 g; am-
monium acetate, 3.00 g; para-aminobenzoic acid (pABA), 0.10 g; MgSO4•7 H2O,
1.00 g; FeSO4•7 H2O, 0.50 g and glucose, 100 g or in CGM102 containing per litre:
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Table 3.1: Strains and plasmids
Strain or plasmid Relevant
characteristicsa
Remarks Source
Strains
E. coli TOP10 Cloning strain Invitrogen
E. coli TOP10 (pAN2) Methylation strain This study
C. acetobutylicum WUR Originally obtained as
ATCC 824 but shown to
deviate from type strain
behaviour216
Laboratory
stock
C. acetobutylicum WUR AK ack– Acetate kinase knockout
mutant of WUR strain
This study
Plasmids
pAN2 p15A ori; TcR φ3tI Methylation plasmid derived
from pAN1 but with
tetracycline resistance
selection
Laboratory
stock152
pMTL007::Cac-spo0A-242a ColE1 ori, pCB102
ori; CamR LtrA
intron II
Supplied pMTL007
backbone and is a positive
control targeted to insert
in spo0A between bp 242
and 243 in the antisense
orientation
Laboratory
stock152
pMTL007::Cac-ack-1027a ColE1 ori, pCB102
ori; CamR LtrA
intron II
Targeted to insert in ack
between bp 1027 and 1028
in the antisense
orientation
This study
pMTL007::Cac-ack-84s ColE1 ori, pCB102
ori; CamR LtrA
intron II
Targeted to insert in ack
between bp 84 and 85 in
the sense orientation
This study
a ermB, confers resistance to erythromycin; p15A ori, E. coli origin of replication; TcR, tetracycline
resistance; φ3tI, Bacillus subtilis phage gene encoding the φ3T I methyltransferase; ColE1 ori, E. coli
origin of replication; pCB102 ori, clostridial origin of replication; CamR, chloramphenicol resistance;
LtrA, the intron-encoded protein of the Lactococcus lactis Ll.LtrB group II intron.
yeast extract, 5.00 g; KH2PO4, 0.75 g; K2HPO4, 0.75 g; asparagine•H2O, 2.27 g;
(NH4)2SO4, 2.00 g; cysteine, 0.50 g; MgSO4•7 H2O, 0.40 g; MnSO4•H2O, 0.01 g;
FeSO4•7 H2O, 0.01 g and glucose, 80 g. Media were made anaerobic by flush-
ing with nitrogen gas for 10 to 30 min depending on the volume of the liquid.
All clostridial culture experiments were performed at 37 ◦C, without shaking,
and anaerobically in (a) an anaerobic chamber (Sheldon Manufacturing, Oregon,
USA; gas mixture consisting of 15 % CO2, 4 % H2 and 81 % N2) or (b) in glass
serum vials as described previously.225
Culture media were supplemented with ampicillin (100 µg/mL), chloramphe-
nicol (30 µg/mL), thiamphenicol (15 µg/mL), erythromycin (40 µg/mL stand-
ard; 5–10 µg/mL for initial mutant isolation) or kanamycin (50 µg/mL) when
appropriate. Biomass was determined spectrophotometrically (Pharmacia Bi-
otech Ultrospec 2000) based on a experimentally determined relationship between
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optical density measurements (OD600) and cell dry weight [CDW = OD600 −
0.40/2.91].
3.2.3 DNA Isolation, Manipulation and Transformation
Standard molecular work was done according to established protocols.224
DNA from C. acetobutylicum was isolated using the GenElute Bacterial Genomic
DNA Kit (Sigma-Aldrich) using the Gram-positive isolation procedure which in-
corporates a lysozyme (from chicken egg white; Fluka) treatment. E. coli plasmid
DNA was isolated by the GenElute Plasmid Miniprep Kit (Sigma-Aldrich). Both
kits were used according to the manufacturers’ instructions. DNA amplification
by PCR on C. acetobutylicum DNA was done using Pwo polymerase (Roche Dia-
gnostics), and E. coli colony PCR reactions were carried out using REDTaq DNA
polymerase (Sigma-Aldrich).
Prior to transformation into C. acetobutylicum, plasmids were methylated in
vivo147 by electroporation into E. coli TOP 10 (pAN2) cells. Electrotransform-
ation of C. acetobutylicum was carried out as previously described.142 All ma-
nipulations were carried out anaerobically and on ice. After transformation and
recovery, the cells were plated on pre-warmed plates containing thiamphenicol.
3.2.4 Primers and DNA Sequencing
All DNA primers used in the study are listed in Table 3.2. Primers were
obtained from Eurogentec (Seraing, Belgium). DNA sequencing of clones was
done by BaseClear (Leiden, The Netherlands).
Table 3.2: Primer sequences
Primer name Sequence (5′ → 3′)a
AK1027a ibs aaaaaagctt ataattatcc ttaTGTTTcT GCATAgtgcg cccagatagg gtg
AK1027a ebs1d cagattgtac aaatgtggtg ataacagata agtcTGCATA TTtaacttac ctttctttgt
AK1027a ebs2 tgaacgcaag tttctaattt cgGttAAACA Tcgatagagg aaagtgtct
AK84s ibs aaaaaagctt ataattatcc ttaGTACTcG CTAAAgtgcg cccagatagg gtg
AK84s ebs1d cagattgtac aaatgtggtg ataacagata agtcGCTAAA GGtaacttac ctttctttgt
AK84s ebs2 tgaacgcaag tttctaattt cgAttAGTAC Tcgatagagg aaagtgtct
EBS Univ cgaaattaga aacttgcgtt cagtaaac
Cac ack fwd atgaaaaact tagttattaa ctgcg
Cac ack rev ttattttaac ttgcctacta tatcttt
5402F fwd ttaaggaggt gtatttcata tgaccatgat tacg
pMTL007 rev agggtatccc cagttagtgt taagtcttgg
ErmRAM-F acgcgttata ttgataaaaa taataatagt ggg
ErmRAM-R acgcgtgcga ctcatagaat tatttcctcc cg
TT Probe f aatctgtagg agaacctatg ggaacg
TT Probe r cgcgtcgcca cgtaataaat atctgg
a Nucleotides that are not complementary to the template sequence are given in uppercase.
HindIII and BsrGI restriction sites incorporated in the primers are underlined.
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3.2.5 Construction of ClosTron Plasmids
Plasmids were constructed according to the protocol by Heap et al.152 using
the Sigma Targetron design website (www.sigma-genosys.com/targetron). The
retargeted cassettes were ligated into the pMTL007 backbone, resulting in plas-
mids pMTL007::Cac-ack-1027a and pMTL007::Cac-ack-84s. Correct plasmids
were identified by restriction digestion and by sequencing the retargeted region
using primers 5402F fwd and pMTL007 rev.
3.2.6 Induction of the ClosTron System and Mutant
Isolation and Verification
One-millilitre CGM with thiamphenicol was inoculated with a 100-µL sta-
tionary phase overnight culture and incubated for 1.5 h at 37 ◦C. Then IPTG
was added to a final concentration of 1 mM, and incubation was continued for
3 h. Cells were centrifuged at 5 200 × g for 1 min, and the supernatant was
removed. After addition of 0.5 mL PBS, cells were resuspended and centrifuged
again at 5 200 × g for 2 min. The supernatant was removed and replaced with
1-mL CGM without antibiotics. The cells were resuspended and incubated for
3 h at 37 ◦C before plating on CGM agar plates containing 5 µg/mL erythro-
mycin and incubated for 1 or 2 days at 37 ◦C. Selected colonies were restreaked
on plates containing 10 µg/mL erythromycin. Isolated mutants were checked for
absence of the 1.3-kb plasmid sized, intron I containing, ermB gene using primers
ErmRAM-F and ErmRAM-R.
3.2.7 Southern Blot
Genomic DNA of the wild type, the AK mutant and the pMTL007 plas-
mid was restriction digested using four different mixes for each sample (KpnI
and SacI, BglII and EcoRV, HindIII, HpaII). Digests were then subjected to
Southern blot analysis using a random-labelled DIG probe (Roche) and was per-
formed according to the manufacturer’s instructions. Primers TT Probe f and
TT Probe r were used to generate the probe, with pMTL007 plasmid DNA as a
template. The resulting probe hybridised to nucleotides 312 to 694 of the inser-
ted intron II sequence. Irrespective of restriction enzyme used, no DNA fragment
was released from the wild-type genomic DNA that hybridised to the probe. In
contrast, restriction fragments of the expected size were derived from both the
genome of the AK mutant and the ClosTron plasmid which gave a positive signal
on the Southern blot.
3.2.8 Cell-free Extracts and Enzymatic Activity Assays
C. acetobutylicum cells were harvested from cultures with an OD of approx-
imately 1.0 by centrifugation (15000 × g, 7 min, 4 ◦C) and resuspended in 50 mM
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MOPS buffer (pH=7.0) containing 1 mM DTT. Crude cell extracts were prepared
by French press (Thermo Scientific) homogenization (two passes at 16 000 psi).
The homogenates were centrifuged (20 817 × g, 15 min, 4 ◦C) decantated and
centrifuged as before. The cell-free extracts were stored at −80 ◦C until analysed.
AK and BK were assayed at 29 ◦C in the acyl phosphate forming direction ac-
cording to the method of Rose.241 Units of AK or BK activity were defined
as micromoles of substrate converted per minute. Acetyl phosphate was used
for preparation of a calibration curve for both reactions. Phosphotransacetylase
(PTA) and phosphotransbutyrylase (PTB) activities were measured in the acyl
phosphate forming direction by measuring the release of coenzyme A as previ-
ously described.242 Units of PTA or PTB activity were defined as micromoles of
CoA released per minute. Homogenisation and enzyme assays were carried out
aerobically. Total protein in crude extracts was determined using Quick Start
Bradford Protein Assay (Bio-Rad) with bovine serum albumin as a standard.
3.2.9 Batch fermentations of C. acetobutylicum
Fermentations were performed in 2 L bioreactors (1 L working volume) con-
trolled via a Bio Controller ADI 1010 by a PC running Bioexpert software (all
Applikon, The Netherlands). No antibiotics were used during the fermentations.
CGM batch fermentations were set up as follows: Yeast extract, phosphates,
ammonium sulphate and asparagine were autoclaved with the reactor, whereas
autoclaved glucose was added to the reactor after cooling. Metal sulphates and
cysteine were added filter-sterilised. CM1 medium-based batch fermentations
were setup by autoclaving yeast extract, phosphates and ammonium acetate with
the reactor. Autoclaved glucose was added to the reactor after cooling. Metal
sulphates and pABA were added as a filter sterilised mix.
The medium in the reactor was sparged overnight with nitrogen. Prior to
inoculation, Sigma antifoam 204 was added to the reactor (0.1 ‰). The reactor
was inoculated with 50 mL of an overnight pre-culture grown on the same medium
but supplemented with erythromycin in the case of the mutant. After inoculation,
the starting pH was allowed to fall to 5.0, after which it was controlled by addition
of 6 M ammonium hydroxide solution (CGM) or 4 M KOH (CM1). During the
fermentation, the headspace was flushed with nitrogen and the outgoing gas flow
was passed through a condenser at 4 ◦C. The agitation rate was 200 rpm.
3.2.10 Analysis of Metabolites
Metabolites present in culture supernatants (glucose, acetate, butyrate, lact-
ate, acetoin, meso-2,3-butanediol, acetone, butanol, and ethanol) were determ-
ined by HPLC as described previously216 using valeric acid as an internal stand-
ard.
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3.3 Results
3.3.1 ack Gene Disruption
Sequencing of the acetate kinase gene (ack or askA, CA C1743) of the
C. acetobutylicum WUR strain showed that it is identical to the published ge-
nomic sequence of the ATCC 824 strain (data not shown). After submitting
the gene sequence to the TargeTron website, ten possible insertion sites were re-
turned. The two top scoring ones were selected for our mutagenesis work. Each
site requires its own set of three unique primers and a general one (EBS Univ) for
the splicing by overlap extension (SOEing) PCR152,243 that is used to replace the
standard sequence with a sequence that will recognise the desired insertion site.
The first set of unique primers, consisting of AK1027a ibs, AK1027a ebs1d and
AK1027a ebs2, was used to target the intron to insert in the anti-sense orienta-
tion between base pairs 1027 and 1028 of ack. The second set of unique primers,
consisting of AK84s ibs, AK84s ebs1d and AK84s ebs2, targeted the intron to
insert in the sense orientation between base pairs 84 and 85 (Table 3.2).
The retargeted plasmids were constructed as described in the materials and
methods section. Transformation of the plasmids, selection and induction of
the intron II system resulted in erythromycin-resistant colonies. Colonies were
screened for insertion in the ack gene by PCR on genomic DNA using primers
Cac ack fwd and Cac ack rev. Of the eight colonies screened, three were positive
for insertion between base pairs 1027 and 1028. Of the 16 screened colonies
that contained the pMTL007::Cac-ack-84s construct, none showed insertion in
the ack gene. All of the screened colonies tested positive by PCR for a correctly
sized ermB gene of approximately 900 bps (the length of the active, genomically
inserted, ermB gene). This shows that in the cases where the ack gene was not
affected, the intron II must have integrated somewhere else in the genome.
The insertion efficiency at the intended site of the pMTL007::Cac-ack-84s
system appeared to be lower than that for the pMTL007::Cac-ack-1027a system,
and therefore, no further attempts were made to isolate a mutant with insertion
at the 84/85 site. One of the successful 1027a insertants was selected and further
purified by re-streaking on fresh erythromycin plates. DNA isolated from this
mutant strain was analysed by PCR amplification of the full-length ack gene
using primers Cac ack fwd and Cac ack rev. Only a 3.0-kbp PCR product was
obtained, corresponding to the ack gene with an inserted intron. The absence
of a wild type, 1.2 kbp amplicon, indicated that a pure culture was obtained
(Figure 3.1). Loss of the pMTL007 plasmid by the mutant was confirmed by PCR
using the ermB gene primers (not shown). To check if only one copy of the intron
had inserted in the genome, a Southern blot was performed. The probe employed
was complementary to nucleotides 312 to 694 of the inserted intron sequence.
Only bands, corresponding to the expected sizes, were detected (Figure 3.2 and
Figure 3.3). Also this analysis confirmed that pMTL007 plasmid DNA was not
present in the sample. Insertion of the intron II at the intended site in the ack
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gene was confirmed by sequencing (data not shown). Spore suspensions from
the obtained mutant, designated C. acetobutylicum AK, were used for further
studies.
  
Fig. S1 PCR products obtained after amplification of the askA gene, using 
primers Cac_askA_fwd and Cac_askA_rev, from genomic DNA isolated 
from the AK mutant (lane 1) and wild type (lane 2) 
  
Figure 3.1: PCR products obtained after amplification of the ack gene, using primers
Cac ack fwd and Cac ack rev, from genomic DNA isolated from the AK
mutant (lane 1) and wild type (lane 2).
3.3.2 Activities of Acetate and Butyrate Pathway Enzymes
The characterisation of the mutant was performed using two different media.
CGM medium, which has been used previously for the characterisation of similar
mutants126 and does not contain acetate, was selected in order to be able to
compare our results to earlier reports and to observe acid production without
background levels, while CM1 medium is used routinely in our laboratory for
growth experiments and contains 39 mM acetate and a higher concentration of
iron and magnesium than CGM.
To confirm functional inactivation of acetate kinase, cell-free extracts of ex-
ponentially growing cultures were assayed for enzyme activities involved in acid
production. The determined specific enzyme activities are shown in Table 3.3.
Acetate kinase enzyme activity in cells from cultures grown in both media was
reduced by more than 97 % compared to the wild type. The PTA activity, en-
coded by the pta gene which resides upstream of ack in the same operon, was
also negatively affected by the insertion, being reduced by 41 % in CM1 medium
and 29 % in CGM. Interestingly, BK activity, involved in butyrate production
and encoded by the ptb-buk1 operon, also showed reduced activity in both media.
While PTB activity was still comparable (90 % and 100 % activity of the wild
type in CM1 and CGM medium, respectively), BK activity was reduced to 72 %
and 53 % activity of the wild type in, respectively, CM1 and CGM medium.
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Fig. S2a Southern blot analysis of undigested (lanes 1 through 3) and digested 
(lanes 4 through 9) genomic DNA of: C. acetobutylicum WUR (WT), 
C. acetobutylicum WUR ack— mutant (AK); and plasmid pMTL007 (P) 
DNA. The probe hybridises to a 383 bp long part of the inserted intron II 
sequence and was generated as described in the materials and 
methods. Samples in lanes 4 through 6 were digested with HindIII and 
samples in lanes 7 through 9 were digested with HpaII. Expected 
fragment sizes are 3391 bp (HindIII) and 6848 bp (HpaII) for the AK 
strain. Marker lanes are indicated with M and sizes of the bands are 
shown on the right. Only AK and plasmid DNA samples gave a positive 
signal.  
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ure 3.2: Southern blot analysi of undigested (lanes 1 through 3) and igested
(lanes 4 through 9) genomic DNA of: C. acetobutylicum WUR (WT),
C. acetobutylic m WUR ack– mutant (AK); and plasmid pMTL007 (P)
DNA. The probe hybridises to a 383 bp long part of the inserted intron II
sequence and was generated as described in the materials and methods.
Samples in lanes 4 through 6 were digested with HindIII and samples in
lanes 7 through 9 were digested with HpaII. Expected fragment sizes are
3391 bp (HindIII) and 6848 bp (HpaII) for the AK strain. Marker lanes
are indicated with M and sizes of the bands are shown on the right. Only
AK and plasmid DNA samples gave a positive signal.
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Fig. S2b Southern blot analysis of digested genomic DNA of: C. acetobutylicum 
WUR (WT), C. acetobutylicum WUR ack— mutant (AK); and plasmid 
pMTL007 (P) DNA. The probe hybridises to a 383 bp long part of the 
inserted intron II sequence and was generated as described in the 
materials and methods. Samples in lanes 1 through 3 were digested 
with both KpnI and SacI, samples in lanes 4 through 6 were digested 
with both BglII and EcoRV. Expected fragment sizes are 2634 bp 
(KpnI/SacI) and 5056 bp (BglII/EcoRV) for the AK strain. Marker lanes 
are indicated with M and sizes of the bands are shown on the right. 
Only AK and plasmid DNA samples gave a positive signal. 
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Figure 3.3: Southern blot analysis of digested genomic DNA of: C. acetobutylicum
WUR (WT), C. acetobutylicum WUR ack– utant ( K); and plasmid
pMTL007 (P) DNA. The probe hybridises to a 383 bp long part of the
inserted intron II sequence and was generated as described in the materials
and methods. Samples in lanes 1 through 3 were digested with both KpnI
and SacI, samples in lanes 4 through 6 were digested with both BglII and
EcoRV. Expected fragment sizes are 2634 bp (KpnI/SacI) and 5056 bp
(BglII/EcoRV) for the AK strain. Marker lanes are indicated with M and
sizes of the bands are shown on the right. Only AK and plasmid DNA
samples gave a positive signal.
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3.3.3 Characterisation of the C. acetobutylicum
AK Mutant in Batch Cultures on CM1 Medium
Product formation by the mutant strain was studied using pH-controlled batch
cultures. The initial pH of the cultures was 6.6, and it was allowed to drop to
5.0 before it was controlled by addition of potassium hydroxide. Final product
concentrations of duplicate fermentations after approximately 47 h are presented
in Table 3.4. Figure 3.4 shows a typical fermentation profile in this medium.
During fermentations by the wild-type strain on CM1 medium, both acetate and
butyrate accumulated in the broth during the acidogenic phase of the fermenta-
tions. Butyrate production reached an average maximum of 62 mM, whereas the
maximum average acetate concentration was 85 mM, a 43-mM increase relative
to the starting concentration of 42 mM (Table 3.4). Both acids were, to some ex-
tent, taken up during the solventogenic phase of the fermentation. Butyrate levels
dropped to around 16 mM, but acetate levels remained 27 mM above the starting
concentration (Figure 3.4a). Solvent production by the wild type reached con-
centrations of 161, 101 and 30 mM for butanol, acetone and ethanol, respectively.
The C. acetobutylicum AK strain consumed somewhat less glucose but had in-
creased acetate assimilation. Final concentrations of solvents of C. acetobutylicum
AK strain fermentations (157, 98 and 35 mM for butanol, acetone and ethanol,
respectively) were similar to those in wild-type fermentations. The production
of acids by the AK mutant was markedly different. Acetate levels increased with
only 9 mM, a reduction of 79 % compared to the wild-type strain. The maximum
butyrate levels were also lower compared to the wild-type fermentations (47 vs.
62 mM; Figure 3.4c). During the solventogenic phase of fermentations by the
AK strain, butyrate was re-assimilated to reach similar levels as in fermentations
by the wild-type strain. Contrary to butyrate, the acetate re-assimilation by the
AK mutant resulted in net consumption (7 mM) of initially present acetate.
3.3.4 Characterisation of the AK Mutant in Batch
Cultures on CGM Medium
To allow more precise monitoring of acetate levels, we characterised the mu-
tant in CGM medium, which contrary to CM1 does not contain any acetate.
In addition, CGM medium has been used in earlier fermentation studies with
C. acetobutylicum.126 Figure 3.5 shows typical optical density and production
profiles of acids and solvents from wild-type and AK strain fermentations. The
average product levels for three independent fermentations per strain after a
minimum of 72 h are shown in Table 3.4 (page 65). Fermentations by the AK
mutant strain consistently reached a higher biomass concentration than the wild
type. Typical values of dry weight biomass concentration obtained were 4.5 ±
0.3 mg/mL for the wild-type and 5.5±0.1 mg/mL for the AK mutant (Table 3.4).
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Figure 3.4: Typical optical density and production profile of a wild-type (a and b)
and AK mutant strain (c and d) fermentation in pH 5.0 controlled batch
reactors using CM1 medium containing 100 g/L glucose. a, c Production
of acids −N− acetate, −− butyrate, −×− lactate, solid line pH, −−
OD600. b, d Production of solvents −4− ethanol, −− butanol, −#−
acetone, −×− acetoin, −− OD600.
An interesting observation was that the fermentation broths from the AK mutant
strain showed an intense yellow colour at the end of every fermentation, which
was not the case for wild-type cultures. Spectrofotometrical analysis of the broth
supernatant gave a local absorption maximum at 450 nm, suggesting increased
build-up of riboflavin (vitamin B2) in the medium.
During the fermentation, acetate was still produced by the AK strain but at
slightly reduced maximum levels (WT 30 mM, AK 26 mM) compared to the wild
type, as is shown in Figure 3.5, c. Maximum butyrate levels also did not seem
to be affected to a great extent, with somewhat higher values for the mutant
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Figure 3.5: Typical optical density and production profile of a wild-type (a and b)
and AK mutant strain (c and d) fermentation in pH 5.0 controlled batch
reactors using CGM containing 80 g/L glucose. a, c Production of acids
−N− acetate, −− butyrate, −×− lactate, solid line pH, −− OD600.
b, d Production of solvents −4− ethanol, −− butanol, −#− acetone,
−×− acetoin, −− OD600.
(WT 38 mM, AK 43 mM). There was, however, a clear difference at what time
point, compared to one another, the maximum acetate and butyrate levels were
reached. The production of acetate by the AK mutant was delayed compared
to that of butyrate. This difference was best observed by plotting the ratio
between butyrate and acetate at various time points (Figure 3.6). From the start
of the fermentation by the wild type, the ratio between butyrate and acetate
rose, levelling off after 9 h at 1.5 and stayed at that ratio for 7 h. The ratio in
fermentations by the AK strain continued to increase with a maximum of 4.3 after
14 h. The ratio then decreased to similar levels as those observed for the wild
type, and both reached a minimum of 0.1. Analysis of the fermentations with
CM1 medium gave a similar difference in acid ratio production (Figure 3.6b).
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a b 
Figure 3.6: Butyrate–acetate ratios in CGM (a) or butyrate-relative acetate ratios
CM1 (b) of a wild-type strain (−4−) and AK mutant strain (− −)
fermentation in pH 5.0 controlled batch reactors. On the horizontal axis,
normalized time is plotted to account for variations in lag time of the
cultures. In the graph, 9 h corresponds to an OD600 of 1.0. Relative
acetate is calculated by the subtracting the initial acetate level at time of
inoculation from the measured acetate levels later during the fermentation.
Lactate, normally only detected at low levels,57,126 if at all, in C. acetobu-
tylicum ATCC 824 fermentations in CGM medium, was produced in all three
fermentations by C. acetobutylicum WUR (57 ± 7 mM). The AK mutant also
produced lactate but consistently at lower levels (28± 2 mM). Various attempts
— filter sterilisation of minerals, reduced stirring speed, extended sparging time
with nitrogen gas before inoculation — were made to reduce lactate production
in fermentations by the wild-type, but without success.
Butanol and ethanol production by the AK mutant were, respectively, 16 %
and 59 % higher compared to the wild-type production. Acetone production
levels were not significantly affected. The conversion of glucose to butanol by the
mutant had increased with 19 %, and total solvent yields from glucose were up
with 21 % (0.54 mol ABE/mol glucose consumed vs. 0.66 mol ABE/mol glucose
consumed). The final concentration of the by-product acetoin had increased with
58 %, from 15 mM with the wild type to 24 mM for the mutant.
3.4 Discussion
The inactivation of the butyrate kinase (buk1 ) gene of C. acetobutylicum
has previously been shown to result in reduced butyrate formation, increased
peak acetate levels and increased butanol and ethanol production.128 Acetone
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is one of the major by-products of butanol production as it is formed as a con-
sequence of the uptake of acids from the medium. It has been shown through
a computational approach that even under solvent forming conditions acetate
production continues, while extracellular acetate levels drop.75 Produced acetate
is continuously converted to acetyl-CoA, mediated by the enzyme acetoacetyl-
CoA:acetate/butyrate:CoA transferase, ultimately resulting in acetone produc-
tion. This approach allows C. acetobutylicum to continue acetate-mediated ATP
generation during the solventogenic phase. With the aim to reduce the formation
of acetate and indirectly that of acetone, by C. acetobutylicum, we have inactiv-
ated the acetate kinase (ack) gene which encodes the enzyme catalysing the last
step in acetate production. In this substrate level phosphorylation reaction, the
phosphate group of acetyl phosphate is transferred to ADP, generating ATP and
acetate. In addition, we were interested to see if solvent formation would be
similarly beneficially affected, as reported for buk1 gene disruption.128
In this study, site-directed gene disruption was accomplished by integration of
a group II intron using the ClosTron system.152 This system is markedly different
from the non-replicative plasmid integration-based approach used for the previ-
ously generated buk1 and pta mutants of C. acetobutylicum.126 Mutations based
on single cross-over recombination are inherently unstable, whereas insertion of
the group II intron in the anti-sense orientation, relative to the gene, results
in permanent inactivation.152 The ClosTron and a similarly adapted TargeTron
system156 have been used to generate various mutants, including adc and hbd
knockout mutants.176,203
Successful insertion of the intron after transformation of pMTL007::Cac-ack-
1027a would, after translation of the mutated gene, truncate the native sequence
of the AK protein at amino acid 342. However, additional intron sequence en-
coded amino acids will be added to the native sequence. In the case of insertion
after nucleotide 1027, the sequence would be extended by 86 amino acids, so
intron insertion actually results in a protein that is 27 amino acids longer than
the native enzyme.
Although the retrohoming system of the group II introns is expected to be
site-specific, it is possible that no or only a limited number of correctly positioned
insertants can be found.152,226 Our results show efficient insertion into insertion
site 1027a, but for insertion site 84s, 16 screened colonies did not yield a correct
insertant. These results emphasise the need to test multiple insertion sites when
using TargeTron-based systems.
AK activity in the AK mutant was less than 3 % of the wild-type enzyme
activity (Table 3.3), demonstrating that while the insertion was close to the 3′-
side of the ack gene, it still resulted in functional inactivation of the enzyme. A
study by Singh-Wissmann et al.244 showed that a conserved glutamate residue in
sequence of the AK of Methanosarcina thermophila near the C-terminus is essen-
tial for enzyme activity. This glutamate is conserved in acetate kinase sequences
from widely divergent organisms and is also present in the C. acetobutylicum
AK.244 In our AK strain, this glutamate residue is not present anymore, so no
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activity from the enzyme encoded by the disrupted gene is expected, which is in
line with the low enzyme activities observed (Table 3.3).
It was expected that disruption of acetate kinase would result in decreased
acetate levels and increased butyrate levels to compensate for the loss in ATP
production,245 but this was not immediately observed. In both tested media,
the AK mutant strain had peak butyrate levels that were lower than those for
the wild type, while peak acetate levels were reduced compared to wild-type
fermentations. Final acetate levels were equal (CGM), or reduced in comparison
to wild-type fermentations.
The fact that inactivation of AK does not abolish acetate production has
been previously observed in both Clostridium tyrobutyricum246 and the degen-
erated C. acetobutylicum strain M5.129 In the C. tyrobutyricum ack– strain, the
fermentation time was extended and both acetate and butyrate levels surpassed
those of the wild type. The M5 ack– strain (M5 AKKO) produced acetate at re-
duced levels but with similar butyrate formation. When a plasmid-based alcohol
dehydrogenase (aad) is expressed in M5 AKKO, acetate production is again high
(180 mM) while butyrate production levels are depended on the fermentation pH
ranging from 75 mM for pH 5.5 to 287 mM for pH 6.0 fermentations.129 Lee et
al.245 suggest that an alternative acetate-producing pathway is operational in the
M5 AKKO mutant. This could also be applicable to our WUR strain and derived
mutants.
Green et al.126 reported on another acetate pathway mutant in C. acetobuty-
licum which the pta gene was inactivated. They reported reduced acetate levels
and increased butyrate levels compared to the WT under conditions favouring
acid formation (pH 5.5). Later data from Zhao et al.165 from static flask batch
cultures showed that acetate levels were reduced by approximately 50 %, while
butyrate levels were unaffected under these conditions. Both culturing condi-
tions are different from those employed in this study and complicate a direct
comparison. While higher butyrate levels seem to correlate with increasing pH,
the reduction in acetate is common to both. This would be in agreement with
our lower butyrate levels at pH 5.0, but not with the acetate levels that we ob-
served. Apparently an AK negative mutant is more likely to produce acetate
than a mutant in which PTA is inactivated. A similar observation can be made
for C. tyrobutyricum pta– and ack– mutants246,247 and is likely due to the operon
structure in both species in which ack is located downstream of pta.
Besides an alternative acetate forming pathway, another possible explanation
for the continued acetate production by the ack– mutants could be that acetate
production is catalysed by BK. BK from C. acetobutylicum is active on acetate
with 6 % relative activity, in the acetyl phosphate-forming direction, compared
to butyrate, based on in vitro data.248 Although BK activity is reduced in CGM
medium (Table 3.3), Desai and Papoutsakis174 showed that even if BK activity
is reduced by more the 80 % in an asRNA mutant, butyrate fluxes remain unaf-
fected and butyrate accumulates in the growth medium. Apparently the butyrate
production pathway has a far greater catalytic capacity, which could possibly be
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used for acetate formation.
CM1 and CGM media differ mainly in the respect that the former contains
more iron, magnesium and 39 mM acetate. The marked differences between
fermentation performances by the wild-type and C. acetobutylicum AK strains
grown on each medium are evident from the data presented in Table 3.4. In
CM1 medium acetate production is strongly reduced (AK mutant 9 mM vs.
WT 43 mM, both in addition to the starting concentration of 42 mM), while
in CGM medium the peak acetate concentrations are quite similar (AK 26 mM,
WT 30 mM). The possible effect that additional acetate in the medium has could
be an indication that the intracellular metabolism involved in acetate production
in the AK strain is sensitive to elevated levels of extracellular acetate. Future
experiments using CM1 medium with varying, initial, concentrations of acetate
can help to determine if the same maximum acetate concentration of 50 mM is
reached for both lower and higher starting concentrations of acetate. This would
support our current observation that acetate production is inhibited at a lower
concentration (50 mM) in the AK strain than for the wild type, which accumu-
lates more than 80 mM of acetate in CM1 medium under the same conditions.
This is similar to strain ATCC 824 that accumulates up to 71 mM in CGM
medium.128
In both media, however, an important difference that was observed between
the mutant and the wild-type strain was the delay in the acetate production. In
the wild-type strain fermentations, acetate and butyrate production occurs with
approximately 1.5 (CGM) or 1.8 times (CM1) as much butyrate formed compared
to acetate. Figure 3.6 clearly shows that the AK mutant produces considerably
more butyrate [1.86 times (CGM) and 7.2 times (CM1)] than acetate in the be-
ginning of the fermentation, in line with the expectation that acetate production
would be negatively affected by an AK disruption. It appears that when the bu-
tyrate concentration has reached its maximum level, only then acetate production
is allowed to reach its full potential if no extracellular acetate is present (CGM
medium). If indeed BK is involved in acetate formation, then competition of
acetyl-phosphate and butyryl-phosphate for the available enzyme could explain
the delayed acetate production.
In CGM fermentations, lactate production was seen with both the wild type
and the mutant. Interestingly enough, the AK mutant strain made consider-
ably less lactate, but more acetoin. The increase in acetoin (9 mM), however,
is not enough to account for the full reduction in lactate production (29 mM),
but only for up to 62 %. Production of acetoin does not require oxidation of
a reducing equivalent (NADH)249 as is needed for lactate production. This ad-
ditional reduction capacity could have possibly been used for solvent formation
instead. Lactate production in CGM fermentations has been reported before
(approximately 70 mM)126 but only for mutants, not for the WT. It seems that
in our hands, C. acetobutylicum WUR, contrary to the ATCC 824 strain, is more
likely to produce lactate under these fermentation conditions in CGM, whereas
it does not do so in CM1 medium. This is the second difference that we have
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observed, next to meso-2,3-butanediol production.216 A likely explanation for
this behaviour could be that the WUR strain is sensitive to lower levels of iron
and/or magnesium compared to the ATCC 824 strain. Both these metal ions are
co-factors in various oxidoreductase enzymes. If the activity of these enzymes
is compromised, then remodelling of the flow of reducing equivalents within the
cell, ultimately leading to lactate formation, could be the result.
Inactivation of the acetate pathway in the AK mutant is expected to lead to
accumulation of acetate-preceding intracellular intermediates, such as acetyl-CoA
and acetyl-phosphate. These higher intracellular levels could then alter product
formation of ethanol and metabolically more upstream intermediates such as
lactate and acetoin.250 The increased acetoin and ethanol levels in the AK mutant
CGM fermentations follow the expected trend (Table 3.4). The reduced lactate
production levels of the AK mutant, relative to those by the wild-type, are not in
line with this expectation. The wild-type C. acetobutylicum WUR strain showed
(high) lactate production levels on CGM in contrast to strain ATCC 824 which
produced none under similar conditions.128,174 This dissimilarity could be due to
a different regulation of gene expression or different enzymatic properties of the
iso-enzymes involved in lactate formation in both strains.
Out rationale for disrupting AK activity was that it is expected to result
in intracellular accumulation of acetyl-phosphate. This accumulation could po-
tentially be a molecular trigger239 resulting in an observable phenotype, akin
to butyryl-phosphate accumulation after buk1 disruption.128 In CGM, there was
significant increase in acetoin, ethanol and butanol formation by the AK mutant;
however, the fermentations of both the wild type and to a lesser extent the AK
mutant were affected by lactate production. In CM1 medium, hardly any lactate
was produced by both strains. The AK mutant produced at peak levels 34 mM
(79 %) less acetate compared to the wild-type strain, but no changes in the other
fermentation products were seen. This supports the earlier observations of Green
et al.126 and Zhao et al.165 that acetate pathway disruption in C. acetobutylicum
does not result in altered solvent production.
Despite the absence of an effect on acetone and butanol formation in ferment-
ations in CM1 medium, AK inactivation did result in increased acetate uptake in
that medium and increased butyrate uptake in CGM fermentations (Table 3.4).
Acetate production was only impaired when acetate was present in the medium
(CM1), but in both CGM and CM1, an altered initial acetate/butyrate product
ratio was observed showing a reduced acetate production rate. The absence of
an impact on solvent production by the pta– mutant of Green et al.126 and our
AK mutant in CM1 medium is in agreement with the prediction by Zhao et al.165
that levels of acetyl phosphate are not linked with induction of solvent forma-
tion. Potential other roles of acetyl phosphate cannot be excluded based on these
experiments. It is of further interest to note that the accumulation of a yellow
compound in the fermentation broth is likely to be riboflavin251,252 which can help
to facilitate the economic competitiveness of the ABE fermentation process.253
We now propose the construction of an alcohologenic strain, which is unable
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to produce either acetate or butyrate and subsequently will not produce acetone
because there are no acids to be taken up from the medium. Ideally this strain
would produce only the alcohols butanol and ethanol when grown on glucose.
Construction of such a strain would require the combined knockout of both acet-
ate kinase (ack) and butyrate kinase (buk1 ), so that it would no longer be able
to perform the, proposed, in vivo complementation of acetate production by bu-
tyrate kinase. Such a mutant would also allow us to test whether the remaining
acetate production in our AK mutant is due to complementation of the enzyme
activity by butyrate kinase or if one or more alternative acetate-forming pathways
operate in C. acetobutylicum. We are currently investigating this option.
3.5 Acknowledgements
The authors would like to thank Ms H. van der Wal for her technical support.
This project is financially supported by the Netherlands Ministry of Economic Af-
fairs and the B-Basic partner organisations (www.b-basic.nl) through B-Basic, a
public–private Netherlands Organisation for Scientific Research–Advanced Chem-
ical Technologies for Sustainability programme.
Open Access
This article is distributed under the terms of the Creative Commons Attribu-
tion Noncommercial License which permits any noncommercial use, distribution,
and reproduction in any medium, provided the original author(s) and source are
credited.
72
3 
73
This chapter will be submitted as:
Wouter Kuit, John van der Oost, Serve´ W. M. Kengen, Ana M. Lo´pez-Contreras and Gerrit
Eggink; “Fermentation Analysis of a Novel Clostridium acetobutylicum buk1– Mutant and
C. acetobutylicum buk1– ack– Double Mutant”
4 
Chapter 4
Fermentation Analysis of a
Novel Clostridium
acetobutylicum buk1–
Mutant and
C. acetobutylicum buk1–
ack– Double Mutant
Abstract
Clostridium acetobutylicum ATCC 824 with an inactivated butyrate kinase (buk1 )
gene is under optimised conditions one of the best butanol producing strains re-
ported to date. By comparison a buk1 knock-out mutant of the C. acetobutylicum
WUR strain does not sporulate and no longer has a bi-phasic growth pattern.
It produces mainly butanol and acetate combined with low levels of acetone,
ethanol and butyrate. At a pH of 5.5, in medium without added acetate the
mutant strain produces 195 mM butanol, 127 % more than the wild type un-
der the same conditions and 21 % more than the wild type under its optimal
conditions. In order to decrease acid formation an ack– buk1 – double mutant
was constructed by selectively disrupting acetate kinase. This mutant however
continued to produce both acetate and butyrate during fermentation at various
tested pH levels. In a non-pH controlled batch fermentation final acids levels
were very low (9 mM), but still 55 mM acetone was produced combined with
131 mM butanol and 98 mM ethanol. At pH 6.0 alcohol production was lower
(butanol 125 mM, ethanol 23 mM), no acetone was formed, but high levels of
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acetate (120 mM) and butyrate (47 mM) were produced combined with acetoin
(61 mM) and lactate (21 mM). These results suggest that there are alternative
acid producing pathways active in these mutants and possibly in the wild type
strain.
4.1 Introduction
The current energy demand of the human population of this earth is far fromsustainable with now in use methods. The expected trend for the future isthat the energy demand will only increase, mainly due to increasing mater-ial wealth of an ever growing population.254 These trends, combined with
increasing energy security demands, have resulted in a search for sustainable
sources for production of transport fuels and chemicals. Fermentation of ligno-
cellulosic materials into butanol could be such an alternative method for the cur-
rent petrochemical production process.20,45 Fermentative production of butanol
is carried out by various Clostridial species as part of the acetone-butanol-ethanol
(ABE) process.57,115,194 To date, two of most important drawbacks that prevent
commercial reintroduction of the ABE process are the low butanol yields, due to
the formation of by-products and the toxicity of butanol itself to the cultures,
and the high costs of the separation of the different products.236
Several strategies to increase the production of butanol and reduce by-product
formation by metabolic engineering have been described.204,237 One of the most
successful approaches to increase butanol production levels has been the inac-
tivation of the enzyme butyrate kinase (BK) of Clostridium acetobutylicum in-
volved in the ATP generating conversion of butyryl-phosphate to butyrate.128
Butyryl-phosphate itself is produced from butyryl-CoA through the action of
phospho-transbutyrylase (ptb). Single crossover homologous recombination of a
suicide plasmid into the buk1 gene resulted in a decrease of 81 % of in vitro
BK activity126 and 42 % more butanol compared to wild type levels.128 Shao et
al. disrupted buk1 using a TargeTron based system and also observed a similar
relative increase in butanol production.156 Besides an increase in butanol levels
also ethanol and, acid phase associated, acetate production is increased in buk1 –
mutant fermentations. Conversely, butyrate peak and final levels are reduced by
76 % and 61 %, respectively.
Recently Lehmann and co-workers reported on acid pathway mutants with
an inactivated phospho-transacetylase pta179 or ptb gene.166 The pta knock-out
mutant was unaffected in its fermentation profile under the conditions tested,
contrary to the results of Green et al.126 who reported reduced acetate and in-
creased peak butyrate levels. When the acetone production pathway was also
inactivated in a pta– background a reduction of acetate and an increase in butyr-
ate levels were observed combined with overall severely reduced solvent levels.179
The ptb– mutant no longer produced any butyrate, ethanol was increased 17-fold,
but acetone and butanol levels were reduced.
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In the related degenerated strain C. acetobutylicum M5, lacking the pSOL1
megaplasmid and therefore devoid of solvent production,172 Sillers et al. created a
butyrate kinase knock-out strain (M5 BKKO) and acetate kinase knock-out strain
(M5 AKKO).129 Both M5 knock-out strains had reduced, but not eliminated, acid
accumulation corresponding to the inactivated pathway, and grew more slowly.
Attempts to restore solvent formation by these acid production mutants using
plasmid based expression of an alcohol dehydrogenase, adhE, was unsuccessful
for the M5 BKKO strain. M5 AKKO could be transformed but it still produced
large amounts of acetate and butyrate with reduced alcohol production compared
to the wild type and M5 adhE expressing strain.173 Sillers et al. attributed
their inability to transform M5 BKKO with the adhE expression plasmid to the
organism’s low growth rate and the inflexibility of the M5 strain to redistribute
reducing equivalents over the various metabolic end products.129
The wild type is expected to be endowed with this flexibility as demonstrated
by the alcoholic cultures that have been reported which produce mainly butanol
and ethanol.255–259 Although this is a desirable fermentation characteristic it
requires either reduced co-substrates such as glycerol or the use of redox dyes such
as methyl viologen. We wanted to achieve an alcohologenic fermentation through
metabolic engineering of C. acetobutylicum by inhibiting production of acetate
and butyrate and in this way, remove acetone production. By inactivating acetate
kinase (AK) in C. acetobutylicum we endeavoured to reduce acetate production
and increase solvent formation.217 Acetate production by this C. acetobutylicum
AK mutant was not stopped, but only delayed, and overall butanol formation
was not significantly improved.
In various publications it has been suggested that the corresponding enzyme
of the other acid pathway compensates the inactivated one.126,179 To test the
hypothesis that the BK enzyme complemented AK enzyme activity in the ack–
mutant we aimed to construct an ack– buk1 – double mutant. As a first step we
wanted to confirm that the buk1 gene in our C. acetobutylicum WUR strain could
be disrupted as reported for the ATCC 824 strain.126,156 Others have reported
that attempts to disrupt the buk1 gene in all cases also resulted in inactiva-
tion of the upstream gene ptb, encoding phospho-transbutyrylase.260 Here we
demonstrate that buk1 disruption in strain C. acetobutylicum WUR is possible,
while retaining PTB activity, but results in a different phenotype than previously
described for the ATCC 824 buk1 – strain (PJC4BK). The resulting strain was
asporogenic and produced mainly acetate and butanol without the characteristic
solvent switch. Subsequently an ack– buk1 – double mutant was generated result-
ing in wild type-like behaviour, including an initial acid phase, but with reduced
final butyrate levels and strongly increased acetoin accumulation.
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4.2 Materials and Methods
4.2.1 Bacterial strains and plasmids
All bacterial strains and plasmids used in this study are listed in Table 4.1.
Stock cultures of C. acetobutylicum were maintained as spore suspensions in
sterile 15 % (v/v) glycerol at −20 ◦C. The non-sporulating strains BUK1KO
and DAPKO were stored by adding glycerol (87 % (v/v) to an in mCGM grown
overnight culture) to a final concentration of 15 % (v/v). The culture was then
transferred, inside the anaerobic cabinet, to a thick-walled glass tube with a screw
cap [supplied with Hach Lange (NL) test kits]. A butyl-rubber stopper [hight:
8 mm, Rubber B.V. (NL)] was inserted in the opening before screwing the cap
on, to prevent oxygen entering the tube. Tubes were then stored at −80 ◦C.
Alternatively 5 mL of grown liquid cultures were added to nitrogen flushed serum
flasks(10 mL, capped with a thick butylrubber stopper and a crimp cap seal)
containing glycerol, also these were stored at −80 ◦C. Chemical competent E. coli
TOP 10 cells (Invitrogen) were used for vector maintenance and cloning.
4.2.2 Media and growth conditions
E. coli strains were grown in lysogeny broth (LB) medium223,224 at 37 ◦C,
200 rpm supplemented with the appropriate antibiotics. Clostridial spore sus-
pensions were prepared as previously described216 and heat-shocked for 10 min
at 70 ◦C, prior to using them as an inoculum for precultures. Non-sporulating
strains were revived from storage at −80 ◦C by overnight growth in mCGM.216
Liquid cultures of C. acetobutylicum strains were grown in CM1 medium217 either
with or without acetate as indicated, and 100 g/L glucose. Media were made an-
aerobic by flushing with nitrogen gas for 10 to 30 min depending on the volume of
the liquid. All clostridial culture experiments were performed at 37 ◦C, without
shaking, and anaerobically in (a) an anaerobic chamber (Sheldon Manufacturing,
Oregon, USA; gas mixture consisting of 15 % CO2, 4 % H2 and 81 % N2) or (b)
in glass serum vials as described previously.225
Culture media were supplemented with ampicillin (100 µg/mL), chloram-
phenicol (12.5 µg/mL), thiamphenicol (12.5 µg/mL), erythromycin (40 µg/mL
standard; 5–10 µg/mL for initial mutant isolation), or kanamycin (50 µg/mL)
when appropriate. Biomass was determined spectrophotometrically (Pharmacia
Biotech Ultrospec 2000) as previously reported.217
4.2.3 DNA isolation, manipulation and transformation
Standard molecular work was done according to established protocols.224
DNA from C. acetobutylicum was isolated using the GenElute Bacterial Genomic
DNA Kit (Sigma-Aldrich) using the Gram-positive isolation procedure which in-
corporates a lysozyme (from chicken egg white; Fluka) treatment. E. coli plasmid
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DNA was isolated by the GenElute Plasmid Miniprep Kit (Sigma-Aldrich). Both
kits were used according to the manufacturers’ instructions. Restriction enzymes
were from Fermentas or NEB, T4 DNA polymerase and T4 DNA ligase were from
NEB. DNA amplification by PCR on isolated C. acetobutylicum DNA was done
using Pwo polymerase (Roche Diagnostics). Colony PCRs (cPCRs) on E. coli
were carried out using REDTaq ReadyMix PCR Reaction Mix (Sigma-Aldrich)
and cPCRs on C. acetobutylicum were done using 2× DreamTaq Green PCR
Master Mix (Fermentas, now Thermo Fischer Scientific).
cPCRs were carried out by using the tip of a hypodermic needle to take an
absolute minimum amount of colony material and streaking this on the inside of
the PCR-tube containing 5 µL water. After that the needle was used to inoculate
a new plate by stabbing it into the agar. After removing the PCR-tubes from
the anaerobic chamber, 15 µL reaction mix was added, containing 5 µL water
and primers, and 10 µL 2× DreamTaq master mix. The cells were lysed before
regular cycling, by heating at 94 ◦C for 10 minutes. It was essential that the
PCR always resulted in a product to detect reactions that failed due to too little,
or too much colony material.
Prior to transformation into C. acetobutylicum, plasmids were methylated in
vivo147 by electroporation into E. coli TOP 10 (pAN2) cells. Electrotransforma-
tion of C. acetobutylicum was carried out as previously described.142 Erythromy-
cin was added to all culture media for the preparation of competent BUK1KO
cells. All manipulations were carried out anaerobically and on ice. After trans-
formation and recovery, the cells were plated on pre-warmed plates containing
thiamphenicol, no erythromcyin was added.
4.2.4 Primers and DNA sequencing
All DNA primers used in the study are listed in Table 4.2. Primers were
obtained from Eurogentec (Seraing, Belgium). DNA sequencing of clones was
done by BaseClear (Leiden, The Netherlands).
4.2.5 Construction of ClosTron plasmid
pMTL007::Cac-buk1 -49s
Plasmids were constructed according to the protocol by Heap et al.152 In
short, the retargeted cassette, generated in a SOEing PCR using the following
primers, BK49a ibs, BK49a ebs1, BK49a ebs2, and EBS Univ, and the template
from the TargeTron kit, was ligated into the pMTL007 backbone, resulting in
plasmid pMTL007::Cac-buk1 -49s. Correct plasmids were identified by restriction
digestion and by sequencing the retargeted region using primers 5402F fwd and
pMTL007 rev.
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4.2.6 Construction of plasmid
pWOK003::Cac-ack-1027a
As the previous constructed plasmid pWOK001::Cac-ack-1027a,261 employed
erythromycin resistance for plasmid maintenance. The plasmid needed to be
changed to use another resistance marker. The catP gene was isolated by PCR
with primers CatP fwd and CatP rev using a pMLT007 vector as template and
TOPO cloned into pCR-BluntII (Invitrogen). After verification of function by
growth on chloramphenicol containing LB plates the catP gene was released
from the pCR-BluntII::catP vector using KpnI and XbaI and inserted in the
pMTL500E vector which was linearised with the same enzymes creating plasmid
pMTL500E/C. To inactivate and remove as much as is possible of the erythro-
mycin resistance gene pMTL500E/C was subsequently cut with Eam1105I and
XcmI, with a gel purification step in between. The 5.86 kbp fragment was then
blunted using T4 DNA polymerase, gel purified, and self-ligated with T4 DNA
ligase. Upon transformation in E. coli the plasmid, pMLT500C, was maintained
using chloramphenicol as also a large part of the ampicillin resistance gene was
deleted. Plasmid pWOK001::Cac-ack-1027a was then cut with XhoI and SphI
to release the TargeTron system which was then gel purified and ligated into
pMTL500C which was linearised with the same enzymes resulting in a plasmid
designated as pWOK003::Cac-ack-1027a (see Table 4.1).
4.2.7 Isolation of mutants
4.2.7.1 BUK1KO strain
After transformation of pMTL007::Cac-buk1 -49s, colonies resistant to thi-
amphenicol were picked, and plated on mCGM plates containing erythromycin.
After incubation for several days at 37 ◦C colonies were visible on plate. After
inoculation of a liquid culture genomic DNA was prepared and PCR amplific-
ation of buk1 gene using primers Cac buk1 fwd and Cac buk1 rev was used to
confirmed successful integration.
4.2.7.2 DAPKO strain
The double mutant was made by transforming vector pMTL007::Cac-buk1 -
49s into competent BUK1KO cells. After transformant isolation a random colony
was picked and re-streaked on a plate containing thiamphenicol. After growth,
colonies were suspended in mCGM and a serial dilution was made. Various dilu-
tions were plated on mCGM plates containing thiamphenicol to obtain discrete
colonies. Approximately 200 individual colonies were screened by colony PCR
using primers Cac ack fwd and Cac ack rev and re-streaked on library plates. Of
these, three PCR reactions gave a positive signal for a pure mutant. However,
only one of these could be recovered from the library plate, the other two had not
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grown. This was presumably due to the extremely small amounts taken from ini-
tial colonies that were used for cPCR sampling and subsequently used for library
plate streaking.
4.2.8 Southern blot
Genomic DNA of the BUK1KO mutant was checked using the same proced-
ure as described previously.217 Irrespective of restriction enzyme used, no DNA
fragment was released from the wild-type genomic DNA that hybridised to the
probe. In contrast, restriction fragments of the expected size were derived from
both the genome of the BUK1KO mutant and the ClosTron plasmid which gave
a positive signal on the Southern blot.
4.2.9 Cell-free extracts and enzymatic activity assays
Cell-free extracts preparation, enzymatic activity assays (PTA, AK, PTB,
BUK), and protein assays were performed as described in Kuit et al.217
4.2.10 Batch fermentations of C. acetobutylicum
Fermentations were performed in 2-L bioreactors (1-L working volume) con-
trolled via a Bio Controller ADI 1010 by a PC running Bioexpert software (all
Applikon, The Netherlands). No antibiotics were used during the fermentations.
CM1 medium-based batch fermentations were setup by autoclaving yeast extract,
phosphates, and ammonium acetate or ammonium sulphate as applicable, with
the reactor. Autoclaved glucose (final concentration 100 g/L unless otherwise
noted) was added to the reactor after cooling. Metal sulphates and pABA were
added as a filter sterilised mix.
The medium in the reactor was sparged for at least 6 hours with nitrogen.
Prior to inoculation, Sigma antifoam 204 was added to the reactor (0.1 ‰). The
reactor was inoculated with 50 mL of an overnight pre-culture grown on the same
medium but supplemented with erythromycin in the case of the mutants. After
inoculation, the starting pH was allowed to fall to the pre-set pH, after which
it was controlled by addition of 4 M KOH. During the fermentation, the head
space was flushed with nitrogen and the outgoing gas flow was passed through a
condenser at 4 ◦C. The agitation rate was 200 rpm.
4.2.11 Analysis of metabolites
Metabolites present in culture supernatants (glucose, acetate, butyrate, lact-
ate, acetoin, meso-2,3-butanediol, acetone, butanol, and ethanol) were determ-
ined by HPLC as described previously216 using valeric acid or 4-methyl-valeric
acid as an internal standard.
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4.3 Results
4.3.1 Isolation and characterisation of a buk1 – strain
A buk1 gene disruption was previously shown to impart a favourable pheno-
type regarding butanol production. We therefore wanted to recreate this strain
using the ClosTron method. The C. acetobutylicum mutant strain BUK1KO
(Table 4.1) was obtained as described in the Materials and methods section. The
mutant has a group II intron inserted in the sense orientation between basepair
positions 49 and 50 of the wild type gene sequence. The BUK1KO strain did not
produce any spores, both on plate and in liquid culture, as determined by micro-
scopic inspection and heat shock treatment (data not shown). To confirm gene
inactivation, enzyme activity assays of all four enzymes involved in acetate and
butyrate formation from acetyl-CoA and butyryl-CoA, respectively, were carried
out using cell-free extracts of exponentially growing cultures of the wild type and
mutant strains (Table 4.3, page 85). BK activity was essentially at background
levels while also PTB, present upstream in the same operon, was somewhat re-
duced by approximately 30 %. Enzyme activities of the acetate pathway were
not significantly affected in the BUK1KO strain under the condition tested. To
ascertain that only one insertion had taken place a Southern blot was prepared
using a probe that hybridizes to the intron II DNA sequence.217 Only one band,
of the expected size, was observed in all three digests of genomic DNA isolated
from the BUK1KO strain (data not shown).
4.3.2 Fermentation characteristics of strain BUK1KO
The fermentation characteristics of the BUK1KO strain were initially de-
termined for a pH controlled batch fermentation using CM1 medium in which
the initial pH of 6.6 is allowed to drop to 5.0 and then stabilised by the addition
of KOH. CM1 medium was selected based on our previous experiences with the
C. acetobutylicum WUR strain217 and pH 5.0 was chosen as it is reported to be
essential for good butanol production in a similar mutant.128
The course of fermentations of the wild type strain showed the typical bi-
phasic pattern of first acid accumulation followed by a switch to solvent produc-
tion (Figure 4.1A and B, page 87). Both butanol and acetone were detected at
the same time point, approximately three hours before butyrate levels peaked,
with an average of 62 mM. Peak acetate levels were reached five hours after
peak butyrate levels. Levels of both acids then decreased due to their uptake
from the medium with the concomitant production of acetone. Besides acet-
one and butanol also ethanol was produced resulting in a final acetone-butanol-
ethanol (A:B:E) ratio of 3:5:1 after 36 hours. In addition also low levels of acetoin
(12 mM), lactic acid (3 mM), and meso-2,3-butanediol (3 mM) were produced.
Fermentations by the BUK1KO strain under the same conditions gave a very
different result as shown in Figure 4.1C and D, and Table 4.4(page 90). Butyrate
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accumulates in the medium only up to 13 mM and acetone is detected for the first
time after more than 23 hours. Contrary to the wild type fermentations, acetate
levels increased over the entire course of the fermentation, reaching a maximum of
180 mM from a starting level of 40 mM. Butanol production commenced before
butyrate was detected in the medium and continued throughout the fermenta-
tion, levelling off, after 46 hours, at approximately 140 mM, a reduction of 15 %
compared to the wild type.
While the pH of the medium of wild type fermentations increased again after
a period at pH 5.0, those of the BUK1KO strain remained at pH 5.0 in line with
the continued acetate production under pH controlled conditions. Acetone levels
in fermentations by the BUK1KO strain fermentations reached 24 mM, which
was only 24 % of the wild type acetone levels. Ethanol, acetoin and lactate levels
were similar to those in wild type fermentations (Table 4.4).
Butanol toxicity is generally regarded as the main cause for termination of
the fermentation by C. acetobutylicum.50 The butanol levels produced by the
BUK1KO strain at pH 5.0 were lower than for those for the wild type strain
suggesting that a different factor might have halted the fermentation progress
before glucose was depleted. For any concentration of short chain fatty acids,
e.g. acetic acid and butyric acid, the fraction of the acids that exists as undisso-
ciated fatty acids (UFAs) will increase when the pH is lowered, whereas increasing
the pH will decrease the levels. UFAs can traverse the membrane and enter the
cell where the higher intracellular pH allows them to dissociate again, effectively
transporting protons across the membrane and thereby counteracting the trans-
membrane pH gradient.229,262 In addition, it increases the level of acids inside
the cell, compromising cellular functions.263 A higher external pH is therefore
expected to allow for increased acetate accumulation in the medium. We hypo-
thesised that acetate might have accumulated at inhibiting levels in the mutant
strain fermentations. To investigate how growth and product formation of the
BUK1KO mutant was influenced by the external pH several fermentations under
different pH-conditions were carried out. The results are shown in Table 4.4, and
Figure 4.2A and B.
In fermentations in which the pH was allowed to drop below the initially tested
pH setting of 5.0, growth and product formation was negatively affected. In the
pH uncontrolled fermentation the lowest value reached was 4.35, and production
of acetate and butanol was reduced with 58 % and 71 % respectively, compared
to the fermentations at pH 5.0. Fermentations controlled at pH 4.5 gave similar
Figure 4.1 (following page): Typical optical density and production profile of a wild-
type (A and B) and a BUK1KO strain (C and D) fermentation in pH 5.0 controlled
batch reactors using CM1 medium containing 100 g/L glucose. A, C Production of
acids −N− acetate, −− butyrate, −:− lactate, −− glucose, dashed line OD600. B,
D Production of solvents −4− ethanol, −− butanol, −#− acetone, − × − acetoin,
dashed line OD600.
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results. In fermentations with an increased pH limit, 5.5 and 6.5, acetate pro-
duction did not increase, but rather decreased, compared to the fermentations
at pH 5.0, with 18 % and 65 %, respectively. However in the case of ferment-
ations by the BUK1KO strain at pH 5.5 compared to those at pH 5.0, butanol
levels increased significantly from 137 mM to 169 mM and glucose consumption
increased from 314 mM to 405 mM.
Although butanol levels of BUK1KO strain fermentations at pH 5.5 had in-
creased significantly compared to fermentations at pH 5.0 in CM1 medium, these
were not higher than wild type strain fermentations at pH 5.0. To ascertain if
acetate levels, despite the lower concentration at a higher pH, were still influ-
encing butanol production levels, fermentations in CM1 medium without added
acetate were conducted (Table 4.4, and Figure 4.2C and D). This resulted in
another increase in butanol production levels for the BUK1KO strain to 195 mM
(14.5 g/L), 21 % above the wild type levels under optimal conditions (161 mM,
12.0 g/L) and 127 % above wild type levels under the same conditions (CM1
medium without acetate at pH 5.5, Table 4.4). Unfortunately the increase in
butanol and ethanol production of the BUK1KO fermentations at pH 5.5 in
CM1 without acetate, could not offset the reduced acetone levels resulting in a
lower ABE per glucose (g/g) productivity of 23 % compared to 30 % for the wild
type (Table 4.4).
Fermentations by the BUK1KO strain showed enhanced butanol selectivity
(butanol per total solvents on a mole basis) in the range of 68 %–79 %, compared
to the wild type levels of 55 %, due to severely reduced acetone formation under
all tested pH levels. However, the amount of butanol produced per glucose con-
sumed was in all cases lower than the 46 % recorded for the wild type. The most
predominant product, next to butanol (195 mM at pH 5.5 in CM1 without acet-
ate) of the fermentation by BUK1KO strain is acetate (143 mM). We therefore
elected acetate kinase (AK) for the next targeted gene disruption.
4.3.3 Acetate kinase inactivation in BUK1KO strain
The BUK1KO strain was made using the first generation pMTL007 Clos-
Tron,152 therefore the erythromycin resistance gene could not be removed as it
lacks the frp sites used in the second generation ClosTron system.154 Using the
pMTL007 vector again for disruption of the ack gene (encoding acetate kinase,
AK) would not give a selection advantage over the parental BUK1KO strain
Figure 4.2 (following page): Typical optical density and production profile of a
BUK1KO strain fermentation in pH 5.5 controlled batch reactors using CM1 medium
(A and B) or CM1 medium without acetate (C and D), both contained 100 g/L glucose.
A, C Production of acids −N− acetate, −− butyrate, −:− lactate, −− glucose,
dashed line OD600. B, D Production of solvents −4− ethanol, −− butanol, −#−
acetone, −×− acetoin, dashed line OD600.
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and possibly be a disadvantage due the the large size of the group II intron,
which is known to make the process less efficient.222 We had previously construc-
ted a TargeTron based system similar to the pMTL007 plasmid but without a
retrotransposition activated marker (RAM). Mutant selection is dependent on
phenotypical selection or screening, for example by colony PCR, to identify in-
sertants.261
 1 2 3 4 5 6 7 M M 7 6 5 4 3 2 1 
― 0.5 kbp― 
― 1.0 kbp― 
― 1.2 kbp― 
― 1.5 kbp― 
― 2.0 kbp― 
― 3.0 kbp― 
― 6.0 kbp― 
Figure 4.3: PCR products after separation on an 1.0 % agarose gel using primers
amplifying buk1 (left side) using primers Cac buk1 fwd & Cac buk1 rev,
and ack (right side) using primers Cac ack fwd & Cac ack rev. Tem-
plates for PCRs in lanes for both the left and right side: M, Marker;
1, gDNA DAPKO strain; 2, Water; 3, gDNA WUR strain (wild type);
4, gDNA WUR ack– strain217; 5, gDNA BUK1KO strain; 6, plasmid
pMTL007::Cac-buk1 -49s; 7, plasmid pWOK003::Cac-ack-1027a. Expec-
ted product sizes are: wild type buk1 (lanes 3, 4), 1.1 kbp bp; wild type
ack (lanes 3, 5), 1.2 kbp; inactivated buk1 (lanes 1, 5), 2.9 kbp; inactivated
ack, 2.1 kbp (lane 1) and 3.0 kbp (lane 4). The size of the inactivated ack
in the DAPKO strain is smaller as it does not contain an erythromycin
resistance gene.
Plasmid pWOK003::Cac-ack-1027a was constructed as detailed in Materials
and Methods and after methylation used to transform BUK1KO competent cells.
Transformants and subsequent isolation of the double mutant is described in the
Materials and Methods. The identified putative double knock-out strain desig-
nated C. acetobutylicum DAPKO was cultured in mCGM and five times trans-
ferred to fresh medium and then plated on solid media to check for loss of the
pWOK003::Cac-ack-1027a plasmid which was verified by sensitivity to chloram-
phenicol and PCR amplification of two different plasmid regions, the catP gene
(primers CatP fwd and CatP rev) and part of the intron (primers CA Pthl Fw
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and TT Probe r). Further PCR reactions confirmed both a mutant sized buk1
and ack gene (Figure 4.3). Sequencing of the pta-ack and ptb-buk1 operons and
their surrounding regions confirmed that only the intended regions were mutated
(data not shown). The mutant strain, like the BUK1KO parental strain, did
not sporulate and grew slower than the wild type. The DPAKO mutant was
assayed for enzyme activities involved in acid production and showed no signific-
ant acetate kinase or butyrate kinase activity, where as phospho-transacetylase
and phospho-transbutyrylase activities were halved compared to the wild type
activities (Table 4.3).
4.3.4 Fermentation characteristics of strain DAPKO
The DAPKO strain was analysed for its fermentative properties in CM1,
with and without acetate, in a pH controlled batch setup. Fermentation profiles
can be found in Figure 4.4. Fermentation data for the different pH and media
compositions are listed in Table 4.5 (page 95). All fermentations in CM1 showed
a large reduction in final, and produced acetate levels compared to the BUK1KO
strain fermentations. Final levels were reduced with 84 %, 87 %, and 66 % for
respectively the uncontrolled, pH 5.0, and pH 5.5 fermentations, while the amount
of acetate produced was reduced with 142 %, 112 %, and 90 %, respectively,
demonstrating the impact of inactivating the ack gene.
Although fermentations under pH uncontrolled conditions, at pH 5.0 and at
pH 5.5 by the DAPKO strain showed reduced final acetate levels compared to
the BUK1KO strain, acid production was never completely abolished. Surpris-
ingly, fermentations in CM1 without acetate at pH 5.5 and 6.0 resulted again in
high acetate levels being produced by the DAPKO strain (110 mM and 120 mM,
respectively). An important observation, made from the time course data of the
DAPKO strain fermentations, was that the bi-phasic growth pattern of the wild
type strain, absent from the BUK1KO fermentations, was restored (Figure 4.4C).
Although no high temporal resolution was achieved during the DAPKO strain
fermentations the data still clearly showed that acid levels first increased and later
decreased with the concomitant production of acetone. Acetone production had
increased for the DAPKO strain, suggesting increased uptake of acids compared
to the BUK1KO strain. CM1 fermentations without added acetate produced sim-
ilar amounts of acetone compared to CM1 fermentations, with the exception of
pH 5.5 and 6.0 were no acetone at all could be detected (see Figure 4.5, page 97).
Also for this strain the fermentation pH is of importance, but whereas with the
BUK1KO strain increasing fermentation pHs paralleled butanol production, the
DAPKO strain produced more butanol at pH 5.0. The highest recorded butanol
level (174 mM) was for the pH 5.0 fermentation in CM1, but CM1 without acetate
gave similar levels of butanol. In general the DAPKO strain fermentations showed
better solvent formation in CM1 at lower fermentations pHs (ABE/glucose yield
is 29 % at pH 4.86 and 17 % at pH 6.0) whereas the BUK1KO strain again showed
the inverse behaviour (pH 4.35, 16 %; pH 5.5, 23 %), except for the highest pH
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Figure 4.4: Optical density and production profiles of DAPKO strain fermentation
under uncontrolled pH conditions (A and B), and controlled at pH 5.5
(C and D), and at pH 6.0 (E and F) in batch reactors using CM1 medium
containing 100 g/L glucose. A, C, E Production of acids −N− acetate,
−− butyrate, −:− lactate, −− glucose, dashed line OD600. B, D, F
Production of solvents −4− ethanol, −− butanol, −#− acetone, −×−
acetoin, dashed line OD600.
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of 6.5.
Another striking effect of AK inactivation in the DAPKO strain, compared
to BUK1KO fermentations, was the strong increase in acetoin levels which were
more than five-fold up in fermentations at pH 5.0 in CM1 and two-fold in CM1
without acetate at pH 5.5. The highest concentration, 100 mM, was measured
for the CM1 fermentation at pH 6.0, to our knowledge more than ever reported
for this organism. In line with this also the meso–2,3–butanediol levels increased
by 124 % to 5.6 mM.
4.4 Discussion
Acetate and butyrate are the main metabolites during the acidogenic phase
of C. acetobutylicum and provide the organism with additional ATP from sub-
strate level phosphorylation, besides the ATP generated during glycolysis. Acid
pathway mutants in wild type C. acetobutylicum have been reported by Green et
al.(PJC4PTA and PJC4BK with an inactivated phospho-transacetylase (PTA)
and butyrate kinase (BK) enzyme respectively),126 by Shao et al. (BK),156 by
Lehmann et al. (PTA,179 and phospho-transbutyrylase,166 PTB), and by Kuit et
al. (acetate kinase, AK).217 In all cases production of the acid corresponding to
the pathway of the inactivated enzyme continued for unknown reasons with the
exception of the ptb mutant.
It has been suggested that the enzymes of the butyrate pathway can catalyse
the homologous reaction of the acetate pathway, which might explain the con-
tinued production. In vitro enzyme studies of acetate kinase (AK) showed that
it could not accept butyryl-phosphate as a substrate,264 whereas butyrate kinase
(BK) showed 6 % cross-reactivity towards acetate in the reverse reaction.248 Two
recent publications seem to support this hypothesis for the analogous situation
of PTA and PTB enzymes. A pta– strain continued to produce acetate at wild
type levels, presumably due to compensation by PTB. Conversely, a ptb– strain
did not produce any butyrate as PTA, in vivo, does not except butyryl-CoA as
a substrate. Attempts by the authors to isolate a pta– ptb– double mutant were
unsuccessful, which suggested to them that such a mutant is not viable under the
conditions used.166
Previously we showed that an AK negative mutant continued to produce wild
type levels of acetate, although delayed compared to butyrate production.217 The
behaviour was medium depended as CM1, containing 45 mM acetate, severely
inhibited acetate production by the mutant, but not by the wild type. This be-
haviour might be expected if the BK enzyme would complement the AK activity
in vivo. To investigate whether in vivo complementation occurred we set out to
construct an acetate kinase and butyrate kinase double mutant. In addition to
inhibiting acid formation, this double mutant was expected to have an increased
alcohol (butanol and ethanol) versus acetone ratio due to this decreased acid
production.
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Our first target was butyrate kinase inactivation as this had previously been
accomplished by two different groups, one of which also used a mobile group
II intron for inactivation of the gene at the same insertion site.156 The results
presented in this work (Table 4.4) demonstrated that for our buk1 – strain the
phenotypical outcome of inactivation is different from that reported by the previ-
ous two groups.126,156 Butyrate accumulation in the medium was severely reduced
in fermentations by the BUK1KO strain, in line with the observed in vitro BK
enzyme activities. The highest butyrate levels were observed at the end of the fer-
mentation (13 mM for pH 5.0). Although that is not significantly different from
final wild type levels, peak butyrate for the wild type (62 mM) was significantly
higher and reduced by 79 %. It should be noted however that the fermentations
could not be monitored during the time window of 24 to 36 hours, theoretically
allowing for a peak to occur.
When comparing our results of fermentations at pH 5.0 with the results of
Harris et al.,128 data for butyrate levels is similar, but the other product levels are
not. Although Harris et al. also report increased acetate production, their time
course data shows a peak acetate level of 111 mM, which then drops to a final
level of 46 mM, whereas our strain continues to produce acetate to apparently
inhibitory levels (180 mM, Table 4.4). Furthermore, they report higher than wild
type solvent levels for butanol and ethanol, where we observe a reduction of all
final solvent levels.
Our efforts to increase the solvent production by optimising the pH again
illustrates a difference between our BUK1KO strain and the previously reported
PJC4BK strain. The higher pH of 5.5 is optimal for solvent production by the
BUK1KO strain compared to the other tested pH levels (Table 4.4), contrary to
the PJC4BK strain which has an optimum of 5.0.128
Acetate toxicity is caused by proton translocation across the membrane and
increased intracellular acetate levels impeding cellular functions.265 The likeli-
hood that acetate was the inhibitory product for the fermentation in CM1 me-
dium is illustrated by the improved butanol levels and a similar final acetate
levels at pH 5.5 (143 mM vs. 154 mM). Contrary to the expectation that acetate
levels at pH 5.0 would be lower than those at 5.5, due to increased extra-cellular
levels of undissociated acids, a final level of 180 mM was recorded. This would
suggest that the mechanism by which acetate is toxic varies, or that it is not the
growth inhibiting compound after all.
Another difference between fermentations by our strain at pH 5.5 and those
of Green et al. at the same pH is the much lower lactate formation (11 mM vs.
69 mM).126 We also measured an acetoin concentration of 30 mM which was not
reported by Green et al.. Various reasons can be put forward to account for
the observed differences, e.g. difference in growth medium, effect of antibiotic
pressure, inoculum size, and strain differences. Our WUR strain, grown under
the same conditions as, and compared to the ATCC 824 strain, showed excessive
lactate formation during growth on CGM.217 Our strain also produces meso–2,3–
butanediol, a product normally not found in C. acetobutylicum fermentations.216
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Figure 4.5: Optical density and production profiles of DAPKO strain fermentation
under uncontrolled pH conditions (A and B), and controlled at pH 5.5
(C and D), and at pH 6.0 (E and F) in batch reactors using CM1 medium
without acetate, containing 100 g/L glucose. A, C, E Production of acids
−N− acetate, −− butyrate, −:− lactate, −− glucose, dashed line
OD600. B, D, F Production of solvents −4− ethanol, −− butanol,
−#− acetone, −×− acetoin, dashed line OD600.
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It could be that additional strain variations result in a different phenotype upon
inactivation of the same gene. It is of interest to note that also others have re-
ported differences when attempting to create a buk1 – mutant. When attempting
to make a buk1 deletion mutant, Soucaille and co-workers noted that in each
successful case of buk1 removal, also the preceding ptb gene was mutated render-
ing it inactive.260 They concluded that a buk1 deletion on its own was lethal for
their strain. Although all strains in these reports are referred to as ATCC 824 it
seems that laboratory stocks have diverged over time. Comparison of strains by
whole genome resequencing using next generation sequencing (NGS) techniques
could help to see if this is the case and to possibly identify which mutations are
required to be able to obtain a buk1 – knock-out strain.
The successful isolation of the PJC4BK and BUK1KO strains, could also be
explained by selection for new secondary mutations during the mutant isolation
procedure. If so, then these mutations must be present elsewhere on the genome
because the strain still showed PTB activity and the fragment on the Southern
blot was of the expected size. The fact that both the BUK1KO and DAPKO
strain did not sporulate and did not give rise to clostridial cell shapes is another
important observation. Normally loss of the pSOL1 megaplasmid is the cause
of this, but our strains continued to produce acetone indicating that they did
not degenerate. During frequent microscopic inspection of the culture we never
observed spores or clostridial-stage cells. For the BUK1KO strain this fits with
observed production profile as the cells do not seem undergo a solventogenic
shift which is associated with the appearance of clostridial-stage cells ultimately
resulting in spore formation. For the DAPKO strain the link with the production
profile is less clear but also in that case spores were never seen.
To further improve upon the results of the BUK1KO strain, and to address
the hypothesis that AK and BK enzymes can complement each others activities,
we have generated, to our knowledge, the first C. acetobutylicum mutant with
targeted inactivation of genes in both acid production pathways. The successful
inactivation of both buk1 and ack was demonstrated by enzyme activity assays
showing less than 2 % (AK), and 0.2 % (BK) of wild type activities (Table 4.3)
and by sequence analysis. Surprisingly this did not result in the expected fer-
mentation behaviour. Although DAPKO fermentations of CM1 at various pH
levels showed drastic reduction of acetic acid levels compared to the BUK1KO
strain, in addition to the already low butyrate levels, but it also had increased
acetone levels. The later indicating uptake, and activation, of previously pro-
duced, or already present, acetate and/or butyrate. Surprisingly, when CM1
without acetate is used for the fermentation acetate production increases sug-
gesting that an initial concentration of 45 mM acetate inhibits additional acetate
production. The reasons for this are not known, but the same effect was seen for
the C. acetobutylicum WUR ack– mutant.
One of the proposed mechanisms by which the PJC4BK strain, described by
Green et al., could continue to produce butyrate was that the analogous enzyme in
the acetate pathway, acetate kinase, converted butyryl-phosphate to butyrate.126
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Later tests with purified acetate kinase from C. acetobutylicum DSM 1731 had
shown that AK does not exhibit activity towards butyryl-phosphate in vitro.264
Despite inactivation of both AK and BK, as demonstrated by in vitro enzyme
activities, production of both acetate and butyrate continued. Combined with the
in vitro enzyme characterisation data this disproves the hypothesis that expres-
sion of AK from ack causes butyrate formation in the PJC4BK and BUK1KO
strains. Therefore an alternative explanation is needed for the continued acid
production in our BUK1KO and DAPKO mutants. For example the presence of
isozymes, as also suggested by Green et al.,126 or alternative production path-
ways.
For butyrate kinase an isozyme, BKII encoded by buk2,266,267 has been de-
scribed, however this enzyme has a very narrow substrate specificity an can not
accept acetate as a substrate. Furthermore, based on its enzymatic properties
it was thought to be involved in butyrate uptake rather than its production.
However it could perhaps still explain the observed low butyrate levels in the
DAPKO and PJC4BK fermentations. For acetate kinase no such isozyme has
been described although this does rule out the possibility that it exists. One
reason why this may have gone unnoticed for so far is that acetate kinase enzyme
assays are regularly performed according to the method of Rose241,268. This
method was also employed when the acetate kinase enzyme was purified and isol-
ated.264,269,270 However a possible isozyme might not function in the activity test
and go undetected.
Alternatively, other pathways, involving different enzymes, could also lead to
the observed acetate (and butyrate) formation. Interestingly also an E. coli BL21
triple knock-out strain of genes involved in acetate production (ackA–, pta–, and
poxB–) showed acetate accumulation up to 0.4 g/L.271 The authors conclude that
additional pathways must exist that account for the observed acetate formation.
Such an enzyme could for example be an acetyl-CoA hydrolase, suggested to exist
in Saccharomyces cerevisiae, which might be expressed to deal with the, presum-
ably, increased acetyl-CoA pool.272,273 However, the view that such an enzyme
might exist has recently been contested as the S. cerevisiae enzyme was shown to
actually be an acetyl-CoA-transferase.274 The suggestion that a CoA-transferase
might play a role in the observed continued acid production is intriguing and
deserves further investigation.
The fact that inactivation of both acid production pathways results in in-
creased acetoin production (Table 4.5) could indicate that intracellular accumu-
lation of pyruvate takes place and is, partially, remedied by the cell by convert-
ing it to acetoin. Due to the high levels of acetoin also production of meso–
2,3–butanediol increased as has been observed for exogenously added acetoin.216
Acetoin production reached a maximum of 100 mM in fermentations at pH 6.0,
to our knowledge, the highest level ever reported for this organism. Lactate pro-
duction by the DAPKO mutant (12 mM) also increased but reached not more
than 4 times the wild type level, similar to the PJ4BK strain at pH 5.0. The
incomplete carbon balance of some of the fermentations done at higher pH levels
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(see Table 4.4 and Table 4.5) suggests that alternative products are formed which
merits further investigation as this can also be seen in other publications.179
The aim of our work was to impede acid and acetone production and create an
alcohologenic fermentative strain. Neither of the two created strains had these
properties. The two mutants did show improved butanol selectivities of 70 %
(BUK1KO, CM1 without acetate, pH 5.5) and 85 % (DAPKO, CM1 without
acetate pH 5.5, compared to 50 % got the wild-type. However productivity is
reduced as more glucose is used for formation of other products such as acetate
(BUK1KO, DAPKO) and acetoin (DAPKO). Lehmann et al. observed that
their pta knock-out mutant continued to produce acetate at wild type levels and
was seemingly unaffected also in the presence of acetate in the growth medium.
Unfortunately no enzymatic activity data was presented for the mutant.179 A
pta– mutant with in addition an inactivated acetone pathway did show reduced
acetate levels.
Also in our study acid production was never totally abolished although final
acid levels were very low for the DAPKO strain in CM1 without acetate under
uncontrolled pH conditions. Acetone levels in that case were also reduced by
45 % compared to the wild type fermentation but were still at 55 mM. This
indicated that acid production still had taken place. As with the ack– knock-
out mutant217 the DAPKO strain is sensitive to acetate present in the medium
suggesting that the alternative acetate production pathway is sensitive for, or it
expression regulated by, the initial acetate concentration.
In our effort to create an alcohologenic strain we only partially succeeded.
The DAPKO strain fermentation in CM1 without acetate at pH 6.0 produced
22 % less butanol, but no acetone and similar ethanol levels. Butanol production
selectivity was increased from 55 % for the wild type to 84 % for the mutant,
however also acetate (120 mM) and butyrate (47 mM) were produced in addition
to acetoin (61 mM) and lactate(21 mM). By comparison the approach of Nair
and Papoutsakis to create an alcohologenic fermentation by expressing an alcohol
dehydrogenase (adhE) in the degenerated M5 strain resulted in a better butanol
to ethanol ratio of 84:8 (mM:mM)(91 % selectivity) but also led to massive acid
accumulation.173 Both acetate and butyrate were produced at around 100 mM
each. A new approach, again using the M5 strain as a host to express adhE
now under control of the ptb promoter improved butanol and ethanol levels to
almost wild type concentrations but with extremely high acetate (226–256 mM)
and elevated butyrate levels (73–144 mM).129 Inactivation of AK or BK in an M5
background did not improve this.
The challenging regulation of, and the complex metabolic network under-
pinning the C. acetobutylicum fermentation makes the rational metabolic en-
gineering approaches of this organism difficult. Our lack of knowledge on some
of the very basic metabolic pathways this organism employs seem to hamper
this approach. Recent reports about regulatory genes107,161,162,180,275 and tech-
niques72,73,98,276 will aid in understanding the system but it will continue to
be a challenging organism to work with. In an effort to better understand the
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fermentative behaviour of our DAPKO mutant we are currently undertaking a
whole genome re-sequencing approach using the Illumnia platform, to determine
differences between the DAPKO mutant and wild type strain that could explain
the phenotypical differences. The preliminary results indicate that although the
DAPKO strain has approximately 190 point mutations compared to the pub-
lished genome sequence, the parental WUR strain has these too. The search for
further difference is ongoing. Hopefully we will be able to obtain new targets for
the rational manipulation of the metabolism of our strains.
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Chapter 5
d-2,3-Butanediol Production
Due to Heterologous
Expression of an Acetoin
Reductase in Clostridium
acetobutylicum
Abstract
Acetoin reductase (ACR) catalyses the conversion of acetoin to 2,3-butanediol.
Under certain conditions, Clostridium acetobutylicum ATCC 824 (and strains de-
rived from it) generates both d- and l-stereoisomers of acetoin, but because of the
absence of an ACR enzyme, it does not produce 2,3-butanediol. A gene encoding
ACR from Clostridium beijerinckii NCIMB 8052 was functionally expressed in
C. acetobutylicum under the control of two strong promoters, the constitutive
thl promoter and the late exponential adc promoter. Both ACR-overproducing
strains were grown in batch cultures, during which 89 to 90 % of the natively pro-
duced acetoin was converted to 20 to 22 mM d-2,3-butanediol. The addition of
a racemic mixture of acetoin led to the production of both d-2,3-butanediol and
meso-2,3-butanediol. A metabolic network that is in agreement with the experi-
mental data is proposed. Native 2,3-butanediol production is a first step toward
a potential homo-fermentative 2-butanol-producing strain of C. acetobutylicum.
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5.1 Introduction
To meet our future energy needs, it is necessary to develop sustainable andcarbon-neutral energy sources. Liquid biofuels are attractive candidates,since little or no change is needed to the current petroleum-based fuel tech-nologies.277 For this purpose, biological production of several alcohols is
under investigation, including ethanol and butanol.202,278
Several clostridial species are able to ferment carbohydrates to acetone, 1-
butanol, and ethanol (ABE). Industrial application of this process, also known
as ABE fermentation, has a long history, but the process economics after 1960
became unfavourable compared to the petrochemical process, and its commercial
exploitation was gradually abandoned.57 The inefficiency of the fermentation still
hampers commercial reintroduction of this renewable butanol production process.
Improving the yields and productivities of the solvent products is key to its
successful reintroduction.
One of the factors reducing the fermentation efficiency is the toxic effect that
1-butanol has on the culture. Butanol has membrane-distorting properties, due
to its hydrophobic chain and polar group, which cause severe cell damage.131,132
Many efforts have been made in the past to obtain clostridial strains with in-
creased 1-butanol tolerance but have had limited success.133–137,279
As an alternative to increasing 1-butanol tolerance, we propose replacing the
production of 1-butanol with production of a compound that has similar phys-
ical and chemical properties (heat of combustion, heat of vaporization, and en-
ergy density) but that is less toxic to the cell, making higher titres possible.
2-Butanol matches these criteria and has a lower log Pow value (octanol-water
coefficient) than 1-butanol. The log Pow value is a good indicator for the strength
of membrane-perturbing effects.280 Generally, the lower the log Pow value, the
less toxic the compound is to the membrane. However, Clostridium acetobutyli-
cum is not known to produce 2-butanol nor its potential precursor, 2,3-butanediol
(2,3-BD).281 Nevertheless, it is known to produce acetoin as a minor fermentation
product.57
The 2,3-butanediol biosynthesis route proceeds via pyruvate, acetolactate,
and acetoin to 2,3-butanediol. Acetolactate is formed in vivo by coupling two
molecules of pyruvate with the concomitant release of carbon dioxide, cata-
lysed by acetolactate synthase. Decarboxylation by acetolactate decarboxylase
yields acetoin,282 which can be reduced by an acetoin reductase (ACR) to 2,3-
butanediol.
Our aim is to construct a 2,3-BD-producing C. acetobutylicum strain as a
first step toward biological 2-butanol production. In this study, the cloning and
functional expression of an acetoin reductase-encoding gene from Clostridium
beijerinckii NCIMB 8052 in C. acetobutylicum, resulting in the production of
d-2,3-butanediol, is described.
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5.2 Materials and Methods
5.2.1 Bacterial strains, plasmids and primers
All bacterial strains and plasmids used during this study are listed in Table 5.1.
Escherichia coli stocks were stored in 20 % (vol/vol) glycerol at −80 ◦C. Stock
cultures of Clostridium acetobutylicum strains and C. beijerinckii NCIMB 8052
were maintained as spore suspensions in 15 % (vol/vol) glycerol at−20 or−80 ◦C.
Chemically competent, E. coli NEB 5α F′ lacI q cells were used for cloning and
vector maintenance. Electro-competent E. coli DH10B(pAN1) cells were used to
methylate plasmid DNA before transformation into C. acetobutylicum.147
5.2.2 Media and growth conditions
E. coli strains were cultured in lysogeny broth (LB) medium at 37 ◦C and
200 rpm. Sporulation plates were based on the media used by Nimcevic et al.240
but also contained 15 g/L agar. Prior to inoculation of clostridial precultures,
spore suspensions were heat shocked for 10 min at 70 or 80 ◦C. C. acetobutyli-
cum strains were grown in MG medium or modified CGM (mCGM) medium as
indicated below.
MG medium was based on the semisynthetic medium described by Nimcevic
et al.240 and contained the following (per litre of water): yeast extract, 2.50 g;
KH2PO4, 1.00 g, K2HPO4, 0.76 g; ammonium acetate, 3.00 g; para-aminobenzoic
acid (pABA), 0.10 g; MgSO4•7 H2O, 1.00 g; FeSO4•7 H2O, 0.01 g and glucose,
60 g.
mCGM medium contained the following (per litre of water): yeast extract,
5.00 g; KH2PO4, 0.75 g; K2HPO4, 0.75 g; MgSO4•7 H2O, 0.4 g; MnSO4•H2O,
0.01 g; FeSO4•7 H2O, 0.01 g; NaCl, 1.0 g; asparagine, 2.0 g; (NH4)2SO4, 2.00 g;
cysteine, 0.125 g; and glucose, 12.5 g.
Medium for fermentation was made anaerobic by sparging with nitrogen gas.
Serum flasks (250 mL) containing 100 mL MG medium were inoculated with 2 %
(vol/vol) overnight precultures. Clostridial culture experiments were performed
at 37 ◦C, without shaking, and anaerobically in (i) an anaerobic chamber; or (ii)
in glass serum vials as described previously.225
Culture media were supplemented with ampicillin (100 µg/mL), chloram-
phenicol (30 µg/mL), erythromycin (40 µg/mL for liquid cultures and plates;
25 µg/mL for transformant isolation), kanamycin (50 µg/mL), isopropyl-β-d-
thiogalactopyranoside (IPTG) (50 µg/mL), and 5-bromo-4-chloro-3-indolyl-d-ga-
lactopyranoside (X-Gal) (40 µg/mL) when appropriate. For challenge experi-
ments, acetoin or 2,3-butanediol (2,3-BD) was added to the medium prior to
inoculation with the preculture.
The growth of clostridial cultures was monitored spectrophotometrically at
600 nm (Pharmacia Biotech Ultrospec 2000).
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5.2.3 DNA isolation, transformation, and manipulation
Standard molecular work was performed according to established protocols.224
Genomic DNA from C. acetobutylicum or from C. beijerinckii was isolated us-
ing the GenElute bacterial genomic DNA kit (Sigma-Aldrich). Plasmid DNA
from E. coli was isolated by the GenElute plasmid miniprep kit (Sigma-Aldrich).
PCR amplification of clostridial DNA was done using Pfu polymerase (Strata-
gene). E. coli colony PCRs were carried out using REDTaq (Sigma-Aldrich).
Methylated plasmids were electroporated into C. acetobutylicum by the method
of Oultram et al.142 Correct methylation was checked by restriction analysis using
Fnu4HI.147
5.2.4 Primers and DNA sequencing
All DNA primers used in the study are listed in Table 5.2. Primers were
obtained from Eurogentec (Seraing, Belgium) or Biolegio (Nijmegen, The Neth-
erlands). DNA sequencing of clones was done by BaseClear (Leiden, The Neth-
erlands).
Table 5.2: Primer sequences
# Primer name Sequence (5′ → 3′)a Target DNA region
1 005CA Pthlf GGCATGCgaa tttagaatga agtttcttat gc Promoter thl; Ca c2873
2 017CA Pthlr AAAAGGGCCC ccatagttta tccctaattt atacg Promoter thl; Ca c2873
3 007CA Padcf GGCATGCatg ggaaagccaa cattgc Promoter adc; Ca p0165
4 018CA Padcr AAAAGGGCCC cttcacatta taaatcgcct ct Promoter adc; Ca p0165
5 BG2588 CGCGCGGGCC CAGGAGGGgC GGCGGCatga aagcagcatt atg Cbei 1464 (Cb-acr)
6 BG2402 GCGCGCTCGA Gttaagattt agatacaagt tctt Cbei 1464 (Cb-acr)
a Nucleotides that are not complementary to the genomic sequence are given in uppercase. Restriction
sites are underlined. The artificial ribosome binding site is shown in bold.
5.2.5 Cloning of the C. beijerinckii acr (Cb-acr) gene into
C. acetobutylicum
The clostridial expression plasmids pWUR459 and pWUR460 were construc-
ted as follows. The pMTL500E vector was linearised by digestion with SphI and
XhoI. adc and thl promoter regions were amplified by PCR from C. acetobuty-
licum genomic DNA using primers 1 & 2, and 3 & 4, respectively. The acetoin
reductase (Cb-acr) gene was amplified by PCR from C. beijerinckii NCIMB 8052
genomic DNA using primers 5 and 6. Primer 5 contained an artificial RBS (AG-
GAGG), which was separated from the ATG start codon by the 9-nucleotide se-
quence GGCGGCGGC. Primers 1 and 3 contained a SphI restriction site, primers
2, 4, and 5 an ApaI restriction site, and primer 6 a XhoI restriction site. All PCR
products were digested using the restriction enzymes for the aforementioned sites.
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Plasmids pWUR459 and pWUR460 were obtained by three-way ligation reactions
which contained the linearised vector, the Cb-acr gene and the adc promoter or
the thl promoter, respectively (Figure 5.1).
Competent E. coli NEB 5αcells were transformed with the ligation mix-
tures and subjected to blue-white screening and selected for ampicillin resist-
ance. White colonies were checked by colony PCR for the presence of the corres-
ponding construct, after which restriction analysis and sequencing confirmed the
correct constructs. E. coli DH10B (pAN1) methylation strain was electropor-
ated with plasmids pWUR459 and pWUR460 and transformants were selected
for ampicillin and chloroamphenicol resistance. Correct methylation was checked
by restriction analysis using Fnu4HI.
The clostridial expression plasmids pWUR459 and pWUR460 were construc-
ted as detailed in the supplemental material. These plasmids and the control plas-
mid pMTL500E were used to transform C. acetobutylicum. Each transformation
resulted in multiple erythromycin-resistant colonies. After restreaking, selected
colonies were used to prepare spore suspensions for further experiments.
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Figure 5.1: Plasmid map of A. pWUR459 - Expression plasmid of Cb-acr under con-
trol of the C. acetobutylicum acetoacetate decarboxylase promoter and B.
pWUR460 - Expression plasmid of Cb-acr under control of the C. aceto-
butylicum thiolase promoter.
5.2.6 Acetoin reductase (ACR) enzyme assays
C. acetobutylicum cells were harvested from cultures with an optical dens-
ity (OD) of 5 by centrifugation (4 816 × g, 15 min, 4 ◦C) and resuspended in
20 mM Tris-HCl buffer (pH 7.5) containing 1 mM tris(2-carboxyethyl)phosphine
(TCEP) as reducing agent, because 2-mercaptoethanol was shown to inhibit en-
zyme activity. Crude cell extracts were prepared by French press homogenization
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(two passes at 16 000 psi) and immediately assayed for enzyme activity. Assays
were carried out at 37 ◦C in 100 mM phosphate buffer (pH 6.5) containing 1 mM
TCEP, 50 mM d/l-acetoin, and 0.28 mM NADPH. The reaction was started by
the addition of acetoin. The decrease in absorbance at 340 nm due to NADPH
oxidation was monitored on a Hitachi U2010 spectrophotometer with correction
for background NADPH oxidation. One unit of enzyme activity was defined as
the amount of enzyme required for the oxidation of 1 µmol of NADPH per minute.
Total protein in crude extracts was determined using Roti-Nanoquant (Carl Roth,
Karlsruhe, Germany) with bovine serum albumin (BSA) as a standard.
5.2.7 High-performance liquid chromatography
(HPLC) analysis of glucose and metabolites
Fermentation samples were centrifuged (20 800 × g, 5 min), and the super-
natants were stored at −20 ◦C. After the supernatants were thawed, an equal
volume of internal standard solution (either 100 mM valeric acid [Sigma-Aldrich]
in 1 M H2SO4 or 30 mM 4-methyl valeric acid [Sigma-Aldrich] in 0.5 M H2SO4)
was added to the supernatant sample and then filtered (0.2 µm; Whatman). Sep-
aration of a 10 µL sample was achieved using a Shodex Ionpack KC-811 column,
equipped with a refractive index detector (Waters 2414) and a UV detector (Wa-
ters 2487) operating at 210 nm, with 3 mM H2SO4 as eluent (flow, 1 mL/min;
column temperature, 85 ◦C). The order of elution was glucose, lactic acid, acetic
acid, acetoin, meso-2,3-BD, d/l-2,3-BD, butyric acid, acetone, ethanol, valeric
acid, 4-methyl valeric acid, and 1-butanol.
5.2.8 Chiral GC-MS analysis
To determine the enantiomeric distribution of the 2,3-BD and acetoin pro-
duced, the fermentation samples were treated like the HPLC samples. However,
after thawing, the samples were additionally saturated with sodium chloride and
extracted once with an equal volume of ethyl acetate. To prevent coextraction of
acids, 10 M sodium hydroxide was added, since these compounds interfered with
chromatographic analysis. Samples for acetoin analysis were not treated with so-
dium hydroxide to prevent potential racemization. The extract was then analysed
on a Finnigan Trace DSQ (dual-stage quadrupole) gas chromatography (GC)-
mass spectrometry (MS) system (Thermo Electron Corporation) equipped with
a CP-Chirasil-Dex CB (Varian) fused silica capillary column (25 m by 0.25 mm
by 0.25 µm) with helium as the carrier gas. The injection port temperature was
set at 250 ◦C, with a split ratio of 1:10. The oven temperature program was as
follows: 80 ◦C (10 min), increased to 120 ◦C at 10 ◦Cmin followed by a ramp of
40 ◦Cmin to 200 ◦C (4 min). Samples (1 or 5 µL) were injected using an AS3000
autosampler (Thermo). The ion source (electron ionization [EI]) temperature
was set at 200 ◦C. Compound identification by column retention time was con-
firmed by analysis of the mass spectrum. The retention times of chiral standards
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of d-(−)-(2R,3R)- and l-(+)-(2S,3S)-2,3-BD (Sigma-Aldrich) were used for peak
identification. The elution order of the acetoin enantiomers was inferred from
the stereochemistry of the d-(2R,3R)-2,3-BD product.283 The order of elution
was (3R)-acetoin, (3S)-acetoin, l-(2S,3S)-2,3-BD, d-(2R,3R)-2,3-BD, and meso-
2,3-BD.
5.3 Results
5.3.1 Characterization of C. acetobutylicum
transformants
Wildtype C. acetobutylicum ATCC 824 is known to produce significant levels
of acetoin, but no 2,3-butanediol (2,3-BD).57 Recently, a gene from C. beijerinckii
NCIMB 8052, Cbe 1464 annotated as an alcohol dehydrogenase, was functionally
expressed in E. coli and demonstrated to possess acetoin reductase (ACR) activ-
ity (M. A. J. Siemerink and S. W. M. Kengen, unpublished results). Introduction
of this acetoin reductase (ACR)-encoding gene might enable conversion of acetoin
to 2,3-BD. Therefore, C. acetobutylicum transformants, containing the C. beijer-
inckii acr (Cb-acr) gene under the control of either the thl promoter (pWUR459)
or the adc promoter (pWUR460), were constructed, and their fermentation pat-
tern was analyzed. Both types of transformants were found to produce d-2,3-BD
(Table 5.3, page 112). No d-2,3-BD was produced by the control strain contain-
ing the empty vector. Acetoin was found to accumulate transiently at the end
of the exponential growth phase of both transformant strains, with levels reach-
ing 4 ± 1.6, 8 ± 0.7, and 9 ± 0.3 mM for pWUR460 (thl promoter), pWUR459
(adc promoter), and pMTL500E, respectively (Figure 5.2). These data suggest
that the conversion of acetoin to 2,3-BD is limiting, especially in the case of
the thl promoter construct, which should result in constitutive expression. The
final 2,3-BD concentrations and conversion levels for both Cb-acr strains did
not differ significantly from one another: 22 mM and 90 % acetoin conversion
for the Pthl-Cb-acr strain, respectively, and 20 mM and 89 % acetoin conver-
sion, respectively, for the Padc-Cb-acr. Acetoin levels of the control fermentation
reached 19 mM. However, in fermentations of C. beijerinckii acetoin reductase
(Cb-ACR)-expressing strains, acetoin was still detected at levels of 2 to 3 mM at
the end of the fermentation (Figure 5.2 and Table 5.3).
Analysis of medium samples of the control strain harbouring pMTL500E,
showed a ratio of approximately 12:1 (d:l) in the concentrations of the two acet-
oin enantiomers (data not shown). The acid and solvent production patterns
of the transformants expressing the Cb-acr gene were similar to those of the
control strain harbouring the empty vector (Table 5.3). Remarkably, all three
transformants produced small but nonetheless detectable amounts of meso-2,3-
BD (Table 5.3). To confirm this finding, we also looked at fermentations by our
wild-type C. acetobutylicum strain, in the same (MG medium) and other media
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Figure 5.2: Production of acetoin (triangles) and 2,3-BD (circles) during batch fer-
mentations of glucose by transformant strains of C. acetobutylicum. Strain
codes: EV (closed symbols in panels A and B), C. acetobutylicum car-
rying pMTL500E, the empty vector control strain; ADC (open symbols
in panel A), C. acetobutylicum carrying pWUR459; THL (open symbols
in panel B), C. acetobutylicum carrying pWUR460. Optical densities of
the cultures are shown by a solid line (EV) and a broken line (ADC and
THL). On the horizontal axis, normalized time is plotted such that 0 h
corresponds to an OD600 of 1.0. The control strain did not produce any
d-2,3-BD, only meso-2,3-BD. Data represent the mean of triplicate fer-
mentations averaged for each time interval. Error bars indicate standard
deviations. OD600, optical density at 600 nm.
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Table 5.3: Concentrations of substrate and products of 100-mL batch
fermentations of C. acetobutylicum harbouring pMTL500E,
pWUR459, or pWUR460 on MG medium after 145 h
Substrate or product
concentration or yielda
Value for parameter for
C. acetobutylicum carrying the
following plasmidb:
pMTL500E pWUR459 pWUR460
(control) (Padc-Cb-acr) (Pthl-Cb-acr)
Substrate concns [mM]
Consumed glucose 318 ± 15 307 ± 29 320 ± 18
Initial acetic acidc 37 ± 0.2 38 ± 0.4 36 ± 0.8
Final acetic acid 14 ± 0.7 20 ± 6 19 ± 2
Concns of 2,3-BD pathway
products [mM]
Acetoin 19 ± 2 2 ± 1 3 ± 0.3
meso-2,3-Butanediol 3 ± 0.1 2 ± 0.1 2 ± 0.3
d-2,3-Butanediol 0 20 ± 1 22 ± 3
Acetoin + 2,3-BD 22 ± 2 25 ± 2 26 ± 4
% yield of acetoin + 2,3-BD per
glucose [mM/mM]
7 ± 0.8 8 ± 0.9 8 ± 1
Concns of other fermentation
products [mM]
Butyric acid 2 ± 1 5 ± 3 6 ± 3
Lactic acid 3 ± 0.7 6 ± 1 4 ± 0.4
Acetone 80 ± 9 78 ± 12 86 ± 6
Butanol 161 ± 6 157 ± 15 166 ± 6
Ethanol 40 ± 2 34 ± 5 56 ± 14
a Abbreviation: 2,3-BD, 2,3-butanediol.
b Data are given as the means ± standard deviations of three replicate fermenta-
tions.
c Acetate is present at the beginning (time zero) as a medium component and is
consumed during the fermentation.
(mCGM and CGM media). At the end of all fermentations, small amounts of 1
to 3 mM meso-2,3-BD were found (Figure 5.3 and data not shown). In all these
fermentations, no d- or l-2,3-BD was detected.
Cell homogenates of wild-type and transformed C. acetobutylicum strains were
assayed for acetoin reductase activity. A low, but significant, activity level of
0.042 ± 0.0035 U/mg and 0.042 ± 0.0044 U/mg could be detected in cell ex-
tracts for strains transformed with pWUR459 and pWUR460, respectively. The
background levels were 0.018 ± 0.0015 U/mg and 0.024 ± 0.0021 U/mg for the
C. acetobutylicum WUR strain and strain transformed with pMLT500E vector
control, respectively. Detection was complicated by the rapid loss of activity also
seen with purified enzyme isolated from E. coli extracts (Siemerink and Kengen,
unpublished).
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5.3.2 Product stereochemistry
There are three stereoisomeric forms of 2,3-BD. The main stereoisomer pro-
duced by fermentation in MG medium was identified as d-(2R,3R)-2,3-BD. How-
ever, low levels of meso-2,3-BD were also detected in transformant strains, as
well as in wild-type fermentations by both HPLC and GC-MS analysis. In all
fermentations, l-(2S,3S)-2,3-BD was below our detection threshold. Figure 5.3
(page 114) shows the gas chromatographic analysis of extracts of standard and
medium samples of cultures of the various C. acetobutylicum strains.
The observation that both the plasmid vector control strain as well as our
wild-type strain produced meso-2,3-BD is a new observation for C. acetobuty-
licum and prompted us to investigate this further. An independently obtained
C. acetobutylicum ATCC 824 type strain sample that was grown under identical
conditions did not produce meso-2,3-BD. This suggests that our ATCC 824 lab
strain has diverged from the type strain. We therefore refer to our lab strain as
C. acetobutylicum WUR (Table 5.1).
5.3.3 Acetoin- and 2,3-BD-challenged batch fermentations
To determine possible inhibitory effects of 2,3-BD on the cultures of C. aceto-
butylicum transformants expressing the Cb-acr gene, fermentations in media
supplemented with 20 mM d-(2R,3R) or 20 mM meso-2,3-BD were performed.
In cultures challenged with d-2,3-BD, both transformants containing the Cb-
acr gene produced additional d-2,3-BD in similar amounts (12 mM for strain
pWUR459 and 20 mM for strain pWUR460) compared to their nonchallenged
controls (15 mM and 17 mM, respectively). The use of meso-2,3-BD resulted in
similar behaviour (Table 5.4, page 115).
We also supplemented media with racemic acetoin (20 mM) to check whether
the amount of produced acetoin was limiting for the production of 2,3-BD. Sup-
plemented cultures of ACR-expressing strains converted both d- and l-enantio-
mers into d- and meso-2,3-BD (Table 5.4). This demonstrates that the Cb-ACR
enzyme is able to convert both acetoin enantiomers and is therefore not ste-
reoselective for the configuration at the C-3 position. The total amount of both
2,3-BD diastereomers produced in the challenged cultures, 36 mM (pWUR459)
and 41 mM (pWUR460), corresponds with the total amount of acetoin consumed.
Interestingly, the plasmid control strain produced more meso-2,3-BD in the
acetoin-challenged cultures. It increased significantly from 2±0.4 mM in the non-
challenged control to 4± 0.2 in the racemic-acetoin-challenged culture. However,
still no d- or l-2,3-BD was observed.
5.4 Discussion
Acetoin reductase (ACR) is an enzyme that catalyzes the reduction of acetoin
to 2,3-butanediol (2,3-BD). Although Clostridium beijerinckii NCIMB 8052 con-
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Figure 5.3: GC-MS chromatograms (single ion mode; m/z = 45) of extracts of a
standard, GM medium, and samples taken at the end of the fermentation
of wild-type and transformant cultures. Chromatogram 1, mixture of all
three 2,3-BD stereoisomers; chromatogram 2, GM medium blank; chroma-
togram 3, fermentation of C. acetobutylicum ATCC 824; chromatogram 4,
fermentation of C. acetobutylicum WUR; chromatogram 5, fermentation
of C. acetobutylicum WUR harbouring the empty vector (pMTL500E);
chromatogram 6, fermentation of C. acetobutylicum WUR harbouring the
pWUR460 construct containing the acr gene. The retention time of the
d-2,3-BD peak in chromatogram 6 is somewhat different due to the high
concentration. Spiking experiments confirmed that it is indeed the d-
stereoisomer.
tains a homologue (Cbe 1464 ) of a Bacillus cereus 2,3-butanediol dehydrogenase
gene in its genome,284 we did not find any report in the scientific literature
mentioning the production of either the ACR substrate acetoin or its product,
2,3-butanediol, by C. beijerinckii. In this study, we showed that when the C. beij-
erinckii acr (Cb-acr) gene is expressed in C. acetobutylicum, natively produced
acetoin is reduced to d-(2R,3R)-2,3-BD (Table 5.3). This conversion is in agree-
ment with the proposed acetoin reductase function of the cloned C. beijerinckii
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Table 5.4: Net change of extracellular acetoin and 2,3-butanediol concentrations in chal-
lenged batch cultures of C. acetobutylicumtransformants harbouring pMTL500E,
pWUR459, or pWUR460, after 72 h of fermentation, compared to their inocula-
tion levels
Plasmid Challengea
Nett change in extracellular concn [mM] of:b
Acetoin d-2,3-BD meso-2,3-BD Acetoin +
2,3-BD
pMTL500E (control) No challenge 15 ± 1 0 2 ± 0.4 17 ± 1
Acetoinc 13 ± 2 0 4 ± 0.2 17 ± 2
d-2,3-BDd 12 ± 2 −0.7 ± 1 1 ± 0.05 13 ± 2
meso-2,3-BDe 15 ± 0.2 0.3 ± 0.6 2 ± 1 18 ± 1
pWUR459 (Padc-Cb-acr) No challenge 0.2 ± 0.4 15 ± 1 1 ± 0.2 16 ± 1
Acetoin −20 ± 0.4g 24 ± 1 11 ± 0.5 15 ± 1
d-2,3-BD 0.1 ± 0.2 12 ± 1 0.9 ± 0.1 13 ± 1
meso-2,3-BD 0.2 ± 0.4 17 ± 2 −0.5 ± 0.2 17 ± 2
pWUR460 (Pthl-Cb-acr) No challenge 0 ± 0.3 17 ± 1 0.8 ± 0.1 18 ± 1
Acetoin −21 ± 0.7 29 ± 4 11 ± 0.2 20 ± 4
d-2,3-BD 0.2 ± 0.3 20 ± 3 0.9 ± 0.1 21 ± 3
meso-2,3-BD 0.4 ± 0.4 21 ± 0.5 0.1 ± 1 22 ± 1
a Racemic acetoin, d-2,3-BD, or meso-2,3-BD was added to the medium before inoculation at a
concentration of 20 mM.
b Data are given as the means ± standard deviations for three replicate fermentations and calculated
by subtracting the concentration after 72 h from the concentration at the time of inoculation. For
example, for the d-2,3-BD challenge of C. acetobutylicum carrying pWUR460, the initial d-2,3-BD
concentration of 20 mM was subtracted from the final concentration of 40 mM, resulting in a nett
production of 20 mM d-2,3-BD.
c The medium was supplemented with racemic acetoin.
d The medium was supplemented with d-(2R,3R)-2,3-BD.
e The medium was supplemented with meso-2,3-BD, which also contained approximately 10 %
racemic d/l-2,3-BD.
f Analysis was done by nonchiral HPLC, so no separation of enantiomers was possible; however, on
the basis of previous results, the d-enantiomer is expected to have been formed.
g Negative values indicate consumption of acetoin relative to inoculation conditions.
gene based on functional expression in E. coli and with a recent publication on an
acetoin reductase (BdhA) of Bacillus subtilis.285 The amino acid sequence of this
enzyme is very similar to the C. beijerinckii ACR with 51 % identical residues
and 66 % similar residues.
Clostridium acetobutylicum ATCC 824 is known to produce acetoin as a
minor fermentation product, but it has never been reported to produce meso-2,3-
BD.286,287 Our analysis of fermentations of an independently obtained ATCC 824
type strain confirms this. In the course of this study, however, we found that both
the wild type and the plasmid control of the C. acetobutylicum WUR strain does
produce meso-2,3-BD. Apparently our laboratory stock, originally acquired as
the ATCC 824 type strain, evolved a divergent phenotype. Despite this, we con-
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tinued to investigate the fermentative behaviour of our transformant strains, as
they showed interesting properties.
An earlier report describing an attempt to engineer C. acetobutylicum to
produce 2,3-butanediol by heterologous expression of a Klebsiella pneumoniae
ACR was unsuccessful.287 In contrast to the reported approach, we decided to
express the C. beijerinckii acr gene, which has a GC content (35 %) which is
comparable to that of the DNA of the C. acetobutylicum host (31 %), and a similar
codon usage (Codon Usage Database [http://www.kazusa.or.jp/codon/]). We
also used a different shuttle vector (pMTL500E) with another origin of replication
in an attempt to increase the gene dosage. The pMLT500E plasmid (pAMβ1
origin) has a higher copy number in C. acetobutylicum142,288 than the plasmids
derived from low-copynumber pSOS84 (pIM13 origin) used by Wardwell et al.287
Combined with strong promoters (either Padc or Pthl), our approach resulted
in levels of expression of the Cb-acr gene by C. acetobutylicum high enough to
lead to 2,3-BD production, despite the fact that the detected specific activity is
relatively low.
Two different expression constructs, pWUR459 (Padc-Cb-acr) and pWUR460
(Pthl-Cb-acr), were transformed into C. acetobutylicum to test the influence of
the two different expression profiles of the promoters on fermentation. Both
transformant strains were able to convert approximately 90 % of the natively
produced acetoin into d-2,3-BD, with values reaching 22 to 23 mM. Compared
to the industrial strain Klebsiella pneumoniae SDM, which reaches concentrations
up to 1 664 mM, this is relatively low.289 However, for this species, 2,3-BD is the
main fermentation product, whereas for our strain, 2,3-BD is only a side product
next to the solvents butanol and acetone whose levels remained unaltered.
During the acidogenic phase, the pWUR460 (thl-controlled) fermentation
showed a significantly lower acetoin level compared to the pWUR459 (adc-con-
trolled) culture or the empty vector control. The level of 2,3-BD was concomit-
antly higher in the thl-controlled culture. This difference in acetoin and 2,3-BD
levels between the adc- and thl-driven acr expression is in good agreement with
the differences in promoter activity.227,228 Later during the fermentation, this
difference levelled out. Despite constitutive expression of Cb-acr by the strain
containing pWUR460, accumulation of acetoin in the medium was still observed,
which suggests that the acetoin production flux under these conditions is higher
than the flux from acetoin to 2,3-BD can accommodate.
5.4.1 Identification of bottlenecks for 2,3-BD production
In our experiments, transformant cultures were challenged by the addition
of 20 mM racemic acetoin, resembling the levels observed in the final stages of
normal growth. The observation that similar amounts of acetoin were produced
by the control strain in both unchallenged and acetoin-challenged fermentations
(Table 5.4) indicates that acetoin production is not affected by its extracellu-
lar concentration at the concentrations tested. This is in agreement with the
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fact that in nonchallenged fermentations of Cb-acr-expressing transformants, the
combined levels of acetoin and 2,3-BD do not significantly exceed those of the
acetoin levels of the control strain fermentation. In racemic-acetoin-supplemented
fermentations with Cb-ACR expressing strains, all of the additional acetoin was
converted into d-2,3-BD and meso-2,3-BD. This lack of selectivity for the stereo-
chemistry of the substrate is not uncommon among acetoin reductases.290
When exogenously added d-2,3-BD or meso-2,3-BD (20 mM) is present during
fermentation, the amount of converted acetoin is not affected, resulting in final
d-2,3-BD levels of 40 mM. This shows that at the levels tested, the amount of
2,3-BD is not inhibitory to the reaction or its production. On the basis of these
results, we conclude that the formation of acetoin, for the fermentation as a
whole, is the limiting factor for the production of 2,3-BD, even though, initially,
acetoin accumulates in the medium (Figure 5.2).
5.4.2 2,3-BD production model
On the basis of the combined results of the wild-type strain, strain carry-
ing the plasmid control, and strains expressing the Cb-acr gene, in normal and
challenged cultures, we propose the model shown in Figure 5.4 (page 118) for
acetoin and 2,3-BD production in our C. acetobutylicum strain. The introduced
ACR enzyme can convert both d- and l-acetoin enantiomers into d-2,3-BD and
meso-2,3-butanediol, respectively. The wild type and the plasmid control strain
produced small amounts of meso-2,3-BD and no detectable levels of d- or l-2,3-
BD, as confirmed by GC-MS analysis. In the acetoin-challenged cultures, the
meso-2,3-BD formation by the control strain (pMTL500E) doubled from 2 mM
to 4 mM. Most likely, one or more of the dehydrogenases that are present in
C. acetobutylicum WUR do, to some extent, accept acetoin as a substrate. This
would suggest that it is d-acetoin that is the source of the endogenous meso-2,3-
BD production as the native acetoin enantiomer ratio is 12:1 (d:l). Thus, in the
acetoin challenge experiment, the levels of d-acetoin are increased approximately
1.7-fold (from 14 mM to 24 mM), while the l-acetoin concentration increased
more than 10-fold (from 1 mM to 11 mM). If l-acetoin were the source of the
endogenous 2,3-BD production, then a more-substantial increase of meso-2,3-BD
production would be expected.
5.4.3 Future perspective
If a pathway could be established in which 2,3-BD is dehydrated to 2-butanone
and then further reduced to 2-butanol, then potentially a redox balanced fer-
mentation of glucose to 2-butanol and carbon dioxide could be established in this
organism. The less-toxic nature of 2-butanol compared to 1-butanol280 would
make it an alternative approach to circumvent the limited butanol yield of the
classic ABE fermentation.
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Figure 5.4: Proposed 2,3-BD biosynthesis pathway in the ACR-expressing C. aceto-
butylicum transformants of this study. The boxed area indicates the intra-
cellular space. The size of the arrows indicates the relative flux toward d-
and l-acetoin from pyruvic acid. The grey arrows illustrate the impact of
supplementing the medium with 20 mM racemic d/l-acetoin. The C. beij-
erinckii acetoin reductase (Cb-ACR) enzyme is indicated in bold type on
a gray background. The proposed conversion of d-acetoin to meso-2,3-BD
by an endogenous alcohol dehydrogenase (C. acetobutylicum alcohol de-
hydrogenase [Ca-ADH]) is indicated. In the control strain fermentation,
the ratio of the two acetoin enantiomers is 12:1 (d:l).
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Chapter 6
General discussion and
conclusions
6.1 Introduction
Since the oil crises of the 1970s more research efforts were focused on theproduction of chemicals from renewable resources that are normally derivedfrom petroleum. Those events and later developments and made our in-creasing dependence on oil and its derived products clear. Besides the, in
short term, non-renewable nature of petroleum and the insecurity of supplies,
another driver for a search for alternatives is the supposed anthropogenic global
warming that occurs as a result of increasing carbon dioxide concentration in the
atmosphere.
Production of some of these chemicals through fermentation offers the pos-
sibility of using sugars from plant materials, which are in principal renewable,
as a new resource. Butanol has applications as a replacement of transport fuel,
superior to ethanol, and is used as a feedstock for the chemical industry. The bio-
logical production of butanol as part of the acetone-butanol-ethanol-process has
been known for over a century, but despite many efforts to improve the butanol
yield, the process is currently economically uncompetitive.
The research described in this thesis was undertaken with the aim of im-
proving the butanol production by Clostridium acetobutylicum using metabolic
engineering techniques. Here the work reported in the preceding chapters will be
put into perspective and the initial assumptions of the work will be discussed.
6.2 Premiss
Production of butanol through fermentation is performed by various Clostri-
dial species, most notably C. acetobutylicum and C. beijerinckii. However, in
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all wild-type strains, production of other products is observed next to butanol,
such as the short-chain fatty acids acetate and butyrate, the solvents acetone
and ethanol, and hydrogen gas. Acids are produced by the organism to maxim-
ise ATP-production but results in a decreasing pH of the extracellular medium.
After a certain time the organism starts to produce neutral solvents, presumably
to prevent further acidification which would lead to inactivation of cellular pro-
cesses resulting in cell death.265 The premiss for this work was that it should
theoretically be possible to modify the metabolic network in such a way that a
homo-fermentative butanol strain can be obtained, as per Equation 6.1.‖
C6H12O6 + 2 ADP + 2 Pi + 2 H+ → 2 ATP + 3 H2O + 2 CO2 + C4H10O (6.1)
Fermentation of 1 mole of glucose could then result in 1 mole of butanol being
formed in addition to 2 moles of carbon dioxide and 2 moles of ATP. This is in
fact equivalent to homo-fermentative ethanol production as carried out by yeasts
and, from an energy yielding perspective, also to the lactic acid fermentation
which results in the same amount of ATP being generated.
Research by Maddox and Bahl et al. on fermentation of whey by C. acetobu-
tylicum gives further support for the idea that the organism is able to grow on
production of almost exclusively ethanol and butanol with very little acid and
acetone production.105,291 Later studies into the so-called alcoholgenic ferment-
ation identified other conditions under which predominantly alcohols are pro-
duced.255–259 However, no studies are published that address the question if the
ATP production from glycolysis alone is enough for growth or cellular mainten-
ance of C. acetobutylicum, as this would have be the case for a true butanol-only,
or alcohol-only mutant.
6.3 Biological butanol production
There is no known organism that only produces butanol anaerobically as
major liquid product, either naturally or by optimising the process conditions.
Therefore, there are two options if we want to use biological means to convert bio-
mass to butanol. One is to search for a novel organism, or combination of organ-
isms, that can perform this conversion. The other is to metabolically engineer an
organism to fit the requirements. The challenge with the former approach is that
there is no known method to quickly select for (enhanced) butanol production,
leaving screening as an alternative, which is a virtually insurmountable task. The
lack of a positive selection mechanism or screening system for increased butanol
‖This representation should not be misconstrued to seem to indicate continous proton re-
moval, because formed ATP will eventually be hydrolysed releasing the same amount of protons.
Neither is there a charge inbalance as ADP, ATP, and Pi also carry (unwritten) negative charges
in this equation.
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production also hampers an approach using random mutagenesis of butanol pro-
ducing strains. This leaves metabolic engineering as the only avenue to rationally
develop a butanol-only strain.
One of the most important parameters in a metabolic engineering approach is
the choice of host organism. The host that is to be used for butanol production
should be assessed based on the following criteria:
(i) resistance to butanol;
(ii) natural butanol production;
(iii) amenability to genetic engineering;
(iv) knowledge on the metabolic pathways and regulatory network;
(v) ability to ferment lignocellulosic substrates and other renewable substrates;
(vi) robustness of the strain under industrial process conditions; and
(vii) resistance to extreme conditions (pH, temperature) to facilitate non-sterile
process conditions.
These various criteria will be discussed in the following sections.
Butanol toxicity
Although several clostridia are native butanol producers, their resistance to
this product is limited. Above a butanol concentration of 1.0 %, growth is already
severely reduced and typical production titres are hardly ever above 2.0 % (w/v).
These low concentrations make product recovery more costly. Ethanol concen-
tration after yeast fermentation is for example much higher, reaching up to 12 to
16 % (w/v). A similar sensitivity for butanol has been observed for a wide range
of organisms including various E. coli and Zymomonas mobilis strains, and Pi-
chia and Saccharomyces species. Positive exceptions are Lactobacillus delbrueckii
and L. brevis, that can tolerate up tot 2.5 % and 3.0 % butanol in the growth
medium, respectively.195 Also Pediococcus pentosaceus, P. acidilactici, Enterococ-
cus casseliflavus, Leuconostoc pseudomesenteroides, and Lactobacillus plantarum
were reported to still show growth above a concentration of 3.0 % butanol in the
medium.196
Because resistance to general stresses, such as those induced by butanol, is
difficult to engineer, as they are dependent on multiple genes and regulatory
systems, resistance to the final product should be one of the most important
parameters for host species selection. This phenotype is not difficult to select
for, as has been shown for, amongst others, E. coli292,293 and C. acetobutyli-
cum.133,134,136 The results of the selection procedures for 1-butanol resistance
have been limited however, not reaching above those already obtained by the
mentioned lactobacilli.
Endogenous butanol production
Before the advent of genetic engineering the organism to be used for pro-
duction of a certain compound was required to already be able to produce this
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compound (or a very similar one), if only suboptimal. Random mutagenesis
could then be employed to try to increase production or eliminate additional un-
wanted reactions. Although butanol production can nowadays be engineered into
an non-natural producer, there are inherent advantages to using natural butanol
producing Clostridium species. These organisms have naturally been selected to
achieve maximum growth within the constrains of a certain survival strategy. At
the same time this is also a pitfall as it is important to realise that an organism
was selected for growth, not for the optimised production of a certain compound.
It is therefore highly beneficial in an metabolic engineering approach to couple
(desired) product formation to growth as then a laboratory evolution approach
could be used, to further improve production.
The fact that butanol as a (main) fermentation product was the exclusive
domain of the solventogenic clostridia, made these bacteria the production host
of choice for almost a century. This resulted in C. acetobutylicum becoming the
model organism for solvent production. However, using genetic engineering tech-
niques, it is nowadays relatively easy to endow a host with a new biochemical
pathway for production of a desired compound, making this requirement far less
important. But due to its ‘industrial heritage’, including extensive knowledge
of the process, a wide substrate range including pentose sugars, and process ro-
bustness, and other factors,115 C. acetobutylicum and related species, still feature
prominently as the platform for butanol production.
Amenability to genetic engineering
Genetic tractability of the host is essential for a metabolic engineering ap-
proach to succeed. The possibilities of clostridia in this regard were not very
good up to recently, with only limited genetic tools available. But the gene
knock-out system for clostridia described in chapter 2 part 2 and the recent
plethora of options that has become available for C. acetobutylicum and other
clostridia (see chapter 1) strengthens its position for continued use as a butanol
production platform.
Metabolic pathways and regulatory networks
A thorough understanding of all pathways involved in production of a com-
pound, and how they a regulated, is essential for a rational modification of
the metabolism, especially when no positive selection pressure can be applied
for production of the desired compound. The, only recent, discovery that the
BCD/EtfAB enzyme complex, that catalyses the reduction of crotonyl-CoA to
butyryl-CoA, of C. kluyveri, requires oxidised ferredoxin to function, as it gets
co-reduced, highlights that one of the most basic pathways was not fully under-
stood.99 This discovery explained how in crude extracts an NADH-stimulated hy-
drogen production could be observed despite the theoretical limitations. It is also
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still not elucidated what the actual reducing cofactor of the main aldehyde/alco-
hol-dehydroganese (adhE also known as aad) is.294
Next to these enzyme-related issues, also the global regulation mechanism of
processes like sporulation and solventogenesis are very complex and still not really
understood, although also in that area progress is being made.107,161,162,180,275,295
Fermenting renewable substrates
For producing second generation biofuels, it would be advantages if the host
is able to break down complex lignocellulosic biomass into simple sugars (i.e.
towards a consolidated bio-based process), and can utilise the various result-
ing sugars. In absence of these characteristics it becomes essential that these
functionalities can be engineered into the host, which in all likelihood will be a
complex undertaking. Alternatively other renewable substrates such as seaweed,
glycerol from biodiesel and food wastes could be used which are, somewhat, less
resistant to hydrolysis.
There are strong indications that the C. acetobutylicum genome encodes a
cellulosome,68 similar to various cellulolytic Clostridia. However they can not
grow on cellulose as a substrate. They can grow on cellobiose and can convert
various C5 (and C6) sugars, including xylose,66,121 which is an advantage over
various organisms regularly employed in metabolic engineering approaches such
as E. coli and S. cerevisiae.
Extreme fermentation conditions
It makes the fermentation process in some regards easier when it can be
operated under more or less extreme conditions. If the process can be operated at
higher temperatures then huge savings can be made with regard to cooling costs
and it might be possible to operate the process under non-sterile conditions.
Similarly, if more extreme pH levels are tolerated by the organisms, then also
this might allow for non-sterile operating conditions te be used. Unfortunately,
C. acetobutylicum is neither thermophilic, nor tolerates pH extremes were many
other bacteria can not grow. The need for sterile process conditions is evident
from the known problems of contamination and spoilage of ABE-fermentations
by lactic acid bacteria.296,297
6.4 Non-native butanol production hosts
The genetic recalcitrance and complex fermentation behaviour of Clostri-
dial species, have let various researchers to heterologously express the clostridial
genes of the butanol production pathway in genetically very accessible organ-
isms such as, E. coli,197,198,298 S. cerevisiae,199,201 P. putida, B. subtilis,199 and
L. brevis.200 In all cases, the produced amounts of butanol are below 0.1 g/L, ex-
cept when a highly concentrated cell suspension is used (1.2 g/L)198,298 or when
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using rich medium with glycerol (0.55 g/L).197 In our hands, C. acetobutylicum
WUR by comparison routinely produces 12 g/L butanol and the C. acetobutyli-
cum WUR buk1 – strain produces 14.5 g/L (see chapter 4). All these approaches
utilised the BCD/EtfAB enzyme complex of C. acetobutylicum for the reduction
of crotonyl-CoA to butyryl-CoA, which, as was mentioned above, requires oxid-
ised ferredoxin as a co-substrate for activity. This is most likely the cause for the
very low butanol yields.
Liu et al. developed an approach in Lactobacillus buchneri dependent on
the natively present enzymes for conversion of acetoacetyl-CoA to butanol.299
Acetoacetyl-CoA was made by the bacterium by introducing the clostridial thi-
olase gene and this resulted in a butanol titre of 66 mg/L. The breakthrough in
exogenous butanol production was made by Shen et al.. who recognised that the
clostridial BCD/EtfAB complex was one of the main reasons for the low yields
and they instead employed an NADH dependent trans-enoyl-CoA reductase from
Treponema denticola.300 In addition, they employed a strategy where deletion of
all endogenous NADH-consuming pathways from the E. coli host, resulted in an
‘NADH driving force’ to utilise the butanol production pathway. By doing so,
they coupled survival (growth) to butanol production, allowing them to reach
a final butanol ‘concentration’ of 30 g/L, using gas-stripping to overcome the,
apparent, toxic limit of 3.8 g/L for their strain. Although the production proper-
ties of the modified E. coli strain are impressive at 70 % yield of theoretical, it is
still very sensitive towards butanol and the proposed pathway should ideally be
transferred to a more resistant host organism to see if the results can be improved.
Another novel approach by the same lab was to use non-fermentative pathways
for the production of various linear and especially branched chain alcohols.202 The
method relied on the use of the highly active amino acid biosynthetic pathways
and diverts the 2-keto acid intermediates for alcohol synthesis using a 2-keto-acid
decarboxylase (KDC) enzyme for aldehyde production and an aldehyde dehydro-
genase from yeast for reduction to the corresponding alcohol. Also the β-oxidation
pathway has been used to produce butanol by deriving butyryl-CoA from operat-
ing the pathway in reverse to the normal physiological situation.301 The method
has the advantage of generating a higher ATP-yield than the 2-keto-acid path-
way for linear alcohols (see Figure 6.1). Especially the last two methods look
promising, but the low butanol resistance of E. coli means that these methods
need to be transferred to a more resistant host, possibly even C. acetobutylicum
itself.
To take advantage of the versatile substrate utilisation properties of clostridia,
its reduced number of fermentation products (only acetate and butyrate), and its
less complex life-cycle Clostridium tyrobutyricum, a non-solventogenic species,
has been modified to over-express the AdhE2 aldehyde/alcohol dehydrogenase
from C. acetobutylicum.302 Depending on the plasmid used, the mutants produced
butanol between 0.019 and 1.1 g/L, compared to approximately 7.8 g/L butyrate
and 2.8 g/L acetate. Over-expression of AdhE2 in an acetate kinase knock-out
background improved butanol production 9-fold to 10.0 g/L, but still 5.8 g/L
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Glycolysis
CO2, 4 [H]
ATP
4[H]
trans Δ2-fatty alcohols
(Cn)-Acyl-CoA
β-Ketoacyl-CoA
trans β-Hydroxyacyl-CoA
Acetyl-CoA
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trans Δ2-enoyl-CoA
(Cn+2)-Acyl-CoA
CoA-SH
H2O
1,3-Diols
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1/2 Glucose
Figure 6.1: Illustration of the functional reversal of the b-oxidation cycle as demon-
strated by Dellomonaco et al.301. The following enzymes (gene names
in parentheses) are involved in the functional reversal of the b-oxidation
cycle: (1) thiolase (yqeF, fadA); (2) hydroxyacyl-CoA dehydrogenase
(fadB); (3) enoyl-CoA hydratase (fadB); (4) enoyl-CoA reductase (ydiO).
Each turn of the cycle generates an acyl-CoA that is two carbons longer
than the initial acyl-CoA thioester (indicated as Cn+2). Intermediates in
the engineered pathway can be converted to a functionally diverse set of
molecules using aldehyde-forming acyl-CoA reductases and alcohol dehyd-
rogenases (5) and acyl-CoA thioesterases (6). R, side chain attached to
the acyl-CoA group of the starter molecule (for example, R = H for acetyl-
CoA and R = CH3 for propionyl-CoA); 2[H], NADH/NADPH/ferredoxin.
Dotted lines indicate multiple steps. Dashed lines without arrowheads
connect identical metabolites of different chain length. Picture redrawn
from Dellomonaco et al.301
butyrate and minor amounts of acetate were produced. The yield from glucose
was 66 %. These initial results are interesting, especially the high butanol to
ethanol ratio and high butanol yield combined with the absence of acetone is
promising and demonstrate the compatibility of the pathway between the two
clostridial species.
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6.5 Metabolic engineering of Clostridium
acetobutylicum
The industrial history of the ABE-fermentation, the large body of research
available on solventogenic clostridia, and the (very) low levels of butanol produc-
tion by heterologous hosts are all reasons for the continued research efforts into
the clostridial ABE fermentation. The mix of fermentation products, with a dif-
ferent preferred product depending on the circumstances at the time, has always
been a target for optimisation, with initially acetone as the preferred product,
later butanol.
At the start of the research project described in this thesis, the first ‘mature’
metabolic engineering tools started to become available for the Clostridium genus
(chapter 1). Targeted gene inactivation using group II introns was followed by
double cross-over homologous recombination based approaches that improved
upon the already available single cross-over method which had significant disad-
vantages.107,163
Electroporation for the transformation of DNA into C. acetobutylicum was
already an established technique, although preparing the cells is laborious and
time consuming. A useful addition was our discovery of storage conditions for
electro-competent cells, allowing for the batch preparation of these cells for later
use (chapter 2 part 1). It was shown that over a period of more than 30
months, cells retained their original competence and that even after 54 months
cells were still transformable. Although it is of limited use to keep cells for such
a long period, it does illustrate the robustness of the method. The principle on
which it is based, exclusion of oxygen, suggests that it might also be applicable
to the storage of other obligate anaerobes.
The focus of the research described in this thesis was to eliminate the pro-
duction of especially acetone to improve butanol formation since impeding the
acetone pathway results in high acetate levels.124,175 The attempts of Tummala
et al.and Sillers et al.both resulted in approximately 50 % acetone reduction and
more than 15-fold increased ethanol production, but acetate production contin-
ued. I sought another method of eliminating it without the associated increased
acetate accumulation. As acetone is formed by the uptake of acids, it should
be possible, by eliminating their production, to stop acetone accumulation, and
divert product formation exclusively to the alcohols.
6.5.1 Acetate kinase (ack) inactivation
In line with our strategy to eliminate acid formation and force C. acetobuty-
licum to ferment glucose exclusively to alcohols, we inactivated acetate kinase as
described in chapter 3. The choice to inactivate the second enzyme, ack, of the
pta-ack operon, was made to investigate the suggestion by Zhao et al.165 that
accumulation of acetyl-phosphate is not linked to initiation of solvent formation,
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but that it is instead the intra-cellular butyryl-phosphate levels that might have
a regulatory function, similar to acetyl-phosphate in E. coli.238
Although no intracellular concentrations for acetyl-phosphate were determ-
ined to prove that it accumulates, it is expected that it does, analogous to the
buk1 – mutant. The ack mutation was expected not to affect the initiation, or the
level, of solvent formation, except for acetone, which is expected to be reduced.
The results described in chapter 3 show that when the ack– mutant is grown
in CGM, which does not contain acetate, there is no impact on acetate produc-
tion. When grown on medium with acetate (CM1), a reduction of 128 % is seen in
final acetate levels, while alcohol levels are not affected, confirming the expected
behaviour. However, contrary to our expectations, acetone levels are unaffected.
The sensitivity to exogenously added acetate at the moment of inoculation is
also observed when the ack– mutation is present in a buk1 – background (chapter
4). These results combined suggest an alternative acetate producing pathway.
However, it is either not expressed when increased acetate levels are present
during inoculation, or the enzymes of the pathway might be easily inhibited.
6.5.2 Butyrate kinase (buk1 ) inactivation
We sought confirmation of the high butanol producing phenotype of a buk1
knock-out mutant, as was published previously for the ATCC 824 strain.128 In our
WUR strain, the phenotype of this mutation turned out to different. Although
butanol there too was a major fermentation product, it did not accumulate to
the same level as that of the mutant of the ATCC 824 strain (chapter 4).
Instead, we observed co-production of butanol and acetate, with fermentations at
different pH-levels and medium compositions suggesting that it is acetate that was
accumulating to toxic levels. Butyrate production was indeed severely inhibited,
with enzyme assays confirming the inactivation of butyrate kinase.
The increased acetate production was also observed in the ATCC 824 strain
mutant, but in that case, a distinct solvent switch, like for the wild-type, is
observed, resulting in re-uptake of the acids and in solvent production. In our
mutant strain we did not observe this switch. Butanol is detected at the same time
point as acetate. To improve butanol production, acetate, normally included in
CM1 medium, was not added and the pH of the fermentation was optimised. This
resulted in a 21 % increase in butanol production and an improvement in butanol
selectivity from 55 % to 70 % (expressed as butanol divided by the sum of acetone,
butanol, and ethanol). Although this improved butanol production selectivity,
it still resulted in acetone production and massive acetate accumulation in the
medium. The absence of the solventogenic switch fits with the asporogenic nature
of the strain. In addition, it is another example, next to solventogenic continuous
cultures, of cells that can produce all solvents during vegetative growth as also
observed by cell sorting experiments.113
Despite high acetate levels, the mutation does seem to trigger production of
what could be called an ‘over-flow metabolite’, namely acetoin. Normally only
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present at low levels (∼10 mM) but in fermentations of the BUK1KO strain at
higher pH levels this was increased almost five-fold to 49 mM. Unlike lactate
formation which would be redox-neutral, the formation of acetoin results in net
NADH production which the organism must dispose of in some other way.
6.5.3 Dual acid pathway inactivation
To eliminate further acetate and thereby acetone production, we targeted
acetate kinase for gene disruption using our own TargeTron based system (chap-
ter 2 part 2). A mutant was successfully isolated and enzyme assays confirmed
the inactivation of both butyrate kinase and acetate kinase. The fermentation
pattern of the mutant however was unexpectedly similar to the wild-type at all
tested pH levels in CM1 medium. If acetate was omitted from the CM1 medium
and the pH was not controlled, then acid levels were extremely low, however there
was still a large amount of acetone produced (55 mM), indicating continued acid
production. The results indicate that continued acid production in the case of the
ack mutant (chapter 3) and most likely also for the pta mutant126,179 is, at least
in part, due to an additional acetate producing pathway and not, or not only, due
to catalysis by the homologous enzyme of the butyrate pathway. The existence
of such a pathway might also fit with the observation that exogenously added
13C labelled acetate quickly labels acetyl-phosphate pools,101 while this is not
expected on the basis of the PTA-ACK pathway. However, what the physiological
function of the additional pathway, or alternative enzyme or enzymes with these
characteristics would be is unclear.
Up to now it is not known which pathway could be involved, and if the
buk1 – ack– (DAPKO) strain had accumulated additional mutations explaining
the phenotype. We therefore initiated a whole genome resequencing project using
the Illumnia platform, of both the WUR strain and the WUR DAPKO mutant
strain (data not shown). The preliminary results indicate that although the
DAPKO strain has approximately 190 point mutations compared to the published
genome sequence, the parental WUR strain has these too. It is of interest to
note that also the ATCC 824 reference strain contains most of the same point
mutations, suggesting errors in the reference sequence (unpublished results W.
Kuit & N. P. Minton).
The results thus far showed that no additional mutations occurred while isol-
ating the DAPKO mutant strain, establishing that the phenotype observed is
due only to the two introduced mutations. This supports the hypothesis that
alternative acetate and/or butyrate production pathways are present in wild-
type C. acetobutylicum and that these are responsible for the observed acetate
production.
It should be mentioned that also Lehmann et al. attempted to isolate a
mutant with both acid producing pathways inactivated. Their strategy was based
on obtaining a pta– ptb– mutant, however while both the pta– and ptb– single
mutant could be obtained, a double mutant could not.166 At this point we can
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only speculate why this would be the case as we were able to obtain a double
mutant even without selection pressure, contrary to their approach. While their
pta– mutant, similarly to our ack– mutant, showed continued acetate production,
their ptb– mutant produced no butyrate. It could be that this gene, or its product,
becomes essential in an pta– background. Additionally, strain differences or even
growth medium, could also explain the inability to obtain the mutant.
6.6 Butanol stress
The general consensus in the ABE-fermentation field is that it is the tox-
icity of butanol that limits further production57,130 due to disruption of cellular
functions caused by solubilisation of the cellular membrane132 and other mechan-
isms.130,131 Many efforts have been made in the past to obtain clostridial strains
with increased butanol tolerance. Both chemical mutagenesis133 and adaptation
strategies136 have been used to isolate mutants with increased butanol resistance.
In some cases, this resulted in slight to moderate increases in butanol production
levels, while in other cases solvent production was lost.134 In the case of Van Der
Westhuizen et al.,303 the increased butanol resistance was an unexpected trait
of an autolysis-deficient mutant. Soucaille et al.304 reported a butanol resistant
mutant displaying increased autobacteriocin activity.
In different approaches, the over-expression of two heat-shock related proteins,
GroES and GroEL,137 over-expression of an endogenous putative transcriptional
regulator (CAC1869),135 or disruption of SMB G1518 or SMB G1519,305 resulted
in C. acetobutylicum mutants with increased butanol tolerance. But since butanol
resistance and production do not seem to be directly related these approaches
have met with limited success. This indirectly challenges the assumption that
it is butanol toxicity that inhibits the ABE-fermentation. This is supported
by various engineered strains that have a higher butanol production without
specifically being optimised for butanol resistance. It therefore seems that what
actually stops the fermentation is more complex than generally assumed.
In our research we tried two alternative approaches to either deal with, or
reduce, the stress resulting from 1-butanol accumulation in the growth medium.
The first one was to help the cells withstand the stresses they are exposed to
by adding various compounds, known as compatible solutes, to the medium and
monitoring the butanol production level of these cultures. The second approach
was a first step towards modifying the metabolism of C. acetobutylicum so that
it would no longer produce 1-butanol, but ferment glucose to 2-butanol: a com-
pound less toxic for C. acetobutylicum cells, while still retaining the same bene-
ficial bio-fuel properties.
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6.6.1 Compatible solutes
We selected a range of compatible solutes and their applied concentrations
from the literature.306–315 When these were added to CM1 growth medium,216
we tested whether this resulted in increased butanol production. The compounds
tested and at what concentration is shown in Table 6.1. Normally the 60 g/L
glucose present in the medium is almost completely fermented. In order to al-
low the cells to produce more solvents, the glucose concentration was raised to
90 g/L. Tests showed that the increased glucose concentration did not affect
the fermentation. 1 mL of an overnight pre-culture was used to inoculate flasks
in duplicate. Flasks contained 50 mL CM1 medium with the compatible solute
and the fermentations were monitored over a period of 6 days. Unfortunately,
none of the compatible solute test flasks contained significantly more butanol or
total solvents than the control flasks. We therefore had to conclude that under
the tested conditions the selected solutes did not enable C. acetobutylicum to
produce more butanol, or solvents.
Table 6.1: Potential compatible solutes and their tested concentrations
Tested concentrations of potential
compatible solutes in ABE fermentations
0.01 M and 0.1 M 0.05 M and 0.5 M 0.2 M and 1 M
trimethylamine N -oxide l-carnitine sucrose
(TMAO) l-glutamate d-(−)-sorbitol
putresceine l-proline d-(+)-trehalose
ectoine choline meso-erythritol
hydroxyectoine dimethyl glycine glycerol
glycine betaine
6.6.2 Alternative solvent products
An alternative strategy for avoinding butanol stress that we explored was
to see if less toxic butanol alternatives could be produced by C. acetobutyli-
cum. Data from the literature suggests280, and experimental results316 confirm,
that several 1-butanol analogues are less toxic for C. acetobutylicum. Amongst
these are iso-butanol (2-methyl-1-propanol), 2-butanol, tert-butanol (2-methyl-
2-propanol), and meso-2,3-butanediol. 2-butanol has almost the same properties
as 1-butanol as far as its application as a bio-fuel is concerned and biochemical
production seemed possible. It was therefore selected for further experimental
work.
2-Butanol can be produced by reduction of 2-butanone, which in turn can
be produced by dehydration of 2,3-butanediol. Although C. acetobutylicum
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ATCC 824 does not produce 2,3-butanediol, it does produce its precursor acetoin
(3-hydroxybutanone). In chapter 5 we demonstrated that C. acetobutylicum
WUR, but not C. acetobutylicum ATCC 824, natively produces minor amounts
of meso-2,3-butanediol and through expression of a C. beijerinckii acetoin re-
ductase (ACR) from plasmid pWUR459 (Padc-acr) or pWUR460 (Pthl-acr) can
also produce d-(2R,3R)-2,3-butanediol.
For the next step, a dehydratase was needed to convert the 2,3-butanediol
diasteriomer to methyl ethyl ketone (2-butanone). However, only a dehydratase
with meso-2,3-butanediol specificity317,318 has been described but not one for the
d or l diasteriomers.319 This therefore precludes its use in combination with the
C. beijerinckii ACR.
The specificity of the C. beijerinckii ACR was not known and had to be
experimentally tested. To be able to achieve 2-butanol production, it would be
easiest to express a known meso-2,3-butanediol forming acetoin reductase such
as one from Klebsiella pneumoniae IAM 1063320, but optimise its expression
to avoid the problems Wardwell et al. had,287 instead of the C. beijerinckii
ACR and combine this with the meso-2,3-butanediol dehydratase enzyme from
Lactobacillus brevis.317,318
If production of 2-butanol is possible then an attempt at a homo-fermentative
2-butanol strain can be made by inactivating the pyruvate:ferredoxin oxidore-
ductase enzyme complex (PFOR) by gene disruption of one of its components.
This enzyme complex catalyses the conversion of pyruvate to acetyl-CoA and
CO2 while reducing ferredoxin. The resulting metabolic system can then pos-
sibly bypass the regulatory network that is operating in C. acetobutylicum so
that a solvent switch is not necessary and neither is the initiation of sporulation.
Both these processes make the fermentation production-wise inefficient due to
reduced productivity because of these non-productive phases. Although these
finding would be of academic interest, it should also be investigated if current
2,3-butanediol producers, certain Bacillus and Klebsiella species amongst others,
are sufficiently resistant to, and can be used for, production of 2-butanol.
6.7 Recommendations
6.7.1 Butanol-only production strain
In section 6.2 it was explained that it is generally assumed194 that a homo-
fermentative 1-butanol strain can be made because substrate and product are
in redox balance. It has however not been proven that the organism can grow
and survive on the yield of 2 ATP from that conversion, or that some of the
intermediates are somehow essential for cell survival.
A straightforward way to tackle this question would be to basically turn
C. acetobutylicum into a lactic acid fermenting organism. When a lactate de-
hydrogenase (ldh) gene would be constitutively expressed in C. acetobutylicum it
would enable a homo-lactic acid fermentation if the new pathway would be able
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to sustain the full glycolytic pyruvate flux. The major pathway competing with
lactate formation would be the conversion to acetyl-CoA. If an ATP-yield of 2
ATP per glucose is enough for cell growth, then a strain expressing ldh should
allow inactivation of the PFOR enzyme complex, similar as discussed for the
proposed 2-butanol producing pathway in subsection 6.6.2.
An alternative approach could be a homo-ethanologenic strain, as this would
seem synonymous from a redox and ATP-yield basis. Would seem synonymous,
as no Rnf-complex has been detected in the genome of C. acetobutylicum.166 It
could however be that, via an undetected Rnf-complex, or some other mechanism,
C. acetobutylicum is able to generate energy from the low redox-potential elec-
trons from reduced ferredoxin like many other Clostridia. A recently constructed
strain, defective in C4 product formation, by disruption of the 3-hydroxybutyryl-
CoA dehydrogenase (hbd) gene, can apparently exist. If further inactivation of
the acetate pathway can be accomplished, then only ethanol production should
remain. However, as we have shown in chapter 4, it seems that there are
multiple acetate/acid producing pathways in C. acetobutylicum WUR, and most
likely C. acetobutylicum ATCC 824, which hampers this approach.
In my opinion it should first be investigated if a homo-fermantative 1-butanol
strain can in theory exist using for example the above mentioned strategies, before
attempting further metabolic engineering strategies aimed at improving butanol
production.
6.7.2 Alternative production hosts: Lactic acid bacteria
The analysis of suitable alternative production hosts (see section 6.3) and the
necessity to ascertain that the cell can support growth, or at the very least cellular
maintenance, from the 2 ATP-yield from fermenting glucose to butanol, suggests
that alternative production hosts should be more closely looked at. Notably some
of the lactic acid bacteria (LAB) seem ideal production hosts due to their high
1-butanol resistance and ability to require only 2 ATP per fermented glucose.
Some researchers already looked at the possibilities of using LABs for butanol
production.200,299 But Berezina et al.200 probably did not realise the associated
problems with using the BCD enzyme. This in all likelihood negatively im-
pacted their production which was only 300 mg/L. Expression of thiolase alone
in Lactobacillus buchneri by Liu et al. already resulted in butanol production by
endogenous enzymes but at low levels (66 mg/L). Although interesting in its own
right, the authors realised that it will require further metabolic engineering to
optimise butanol production in this strain. However, so far no follow-up reports
were published.
The provocative approach taken by Dellomonaco et al.301 to reverse the β-
oxidation cycle in E. coli to couple two acetyl-CoA units, and more, in a cyclic
manner, which could then be reduced by an bi-functional alcohol/aldehyde de-
hydrogenase to give butanol, or even higher linear alcohols, is a versatile method.
It could potentially be used in various organisms, and lactic acid bacteria should
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be a prime target to test this approach as a more suitable 1-butanol produc-
tion organism. The main disadvantage of using lactic acid bacteria that should
be mentioned is the extensive nutritional requirements these organisms have,
which could be difficult to sustain for a large scale process such as envisioned for
biobutanol production.
6.8 Concluding remarks
After more than a century, the biological production of butanol seems to be
approaching an historic moment with the convergence of new genetic techniques
in C. acetobutylicum and more knowledge on the enzymes and regulatory path-
ways involved in solvent formation. The insertional inactivation of genes involved
in the two major acid-pathways as reported in this thesis seemed a logical ap-
proach to eliminate acetone production. However, the reported C. acetobutylicum
strain with a double-knock-out of homologous enzymes in both the acetate and
butyrate pathway, a first, did not result in the desired phenotype. Under cer-
tain conditions the mutant showed an improved butanol production selectivity
compared to the wild-type, but it did clearly not perform an alcohologenic fer-
mentation. The results further suggest that an alternative pathway, or pathways,
is active in C. acetobutylicum which further research should identify, if this ap-
proach is to be successful in eliminating acid and acetone production. Future
research should also focus on the conversion of pyruvate to acetyl-CoA to see if
the organism is able to conserve energy stored in the reduced ferredoxins when
it is not generating hydrogen gas, and related to that how its is able to reduce
other cofactors involved in solvent formation.
The rapid strides made by researchers using heterologous hosts for the pro-
duction of butanol have not gone unnoticed and alternative pathways for the
production of higher linear and branched chain alcohols have been developed.
Future projects should carefully consider for each process what the desirable
characteristics of a production host are, and make a balanced decision with those
requirements in mind. Each one will have its own pro’s and con’s but it should
be selected based on those arguments and not merely because it has always been
so, as we have now entered the era of synthetic biology.
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Summary
During the last few decades, there has been an increasing search for alternat-ive resources for the production of products traditionally derived from oil,such as plastics and transport fuels. This has been prompted by the finitenature of our oil reserves, the desire for energy security, and by concerns
about anthropogenic global warming. Petrol and diesel are the two main fuel
types for land based transportation and are currently derived from oil. Butanol,
a four-carbon alcohol that can be produced by certain bacteria in a renewable
way, can be used as a direct petrol replacement. It also has multiple applications
as chemical intermediate and as a solvent. Although it is similar to ethanol it
has superior properties with regard to energy density, vapour pressure, and water
solubility when applied a biofuel.
The acetone-butanol-ethanol (ABE) fermentation of sugars as carried out by
various bacteria of the genus Clostridium has been widely applied in the first
part of the 1900s as a commercial method to produce butanol and acetone. The
two most used species have been Clostridium acetobutylicum and C. beijerinckii.
Both produce not only solvents but also the unwanted acids acetate and butyr-
ate. In the second part of the 20th century, the ABE-process became no longer
economically competitive with the petrochemical process for the production of
these solvents. But today’s high oil prices make the fermentation process inter-
esting again, although there are still challenges that have to be tackled before
the process can be re-commercialised. These include finding ways to make it pos-
sible to use cheap biomass feedstocks (such as lignocelluloses) as substrate rather
than using traditional feedstocks such as starch and molasses, which are relat-
ively expensive. In addition this replacement would avoid the food-versus-fuel
dilemma. Another challenge is to improve butanol production, yield, and titre.
The work described in this thesis focuses on the enhancing of butanol production
and diminishing acid formation by C. acetobutylicum.
A metabolic engineering approach was taken to reduce the number and amount
of by-products in C. acetobutylicum fermentations. Production pathways of the
acids acetate and butyrate were targeted, as we hypothesised that inhibiting acid
formation would also prevent acetone production by C. acetobutylicum, resulting
in only alcohols as the liquid fermentation products. To carry out our metabolic
engineering work, we first developed an essential tool for gene disruption.
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Summary
During this work we studied storage conditions for electro-competent C. aceto-
butylicum cells, allowing for the batch preparation of these cells for later use for
up to 54 months (chapter 2 part 1). The principle on which it is based, exclu-
sion of oxygen, suggests that it might also be applicable to the storage of other
obligate anaerobes.
The second part of chapter 2 describes the adaptation of the TargeTron
gene knock-out system for use in C. acetobutylicum. The TargeTron system uses
a mobile group II intron that can be ‘retargeted’, i.e. reprogrammed, to insert
into a specific site in the genome in a process called retrohoming. We targeted the
acetate kinase (ack) gene and successful insertion of the intron was demonstrated
using a PCR test. But only after the development of a colony PCR protocol for
C. acetobutylicum as described in chapter 4, we were able to apply our system
and quickly detect pure mutants amongst the parental strain.
Another research group also developed a clostridial version of the TargeTron
system and called it ClosTron. The advantage of this system over the one we
developed is that inserted intron copies carry an activated erythromycin resist-
ance gene and can therefore easily be selected. In chapter 3 we used this system
to obtain an acetate kinase gene knockout, which was extensively characterised
in pH-controlled batch fermentations on two media; CGM and Clostridial Me-
dium 1 (CM1). Enzyme assays showed a 98 % reduction in in vitro acetate
kinase activity, however the mutant strain continued to produce wild-type levels
of acetate in CGM which does not contain any added acetate. In CM1 that does
contain acetate, acetate production could still be seen, but was severely reduced.
These results suggest that alternative ways of acetate production may be active
in C. acetobutylicum. The solvent production of the ack– strain was not signi-
ficantly affected in CM1. When grown on CGM our wild-type strain produced
large amounts of lactate and was therefore not suitable as a production medium.
Interestingly our ack– mutant strain performed better.
Subsequently we created a strain with an inactivated butyrate kinase gene
termed BUK1KO, as described in chapter 4. The phenotype of this strain was
essentially that of an acetate-butanol producer. Analysis of the fermentation
behaviour indicated that the strain never seemed to switch from an acidogenic to
an solventogenic state, as the wild-type did. Furthermore, the growth on CM1
in batch culture demonstrated a strong influence of the pH on the fermentation
behaviour. There was a good correlation between increasing fermentation pH
and higher acetate levels within the pH range from 4.5 to 5.5, suggesting that
the produced acetate levels might actually be the growth inhibiting compound.
In addition, the mutant cells never produced the clostridial cell-types associated
with spore formation. This is in line with the absence of a solventogenic switch.
Also in parallel with the increasing fermentation pH was an increased acetoin
accumulation with a maximum of 49 mM at pH 6.5 compared to 12 mM for the
wild type under control conditions. Growth on CM1 without acetate at a pH of
5.5 resulted in a 21 % increase in butanol levels to 195 mM (14.5 g/L) compared to
the wild type under its optimal conditions and 127 % under the same conditions.
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There was also a 60 % reduction in acetone levels and slightly increased ethanol
levels.
A subsequent inactivation of the acetate kinase gene in the buk1 – negative
background using our own TargeTron system (see chapter 2) resulted in isol-
ation of an ack– buk1 – double mutant. Despite abolishment of both acetate
kinase and butyrate kinase enzyme activity in vitro, the mutant continued to
produce both acids. In CM1, acetate levels were severely reduced compared to
the parenteral buk1 – strain, but when acetate was removed from the medium,
large amounts of acetate were produced again. This behaviour is reminiscent
of the ack– mutant and supports the hypothesis that unknown alternative acid
producing pathways or enzymes exist in C. acetobutylicum. Alcohol production
was negatively affected as compared to the parental strain and acetone produc-
tion was not eliminated. Also at certain pH-levels acetoin production was even
further increased to 100 mM, the highest reported value for this organism.
In an alternative take on improving butanol production titre, we envisioned
a homo-fermentative 2-butanol strain. 2-butanol is less toxic to the cell and
should, in the proposed pathway, be produced redox-neutral from glucose. In
addition it retains all the beneficial biofuel properties. As a first step towards
this goal, we demonstrated in chapter 5 that an alcohol dehydrogenase from
Clostridium beijerinckii, over-expressed in C. acetobutylicum, can accept nat-
ively produced d- and l-acetoin as its substrate and reduce it to d- and meso-
2,3-butanediol. In addition we showed that our C. acetobutylicum WUR strain
already produces small amounts (approximately 3 mM) of meso-2,3-butanediol
through an unknown pathway, most likely from d-acetoin. No production of
meso-2,3-butanediol was observed for the ATCC 824 strain. Completion of the
pathway requires a dehydratase and a secondary-alcoholdehydrogenase to pro-
duce methyl-ethyl ketone and 2-butanol respectively.
In the general discussion (chapter 6) the results described in this thesis
were put into perspective, and the existence of an alternative acid pathway in
C. acetobutylicum is suggested. Furthermore the disadvantages and advantages
of C. acetobutylicum as a butanol production platform are discussed together
with developments of butanol production in heterologous hosts.
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De afgelopen decennia is er steeds meer belangstelling voor alternatieve manie-ren om producten te maken zoals plastics en brandstoffen, die traditioneelvan olie gemaakt worden. Dit vanwege de realisatie dat aardoliereserveseindig zijn, dat landen die olie exporteren vaak politiek instabiel zijn en
vanwege de vrees dat de aarde opwarmt door de uitstoot van CO2. Benzine en
diesel zijn de twee belangrijkste brandstoffen voor transport over land en worden
momenteel vervaardigd uit olie.
Ethanol is een bekende biobrandstof die kan worden gemaakt uit ma¨ıs en
suikerriet, maar heeft als nadeel dat deze voor onze huidige auto’s slechts tot
maximaal 15 % kan worden bijgemengd in benzine. Butanol is net als ethanol
een alcohol, maar bestaat uit moleculen met een langere koolstofketen. Het voor-
deel van butanol is dat het hierdoor als volwaardige vervanger van benzine kan
worden gebruikt in de huidige auto’s. Het heeft daarnaast nog een aantal andere
eigenschappen die het een betere benzinevervanger maken dan ethanol, zoals een
hogere energiedichtheid, lagere dampspanning en een lagere wateroplosbaarheid.
Naast de mogelijkheid om butanol als biobrandstof te gebruiken, is het ook een
grondstof voor de chemische industrie en een oplosmiddel.
Net zoals ethanol kan butanol via biologische weg worden geproduceerd door
micro-organismen. Waar ethanol echter door veel verschillende organismen ge-
maakt kan worden, is biologische butanolvorming beperkt tot het bacteriegeslacht
Clostridium. Dit geslacht bestaat uit anaeroob groeiende, Gram-positieve, staaf-
vormige, endospoorvormende bacteriesoorten. In het eerste deel van de twintig-
ste eeuw, voor de opkomst van de petroleumindustrie, werd al op commercie¨le
wijze butanol via fermentatie geproduceerd. Hiervoor werden hoofdzakelijk twee
soorten gebruikt; Clostridium acetobutylicum en C. beijerinckii. Doordat alle
butanolproducerende bacterie¨n naast butanol ook nog andere producten maken,
zoals aceton en ethanol en de organische zuren acetaat (azijnzuur) en butyraat
(boterzuur), is het biologische proces niet erg efficie¨nt. Door het commercie¨le suc-
ces van butanolproductie op basis van petroleum raakte het biologische proces in
onbruik. De huidige hoge olieprijzen maken het fermentatieproces echter weer in-
teressant, al zijn er nog wel hindernissen die overwonnen moeten worden voordat
het kan worden geher-commercialiseerd. Het is onder andere essentieel om goed-
kopere biomassa te kunnen gebruiken als uitgangsmateriaal (zoals lignocellulose)
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in plaats van de traditionele substraten zetmeel en molasses, die relatief duur
zijn. Ook voorkomt deze vervanging het omstreden “voedsel-versus-brandstof”
(food-versus-fuel) dilemma. Een andere uitdaging is om de butanolproductie te
verbeteren, zowel de opbrengst per kilogram uitgangsmateriaal, als ook de uit-
eindelijke concentratie. In dit proefschrift ligt de nadruk op het verbeteren van
butanolproductie en het verminderen van de productie van de zuren acetaat en
butyraat door C. acetobutylicum.
Er is gekozen voor een aanpak waarbij de stofwisseling in de cel wordt ge-
herprogrammeerd (metabolic engineering; het door middel van genetische veran-
deringen aanpassen welke stoffen, in welke mate worden geproduceerd door een
cel) om zo het aantal en de hoeveelheid van de bijproducten in C. acetobutyli-
cum fermentaties te verminderen. Hiervoor werden de metabole productieroutes
van acetaat en butyraat aangepakt, omdat de hypothese was dat door zuurpro-
ductie te voorkomen ook acetonproductie zou worden gestopt, met als resultaat
een fermentatie door C. acetobutylicum waarbij alleen alcoholen gevormd zouden
worden als vloeibare eindproducten. Om het metabolic engineering werk te kun-
nen verrichten, hebben we eerst een essentieel hulpmiddel voor het maken van
gen-uitschakeling in C. acetobutylicum ontwikkeld.
We hebben tijdens deze studie ook de opslagcondities voor electro-competente
C. acetobutylicum cellen onderzocht, wat ons in staat stelde bulkhoeveelheden
hiervan te maken en voor ten minste 54 maanden op te slaan voor later gebruik
(hoofdstuk 2 deel 1). Het principe voor succesvolle opslag is het uitsluiten van
zuurstof en dit zou de methode ook geschikt kunnen maken voor andere obligaat
anaeroben.
Het tweede deel van hoofdstuk 2 beschrijft de aanpassing van het Targe-
Tron gen-uitschakelssysteem voor gebruik met C. acetobutylicum. Het TargeTron
systeem gebruikt een mobiel groep II intron dat kan worden aangepast zodat het
selectief op een andere locatie in het genoom integreert middels een proces dat
retrohoming genoemd wordt. Ons eerste doelwit was het ack gen dat codeert voor
het enzym acetaat kinase (AK) en betrokken is bij acetaatproductie. Met behulp
van PCR is succesvolle insertie in het gen aangetoond, maar pas na de ontwik-
keling van een kolonie-PCR protocol voor C. acetobutylicum zoals beschreven in
hoofdstuk 4, konden we ons systeem toepassen en snel de mutanten herkennen
temidden van de wildtypestam.
Een andere onderzoeksgroep had ook een clostridiale variant van het Tar-
geTron systeem ontwikkeld, genaamd ClosTron. Het voordeel van dat systeem
boven degene die wij ontwikkeld hadden is dat in gevallen waar het intron zich
in het genoom heeft ge¨ınserteerd het organisme erythromycineresistent is gewor-
den en de mutanten daarom makkelijk te onderscheiden zijn van de wildtype-
stam. In hoofdstuk 3 hebben we dit systeem gebruikt om een acetaat kinase
(ack–) mutant te isoleren. Deze mutant is gekarakteriseerd in pH-gecontroleerde
batch-fermentaties op twee verschillende media; CGM en Clostridial Medium 1
(CM1). Enzymactiviteitsmetingen lieten een reductie van 98 % zien in in vitro
acetaatkinase-activiteit, echter de gemuteerde stam bleef wildtype hoeveelheden
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acetaat produceren in CGM, een medium dat zelf geen acetaat bevat. In CM1 dat
wel acetaat bevat, was productie van acetaat meetbaar, maar sterk gereduceerd.
Deze resultaten suggereren dat er alternatieve manieren zijn voor C. acetobutyli-
cum om acetaat te produceren. De oplosmiddelproductie van de ack– stam was
niet significant anders in CM1. Wanneer het wildtype echter CGM fermenteerde,
werden grote hoeveelheden lactaat geproduceerd waardoor het geen geschikt pro-
ductiemedium is. Interessant genoeg deed de ack– stam het hierop veel beter.
Daarna hebben we een stam gemaakt met een ge¨ınactiveerd butyraat kinase
(buk1 ) gen genaamd BUK1KO, beschreven in hoofdstuk 4. Het fenotype van
deze stam was in essentie dat van een acetaat-butanol producent. Analyse van
het fermentatiegedrag liet zien dat de stam schijnbaar nooit wisselde van de aci-
dogene naar de solventogene staat, zoals het wildtype wel doet. Verder toonde
groei op CM1 in batch-cultures aan dat de fermentatie-pH van grote invloed
was op de gevormde producten. Er was een goede correlatie tussen toenemende
fermentatie-pH en hogere acetaatniveaus in het pH-bereik van 4.5 tot 5.5, hetgeen
suggereert dat het geproduceerde acetaat feitelijk de groei-inhiberende compo-
nent was. Daarnaast werden er bij de mutant nooit clostridiale cel-typen aange-
troffen, die betrokken zijn bij sporeformatie of de aanzet daartoe. Dit past binnen
het beeld van de afwezigheid van een wisseling naar de solventogene staat. Pa-
rallel met de toenemende fermentatie-pH trad ook een toenemende accumulatie
op van aceto¨ıne in het medium met een maximum van 49 mM bij pH 6.5, ter-
wijl het wildtype onder dezelfde condities slechts 12 mM vormt. Kweek in CM1
zonder toegevoegd acetaat bij een pH van 5.5 resulteerde in een toename van
21 % in butanolconcentraties tot 195 mM (14.5 g/L) in vergelijking tot wat het
wildtype onder optimale condities kan produceren, en een toename met 127 %
onder dezelfde condities. Verder werd er ook een reductie van acetonproductie
gerealiseerd van 60 % samen met licht gestegen ethanolniveaus.
De daaropvolgende inactivatie van het acetaatkinase-gen in de buk1 – stam
met ons eigen aangepaste TargeTron systeem (zie hoofdstuk 2) resulteerde in
de isolatie van een ack– buk1 – dubbelmutant. Ondanks de eliminatie van zowel
acetaatkinase- en butyraatkinase-enzymactiviteit in vitro bleef de mutant beide
zuren produceren. In CM1 waren acetaatniveaus sterk gereduceerd ten opzichte
van de buk1 – stam, maar wanneer acetaat uit het groeimedium werd weggelaten
werden weer grote hoeveelheden acetaat geproduceerd. Dit gedrag lijkt sterk op
dat van de ack– mutant en sterkt de hypothese dat er een onbekende alterna-
tieve zuurproducerende metabole route of enzymen bestaat in C. acetobutylicum.
Alcoholproductie was negatief be¨ınvloed in vergelijking tot de wildtype stam en
ook aceton productie was niet gestopt. Bij bepaalde fermentatie-pH’s was de
acetoineproductie zelfs nog sterker toegenomen ten opzichte van de buk1 – stam,
tot 100 mM, de hoogst gerapporteerde waarde voor dit organisme.
In hoofdstuk 5 wordt de eerste stap gezet om op een andere manier een
hogere butanolconcentratie in het medium te bewerkstelligen. 2-butanol is minder
toxisch voor de cellen, waardoor een 2-butanol producerende stam zeer interessant
zou zijn, mede omdat het net als 1-butanol redox-neutraal geproduceerd kan
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worden ten opzichte van glucose. Daarnaast heeft 2-butanol dezelfde voordelen
bij toepassing als biobrandstof als 1-butanol ten opzichte van ethanol. Door
over-expressie van een alcoholdehydrogenase (acetoinereductase) van Clostridium
beijerinckii in C. acetobutylicum kan natuurlijk geproduceerd d- and l-acetoine
worden gereduceerd tot d- and meso-2,3-butaandiol. Verder toonden we aan dat
onze C. acetobutylicum WUR stam al kleine hoeveelheden (ongeveer 3 mM) meso-
2,3-butaandiol produceert door middel van een onbekende metabole route, zeer
waarschijnlijk door reductie van d-acetoine. Voor de ATCC 824 stam kon geen
productie van meso-2,3-butanediol worden waargenomen. Voor de voltooiing
van de metabole route naar 2-butanol is naast een acetoinereductase verder nog
een dehydratase en een secundair-alcoholdehydrogenase nodig om respectievelijk
methyl-ethyl keton (MEK) en 2-butanol to maken.
In de algemene discussie (hoofdstuk 6) worden de resultaten die staan be-
schreven in de voorgaande hoofdstukken in perspectief geplaatst, en het bestaan
van een alternatieve zuurproducerende metabole route in C. acetobutylicum wordt
gesuggereerd. Verder worden voor- en nadelen van C. acetobutylicum als een bu-
tanolproductieplatform bediscussieerd, samen met ontwikkelingen op het gebied
van butanolproductie in niet-natuurlijke productieorganismen.
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Overview of Completed
Training Activities
Discipline specific activities
Courses
• Workshop Gene Transfer Techniques for Clostridia (Nottingham, UK, 2006)
• Advanced Course Microbial Physiology and Fermentation Technology
(Delft, the Netherlands 2009)
Meetings
• B-Basic symposia (The Netherlands, 2006, 2007, 2008, 2009)
Oral presentation (2009) and posters (2006, 2007, 2008)
• The Netherlands Biotechnology Congress – 11 (Ede, 2006)
• 3rd DRC-LST/BSDL Symposium (Delft, the Netherlands; 2007)
• Non-Pathogenic Bacteria — A conference (Toulouse, France, 2008)
• Workshops on the Genetics and Physiology of Acid- and Solvent-producing
Clostridia (Wageningen, the Netherlands, 2008; San Diego, USA, 2010;
Nottingham, UK, 2012)
Oral presentation (2008), posters (2010, 2012)
General courses
• VLAG PhD week (Ermelo, the Netherlands, 2006)
• Teaching and Supervising Thesis Students (Wageningen, the Netherlands,
2007)
• Scientific Writing (Wageningen, the Netherlands, 2008)
• Career Perspectives (Wageningen, the Netherlands, 2009)
• Presentation Skills (Wageningen, the Netherlands, 2009)
Optionals
• Preparation PhD research proposal (2006)
• Project meetings with the industrial partner (2006–2009)
• Bioconversion group meetings (every 2 weeks, 2006–2009)
• Recycling group meetings (every 2 weeks, 2006–2007
• Process Engineering PhD study tour to Denmark and Sweden (2006)
• Bacterial Genetics group meetings (every week, 2008–2009)
• Organising Process Engineering study tour to Japan (2008)
• Process Engineering PhD study tour to Japan (2008)
• Brainstorm day Process Engineering (2009)
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